Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,clathrin adaptor activity (GO:0035615),-0.7548263402602919,-2.071739896571743,0.0023923444976076554,0.040402454912178816,0.033,6/15,6.30%,DAB2;HIP1;AP2A2;AP2B1;HIP1R;LDLRAP1
prerank,lipoprotein particle binding (GO:0071813),-0.6258531125862188,-1.9299981781231224,0.0,0.1346748497072627,0.199,8/20,10.27%,MSR1;CD36;THBS1;HSPD1;PLTP;LDLR;LPL;STAB2
prerank,death domain binding (GO:0070513),-0.7277225531819661,-1.9196152000260176,0.0,0.10325071810890141,0.229,6/11,13.29%,BCL2;BCL2L1;MCL1;BAX;RIPK1;RACK1
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.6588216317509574,-1.8947788245304167,0.0,0.08147828407289393,0.288,5/16,4.03%,ATP6V0D1;ATP6V0D2;ATP6V1B2;ATP6V0A1;ATP6V0B
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.6588216317509574,-1.8947788245304167,0.0,0.08147828407289393,0.288,5/16,4.03%,ATP6V0D1;ATP6V0D2;ATP6V1B2;ATP6V0A1;ATP6V0B
prerank,low-density lipoprotein particle binding (GO:0030169),-0.6287369170991877,-1.864064784590232,0.0,0.09913565325673505,0.38,6/16,10.27%,MSR1;CD36;THBS1;PLTP;LDLR;STAB2
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.5724354972883678,-1.8485978798783196,0.002564102564102564,0.09940286526012247,0.434,6/24,5.49%,OSBPL8;GOLPH3L;SESTD1;PLA2G4E;OSBP;PLEKHA3
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.6960806743788825,1.829830260895046,0.001736111111111111,0.5868434808925083,0.424,5/14,3.80%,KCNJ3;KCNH2;KCNA5;KCNE2;KCNJ8
prerank,hyaluronic acid binding (GO:0005540),-0.7193602439934998,-1.8017743797694887,0.009411764705882352,0.14351288671930182,0.6,5/10,12.56%,LYVE1;CD44;IMPG2;STAB2;CHODL
prerank,high voltage-gated calcium channel activity (GO:0008331),0.7466128385497584,1.7550946458577585,0.0018115942028985507,0.6950195339367761,0.748,6/10,16.45%,CACNB4;CACNB2;CACNA1S;CACNA1D;CACNA1B;CACNA1A
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.39210712596989244,-1.7356223670997561,0.0,0.24253942840798698,0.832,21/100,8.32%,IQGAP1;IQGAP2;OSBPL8;DENND1A;HIP1;KIF16B;GOLPH3L;SNX24;SESTD1;DENND1B;PLA2G4E;OSBP;SH3PXD2B;GBF1;ZFYVE16;HIP1R;PLEKHA3;ARAP1;GAB2;CYTH3;RACGAP1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.47766484046570223,-1.7026156059231938,0.005747126436781609,0.2910099044091101,0.906,11/34,8.32%,IQGAP1;IQGAP2;KIF16B;PLA2G4E;GBF1;ZFYVE16;HIP1R;ARAP1;GAB2;CYTH3;RACGAP1
prerank,voltage-gated calcium channel activity (GO:0005245),0.5288075009102664,1.7021390228308984,0.0015455950540958269,0.8251712658541281,0.908,16/37,17.42%,CACNB4;CACNG5;CACNG2;CACNB2;CACNA1S;CACNA2D3;PKD2;CACNA1G;CACNG7;CACNA2D2;CACNA1D;CACNA1B;CACNA2D1;CACNA1A;OPRM1;CACNG3
prerank,nucleotide diphosphatase activity (GO:0004551),0.6636282745731199,1.7009766515699904,0.008880994671403197,0.6253782980713677,0.908,6/14,12.04%,NUDT12;FHIT;NUDT17;NUDT10;NUDT3;ENPP4
prerank,protein phosphatase regulator activity (GO:0019888),-0.4248108272336116,-1.6996216097181127,0.005865102639296188,0.27230846505203343,0.909,20/53,14.67%,PPP2R5C;PPP2R1B;PPP2R2A;ENSA;PPP2R5A;PPP4R1;PPP6R1;PTPA;PPP6R3;SHOC2;LMTK2;BOD1;CABIN1;PPP2R2C;PPP4R2;CALM3;CALM2;PTN;ARPP19;PPP1R2
prerank,sequence-specific mRNA binding (GO:1990825),-0.6786880978803771,-1.6925057762657059,0.011160714285714286,0.2636447231422039,0.923,6/10,20.76%,ETF1;SHFL;LARP6;SSB;TYMS;DHFR
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.6869060735972664,1.6734718196558496,0.011965811965811967,0.6663273447602278,0.959,4/11,3.80%,KCNJ3;KCNH2;KCNE2;KCNJ8
prerank,protein tyrosine kinase binding (GO:1990782),-0.40711877880882064,-1.6733899006175512,0.006734006734006734,0.2830761744808426,0.951,35/71,30.23%,NEDD9;CBLB;GAS6;ITGAX;CASS4;CRK;PTPN1;PCNA;NCK1;BLNK;BANK1;SOCS5;CEACAM1;CBL;RACK1;SHC1;ELMO2;SQSTM1;CD247;PITPNM3;ACVR1;NOX4;BMPR2;ANGPT1;RNF41;PHYHIP;PIK3R2;DUSP3;PTPN14;HSP90AA1;SHC4;DUSP22;ANGPT4;LRP4;CD4
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.6706766865153395,1.6595658848947363,0.0016556291390728477,0.632961454865601,0.966,5/12,9.87%,B3GNT9;B3GNT6;B4GAT1;B3GALT2;B3GALNT1
prerank,GABA receptor activity (GO:0016917),0.5704986873858506,1.6559696765818286,0.013289036544850499,0.562966485738654,0.968,9/21,15.20%,GABRQ;GABBR1;GABRG1;GABRD;GABRG2;GABRA2;GABBR2;GABRB1;GABRR2
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.6726288384166214,1.6544610936837698,0.013745704467353952,0.5004883484194018,0.97,2/11,7.95%,HCN1;CNGB1
prerank,chloride transmembrane transporter activity (GO:0015108),0.6146087874658239,1.6506828371359659,0.012411347517730497,0.46107656752964477,0.975,6/16,10.46%,SLC4A8;SLC1A1;SLC26A4;CLCN6;CFTR;SLC26A7
prerank,chemokine receptor activity (GO:0004950),0.5449101038915698,1.629000485735453,0.0189873417721519,0.5090310066855587,0.986,10/24,16.11%,ACKR4;ACKR3;CCR1;GPR17;CXCR6;CX3CR1;CXCR4;CCR6;CCR9;ACKR2
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.46833881207389694,-1.6278964026308889,0.02406417112299465,0.3649047118258689,0.982,11/34,14.80%,IQGAP1;STK3;ETAA1;FAM20A;CAB39L;SPRY2;CALM3;IGF2;CALM2;MTCP1;INCENP
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.6201709490652256,1.6169786766623822,0.02831858407079646,0.5154295590232532,0.989,5/15,11.20%,SLC4A8;SLC26A4;CFTR;SLC26A7;SLC39A8
prerank,double-stranded RNA binding (GO:0003725),-0.38851050582910485,-1.6153743745304006,0.006514657980456026,0.3726752368843753,0.986,26/70,17.24%,RFTN1;DDX60;OAS2;MBNL1;IFIH1;ACTN1;ZBP1;EIF4B;DHX33;TLR7;OASL;MSN;ZNF346;HSPD1;TFRC;ILF2;TLR8;VIM;RC3H1;OAS3;LRRFIP1;AGO2;PRKRIP1;RC3H2;DUS2;SLC3A2
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.6358488733545367,1.6142306321143802,0.029250457038391225,0.483929210113627,0.989,6/13,9.91%,GLRA3;GABRG1;GABRG2;GLRB;GABRA2;GLRA2
prerank,GTPase inhibitor activity (GO:0005095),-0.582447483934072,-1.6003865729830535,0.03131991051454139,0.38782148126638305,0.991,2/13,0.11%,IQGAP1;IQGAP2
prerank,C-C chemokine binding (GO:0019957),0.551604828807961,1.586068231316392,0.0192,0.5656296890442761,0.995,9/22,16.11%,ACKR4;ACKR3;CCR1;CXCR6;CX3CR1;CXCR4;CCR6;CCR9;ACKR2
prerank,voltage-gated cation channel activity (GO:0022843),0.4087643908147772,1.5800797853589148,0.004081632653061225,0.5517575630136503,0.996,25/97,17.42%,HCN1;KCNMA1;CACNB4;CACNG5;CACNG2;KCNH2;KCND2;KCNA5;CACNB2;CACNA1S;KCNH7;KCNC1;CACNA2D3;PKD2;GRIN1;GRIN2B;CACNG7;CACNA2D2;CACNA1D;CACNA1B;CACNA2D1;KCNC3;CACNA1A;OPRM1;CACNG3
prerank,O-acyltransferase activity (GO:0008374),0.5028186664251175,1.5749442115903907,0.0234375,0.5350304014086444,0.997,7/30,11.46%,PRDX6;DGAT2;AWAT2;PLA2G4C;SOAT2;LPCAT1;LPCAT2
prerank,copper ion binding (GO:0005507),0.4721487795864662,1.5689194069720098,0.007598784194528876,0.5268939836850359,0.997,16/42,19.55%,LACC1;ANG;COA6;GPC1;PRNP;COMMD1;S100A13;AOC2;MOXD1;DCT;ACR;AOC1;ATOX1;IL1A;SNCB;COX17
prerank,C-C chemokine receptor activity (GO:0016493),0.5495697143172849,1.5662241547860778,0.02750809061488673,0.5070428176773226,0.997,9/21,16.11%,ACKR4;ACKR3;CCR1;CXCR6;CX3CR1;CXCR4;CCR6;CCR9;ACKR2
prerank,inward rectifier potassium channel activity (GO:0005242),0.5147250564674537,1.5518473246798523,0.01948051948051948,0.5356184829559524,0.999,9/24,16.59%,KCNJ3;KCNH2;KCNE2;KCNJ8;KCNJ13;KCNK6;ABCC8;KCNJ5;KCNN3
prerank,fatty acid synthase activity (GO:0004312),0.6616809735960681,1.5494424850419002,0.04847396768402154,0.5175443423260878,1.0,5/10,20.82%,CBR4;OXSM;ELOVL6;ELOVL4;ELOVL5
prerank,phosphatase inhibitor activity (GO:0019212),-0.5074792809332794,-1.5428627302388125,0.043689320388349516,0.5354645617527489,0.998,8/20,14.67%,ENSA;LMTK2;BOD1;CABIN1;PTN;TESC;ARPP19;PPP1R2
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.4724175181329604,-1.5394364329285535,0.031413612565445025,0.5170017841539918,0.998,9/26,15.13%,ENSA;LMTK2;BOD1;CABIN1;PTN;PPP1R1A;ARPP19;PPP1R2;PPP1R14C
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.4315767389142681,1.5390546512214873,0.0206794682422452,0.534705408974606,1.0,20/55,18.85%,ATP2A3;TRPC3;ATP2A2;ITPR2;SLC24A5;CACNB2;PKD1L1;TRPM2;PKD2;GRIN1;ATP2C1;CACNA1D;PANX1;PKD1;ATP2B3;SLC24A3;CHRNA7;SLC24A4;TRPV6;PKD2L2
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.4819515901210996,-1.5315866596477028,0.03076923076923077,0.5170214734595047,0.998,7/23,5.22%,HIP1;KIF16B;SESTD1;PLA2G4E;SH3PXD2B;GBF1;HIP1R
prerank,myosin V binding (GO:0031489),0.576459639713325,1.5265489693743828,0.03442340791738382,0.5608883028271149,1.0,4/15,10.85%,RAB6B;RAB3A;RAB8A;RAB3D
prerank,fibroblast growth factor receptor binding (GO:0005104),0.5406739944399225,1.5256504660288155,0.03745928338762215,0.5384322702636456,1.0,6/21,10.90%,FGF10;FGF16;FGF9;KLB;FGF7;FGF2
prerank,phosphotyrosine residue binding (GO:0001784),-0.42237597173335806,-1.5241203155004082,0.012012012012012012,0.5145140404024549,0.998,12/37,11.50%,SH3BP2;STAP1;ABL2;CRK;RASA1;CRKL;LDLRAP1;SYK;BCAR3;HCK;LCK;GRB2
prerank,transmitter-gated ion channel activity (GO:0022824),0.4903999739391864,1.523020338191959,0.02631578947368421,0.5251554760215842,1.0,10/29,9.91%,GLRA3;GABRG1;GRIA2;GABRG2;GRIK5;GRIK2;GRID2;GABRA2;GRIA4;GLRA2
prerank,GABA-A receptor activity (GO:0004890),0.5458565791806641,1.5175069147614564,0.03236797274275979,0.5247854018213333,1.0,7/18,15.20%,GABRQ;GABRG1;GABRD;GABRG2;GABRA2;GABRB1;GABRR2
prerank,voltage-gated potassium channel activity (GO:0005249),0.4028296661759934,1.5163405334629816,0.017094017094017096,0.5080281728890969,1.0,20/80,18.64%,HCN1;KCNMA1;KCNJ3;KCNH2;KCND2;KCNA5;KCNE2;KCNJ8;KCNH7;KCNC1;KCNJ13;PKD2;KCNK6;KCNJ5;KCNC3;KCNN3;KCNT1;KCNT2;KCNQ4;KCNK2
prerank,calcium channel activity (GO:0005262),0.3963716618370808,1.509594576437274,0.011065006915629323,0.5134166188723649,1.0,28/84,18.85%,CACNB4;CACNG5;CACNG2;TRPC3;SLC24A5;CACNB2;CACNA1S;PKD1L1;CACNA2D3;TRPM2;PKD2;GRIN1;CACNG7;CACNA2D2;CACNA1D;TRPC6;PANX1;PKD1;CACNA1B;CACNA2D1;CACNA1A;SLC24A3;OPRM1;CACNG3;CHRNA7;SLC24A4;TRPV6;PKD2L2
prerank,ligand-gated anion channel activity (GO:0099095),0.5578595044856824,1.5090282055525057,0.03502626970227671,0.49643024183563983,1.0,8/17,14.92%,GLRA3;GABRG1;GABRG2;GLRB;GABRA2;GLRA2;CFTR;GABRB1
prerank,adenylate cyclase binding (GO:0008179),-0.6035711341216751,-1.4996233319626155,0.046511627906976744,0.5726353232592539,1.0,5/10,17.10%,AKAP12;ADCY5;CALM3;CALM2;AKAP5
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.5671800056199742,1.499516531803594,0.051666666666666666,0.5137201832338295,1.0,4/15,12.24%,HS3ST6;HS3ST5;HS6ST3;HS6ST1
prerank,protein kinase activator activity (GO:0030295),-0.3789742008303163,-1.4848761903233885,0.012048192771084338,0.6015986752264202,1.0,24/60,22.37%,IQGAP1;STK3;GAS6;MARK2;ETAA1;FAM20A;CD24;PRKAG2;CAB39L;GPRC5B;SPRY2;AGAP2;CALM3;IGF2;CALM2;MTCP1;INCENP;TPX2;AFAP1L2;RGCC;LTF;EPO;DUSP19;PARP16
prerank,glycerophospholipid flippase activity (GO:0140333),0.5980928159566088,1.4813630061217256,0.060658578856152515,0.564142038948336,1.0,9/11,29.17%,ATP8A2;ABCB4;ATP11A;ATP8B1;ATP8A1;ATP8B2;ATP10B;ABCA3;ABCA4
prerank,protein phosphatase activator activity (GO:0072542),-0.5529047939071965,-1.4799053125903923,0.04702970297029703,0.5926669291827583,1.0,6/13,17.71%,PPP2R5C;PPP2R5A;PTPA;CALM3;CALM2;PPP1R15A
prerank,cation channel activity (GO:0005261),0.38016316145113266,1.4767053354023598,0.015256588072122053,0.5633202190001926,1.0,27/94,18.85%,HCN1;TMEM63C;TRPC3;SLC24A5;CACNB2;PKD1L1;TRPM3;TRPM2;KCNK3;TMEM63A;PKD2;GRIN1;TMEM63B;CACNA1D;TRPC6;PANX1;UNC80;PKD1;ABCC8;SLC24A3;ASIC3;KCNK9;CHRNA7;KCNQ4;SLC24A4;TRPV6;PKD2L2
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.5648995895725312,-1.473983589965958,0.0730593607305936,0.5894362779722384,1.0,6/12,24.33%,STAT1;TNF;TRAF1;TRAF4;TRIM37;BABAM2
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.5273031123730326,1.4682233132562637,0.053833605220228384,0.5767492458444899,1.0,7/18,19.54%,TGFBR1;TGFBR3;ACVR1B;AMHR2;ENG;LTBP4;BMPR1B
prerank,outward rectifier potassium channel activity (GO:0015271),0.6042243103495429,1.4667673612409902,0.06653992395437262,0.5648484572316835,1.0,6/11,18.64%,KCND2;KCNA5;PKD2;KCNT1;KCNT2;KCNK2
prerank,sodium channel activity (GO:0005272),0.4457733343091359,1.466232338195014,0.03464566929133858,0.5503767973848035,1.0,18/37,28.56%,HCN1;SCNN1A;GRIK5;GRIK2;PKD2;CACNA1G;ASIC1;ASIC2;SCN2A;ASIC3;SCN1B;GRIK3;SCN8A;GRIK4;SCN7A;KCNK1;CACNA1H;SCN1A
prerank,ligand-gated cation channel activity (GO:0099094),0.3900496203459695,1.4588282171134102,0.0196078431372549,0.5597516746264357,1.0,17/75,10.80%,KCNJ3;KCNH2;SCNN1A;KCNE2;KCNJ8;GRIA2;TRPM2;GRIA1;GRIK5;GRIK2;KCNJ13;GRIA4;GRIN1;GRIN2B;ASIC1;ASIC2;KCNK6
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.41032648944991096,-1.4532081799915721,0.04189944134078212,0.6391219450940998,1.0,15/35,20.07%,PEAK1;ABL2;CSK;TEC;DYRK1A;SYK;LYN;FYN;HCK;LCK;FRK;PTK2B;ZAP70;PKDCC;MELK
prerank,phospholipase C activity (GO:0004629),0.48134100828239323,1.4531117501880269,0.05357142857142857,0.5643195154640391,1.0,5/25,7.58%,PLCH1;PLCL1;PLCD1;PLCG1;CCR1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.541317380255789,1.4494519889185322,0.07357859531772576,0.5632944259498721,1.0,7/15,16.11%,ACKR4;CCR1;GPR17;CX3CR1;CCR6;CCR9;ACKR2
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.5242116062058196,-1.4476644619638122,0.07211538461538461,0.6330581236559983,1.0,7/14,26.20%,CYBB;KMO;CYBA;MICAL1;CYB5R4;NOX4;AIFM1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.4329029108830711,-1.442708945458301,0.05660377358490566,0.627609739422827,1.0,13/28,25.47%,RIPK1;PIDD1;STAT1;EDA;SIVA1;TNF;TRAF1;TRAF4;TRIM37;MYD88;BABAM2;FADD;TMBIM1
prerank,poly(A) binding (GO:0008143),0.5056711699204913,1.4424240344338024,0.05087440381558029,0.5742955104663087,1.0,12/21,30.39%,PABPC1L;PABPC4L;ZC3H14;DDX1;KHDRBS2;RBMS3;TIA1;HNRNPDL;DDX3X;ELAVL4;PABPC4;RBMS2
prerank,cadherin binding (GO:0045296),-0.2810029239057701,-1.4412910471597775,0.0,0.6100049219329854,1.0,83/315,16.55%,IQGAP1;EHD4;AHNAK;SLK;CDH12;EIF2A;CHMP4B;STK38;PDLIM1;FXYD5;RPS26;TRIM25;MARK2;PDLIM5;OLA1;P2RX4;AFDN;STX5;RAB1A;DHX29;ATIC;PTPN1;ENO1;SNX1;SH3GLB1;IDH1;CTNNA1;STK24;NCK1;CLINT1;CRKL;ARHGAP18;TBC1D2;PICALM;DIAPH3;ASAP1;PLEC;RPL6;SNX9;GAPVD1;EPS15;ANXA1;PAICS;HNRNPK;GLOD4;RPL15;DDX6;PSEN1;USP8;EEF1D;LDHA;FMNL2;ARVCF;CEMIP2;RAB10;STAT1;MAPRE1;RPL14;TMPO;CTNNB1;TES;SHTN1;RPL23A;CBL;TBC1D10A;KDR;VASP;LRRFIP1;PACSIN2;LARP1;RACK1;TAGLN2;YKT6;STXBP6;EGFR;CDH2;CDH24;EPHA2;MYH9;VCL;USO1;PI4KA;CAPZB
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.39709440375388805,-1.4409315009397397,0.04878048780487805,0.5901699592056772,1.0,12/35,14.67%,NR3C1;POU2F1;SMARCA4;TAF1;H3-3A;STAT1;HDAC1;AGO2;FOXP1;FOS;NPM1;UBTF
prerank,poly-purine tract binding (GO:0070717),0.46832039723897667,1.4391610353822,0.0598159509202454,0.5714246669166932,1.0,13/27,28.03%,PABPC1L;PATL1;PABPC4L;ZC3H14;DDX1;KHDRBS2;RBMS3;TIA1;HNRNPDL;DDX3X;MCRS1;ELAVL4;PABPC4
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.4755586775542461,-1.424254748762843,0.07616707616707617,0.6282955835648547,1.0,6/18,19.55%,PDLIM1;PDLIM5;ANXA1;RAB10;STXBP6;TRIM29
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.5494509748531106,1.4192349125700447,0.08318264014466546,0.6323900395969618,1.0,4/14,8.54%,ATP2A3;EBAG9;BCL2L13;NOD1
prerank,glycine binding (GO:0016594),0.5882101758099214,1.4187658197239996,0.07815275310834814,0.6181356095413651,1.0,5/11,9.91%,GLRA3;GLRB;GRIN1;GRIN2B;GLRA2
prerank,amino acid:sodium symporter activity (GO:0005283),0.5767241650283779,1.4185062110959976,0.08896797153024912,0.6038517957331332,1.0,4/11,14.30%,SLC38A2;SLC1A1;SLC1A3;SLC6A1
prerank,steroid hydroxylase activity (GO:0008395),0.5255327606653033,1.4089331394320372,0.059800664451827246,0.6261741979098295,1.0,4/16,15.72%,CYP2S1;CYP2U1;CYP39A1;CYP27A1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.38847782806495235,-1.4082215894803112,0.040498442367601244,0.6666043031343625,1.0,6/38,4.15%,DENND1A;HIP1;KIF16B;SESTD1;PLA2G4E;SH3PXD2B
prerank,chloride channel activity (GO:0005254),0.3914675362686281,1.4074709179421196,0.05341246290801187,0.6172696828566511,1.0,17/59,16.91%,GABRQ;GLRA3;GABRG1;GABRD;GABRG2;GLRB;GABRA2;ANO2;CLCN6;GLRA2;CFTR;SLC26A7;SLC1A4;CLCC1;GABRB1;GABRR2;ANO3
prerank,SUMO transferase activity (GO:0019789),-0.49636866779102945,-1.4053756910250261,0.10050251256281408,0.6560839618421259,1.0,9/16,28.13%,NSMCE2;RANBP2;EGR2;PIAS2;MUL1;HDAC4;PIAS4;PIAS3;MDM2
prerank,MAP-kinase scaffold activity (GO:0005078),-0.5522564163749296,-1.404934368389801,0.11818181818181818,0.6376650080836301,1.0,5/11,25.40%,IQGAP1;SH3RF1;MAPK8IP3;DUSP19;KSR1
prerank,potassium channel activity (GO:0005267),0.36610382954330245,1.4045580914752582,0.027855153203342618,0.6142568037377101,1.0,22/89,18.64%,HCN1;KCNMA1;KCNK12;KCNH2;KCND2;KCNA5;KCNH7;KCNC1;KCNK3;GRIK5;GRIK2;PKD2;KCNK6;KCNN4;ABCC8;KCNC3;KCNMB3;KCNT1;KCNT2;KCNK9;KCNQ4;KCNK2
prerank,phosphatase activator activity (GO:0019211),-0.5046412870896345,-1.4041617337806673,0.07635467980295567,0.6217818980234577,1.0,7/14,17.71%,PPP2R5C;PPP2R5A;FRS2;CALM3;CALM2;BMP2;PPP1R15A
prerank,active ion transmembrane transporter activity (GO:0022853),0.4294278604799812,1.40351939890285,0.0703125,0.6048160783558478,1.0,12/37,24.51%,SLCO2B1;UQCRC1;SLC22A8;NDUFA4;UQCR11;SLC22A4;COX4I1;COX6B1;UQCR10;SLCO4A1;COX10;SLC16A7
prerank,kinase inhibitor activity (GO:0019210),-0.4018821087847547,-1.4025631100558704,0.06775067750677506,0.6094357603657703,1.0,15/33,23.16%,GMFG;NCK1;SMCR8;TAOK3;QARS1;NPM1;PRKRIP1;SPRY4;DUS2;LRP6;SOCS1;WARS1;GSKIP;DUSP19;ITPRIP
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.5695068057740332,1.401382021336878,0.09401709401709402,0.5996816913303054,1.0,3/11,5.99%,RDH14;AKR1C1;AKR1B1
prerank,growth factor activity (GO:0008083),0.37649951409041044,1.4012990436657395,0.05052005943536404,0.5872583648508555,1.0,16/74,17.04%,FGF10;FGF16;FGF9;FGF7;IL6;AREG;IL2;CLCF1;NRG3;FGF2;PDGFB;INHA;THPO;IL7;AGT;ANGPTL3
prerank,vinculin binding (GO:0017166),-0.5325387818244924,-1.4002579388989327,0.08647450110864745,0.6004565463452747,1.0,6/11,10.35%,PXN;ACTN1;CTNNA1;UTRN;DAG1;SORBS3
prerank,beta-tubulin binding (GO:0048487),0.4459177399513056,1.3974468170250824,0.05718954248366013,0.5889907523316917,1.0,13/31,22.53%,DLEC1;PDCD5;MAP1S;EMD;LRPPRC;PEX14;FGF13;UXT;TAOK1;EML4;TTLL7;GABARAP;SPAST
prerank,voltage-gated ion channel activity (GO:0005244),0.5376914629911838,1.3945472027068397,0.07979626485568761,0.5871466808309699,1.0,4/14,8.85%,HCN1;KCND2;VDAC1;PKD2
prerank,chemoattractant activity (GO:0042056),0.4600371105092468,1.3938996719471806,0.07742998352553541,0.5778179767243514,1.0,8/26,19.40%,FGF10;FGF7;BMP4;FGF2;PDGFB;HMGB1;CCL15;CCL5
prerank,syntaxin-1 binding (GO:0017075),0.4834511531766943,1.3932351645313925,0.07288135593220339,0.5688368972922759,1.0,9/22,19.06%,SNAP25;SYT1;SYNPR;UNC13B;CPLX2;VAMP3;STXBP2;STXBP5;UNC13C
prerank,calcium activated cation channel activity (GO:0005227),0.5098249922006822,1.3896887875735644,0.09747899159663866,0.5707367130077394,1.0,6/17,16.27%,KCNMA1;TMEM63C;TMEM63A;TMEM63B;KCNN4;KCNMB3
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.5728983854918849,1.3885382646488673,0.0986159169550173,0.5640151713748662,1.0,5/11,11.94%,TRPC3;CYTH2;ITPR2;TRPC6;ITPR3
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.4907882601781589,-1.3840359689609731,0.11529933481152993,0.6375216196277584,1.0,9/15,23.43%,SETD3;PRDM9;WDR82;KMT2C;KMT2D;RBBP5;KMT2B;SETD1A;KMT2A
prerank,protein kinase inhibitor activity (GO:0004860),-0.38043316109384095,-1.3835646106202206,0.052941176470588235,0.6221328309393616,1.0,23/42,29.27%,GMFG;NCK1;CIT;CIB1;SMCR8;TAOK3;SPRY2;RACK1;QARS1;NPM1;PRKRIP1;SPRY4;DUS2;INKA1;INKA2;SOCS1;GSKIP;DUSP19;ITPRIP;CAMK2N2;SPRED1;DNAJC3;PARVA
prerank,titin binding (GO:0031432),0.5356125636576072,1.3803545769396295,0.12048192771084337,0.582080364266652,1.0,4/13,9.08%,CAPN3;TRIM63;MYBPC3;ACTN2
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.3772185467294674,-1.3803344496871388,0.0755287009063444,0.6159935540242876,1.0,12/38,15.60%,STAP1;DLG5;FRS2;NCK1;LDLRAP1;GAB2;BLNK;SORBS1;MAPK8IP3;LRRK2;SHC1;NUP62
prerank,receptor tyrosine kinase binding (GO:0030971),-0.347342685828657,-1.3788655860368255,0.05246913580246913,0.6058965373809037,1.0,26/56,29.91%,CBLB;GAS6;STAP1;ITGAX;FRS2;PTPN1;PCNA;NCK1;GAB2;BLNK;SOCS5;CBL;RACK1;SHC1;ELMO2;SQSTM1;PITPNM3;ANGPT1;RNF41;PIK3R2;DUSP3;PTPN14;SHC4;TRAT1;ANGPT4;LRP4
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.36365680546374624,-1.3704242646330949,0.037900874635568516,0.6174239654465483,1.0,13/42,11.50%,SH3BP2;STAP1;ABL2;CRK;FBXW7;RASA1;CRKL;LDLRAP1;SYK;BCAR3;HCK;LCK;GRB2
prerank,mechanosensitive ion channel activity (GO:0008381),0.557171305587857,1.3703567676452035,0.10350877192982456,0.6075585830517461,1.0,4/12,10.34%,TMC3;TMC8;TMEM63A;TMEM63B
prerank,ligand-gated ion channel activity (GO:0015276),0.43795378497682474,1.3651816312260177,0.075,0.6154295500905951,1.0,9/30,9.74%,GRIA2;GRIA1;GRIK5;GRIK2;GRID2;CNGB1;GRIA4;GRIN1;GRIN2B
prerank,CXCR chemokine receptor binding (GO:0045236),-0.5158976624355012,-1.3634497013120415,0.14446952595936793,0.6251959243255606,1.0,2/11,5.66%,ITCH;PF4
prerank,ligand-gated channel activity (GO:0022834),0.4379598787894068,1.3630784470251223,0.07981220657276995,0.6124356169263226,1.0,9/29,9.74%,GRIA2;GRIA1;GRIK5;GRIK2;GRID2;CNGB1;GRIA4;GRIN1;GRIN2B
prerank,anion channel activity (GO:0005253),0.37684742002510413,1.3606944846229452,0.06095791001451379,0.6101052546195056,1.0,17/61,16.91%,GABRQ;GLRA3;GABRG1;GABRD;GABRG2;VDAC1;GLRB;GABRA2;ANO2;GLRA2;CFTR;SLC26A7;SLC1A4;CLCC1;GABRB1;GABRR2;ANO3
prerank,semaphorin receptor activity (GO:0017154),-0.5419720711579749,-1.3589842067790379,0.11832946635730858,0.6255855567118954,1.0,3/11,0.73%,PLXNC1;NRP1;NRP2
prerank,phospholipase A2 activity (GO:0004623),0.4428782168680419,1.3501045793256918,0.08267090620031796,0.6372055045691879,1.0,5/26,6.63%,PRDX6;PLAAT5;PLA2G3;PLA2G4C;PNPLA3
prerank,sterol transfer activity (GO:0120015),-0.459040790520175,-1.344914472941301,0.1201923076923077,0.6607229747759342,1.0,7/17,16.30%,NPC2;OSBP;PLTP;OSBPL2;ABCG1;GRAMD1C;GRAMD1B
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.5013215808529026,1.3447454812949118,0.1260647359454855,0.6358587332393094,1.0,4/16,4.55%,PTPRD;PTPRT;PTPRO;PTPRU
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.5013215808529026,1.3447454812949118,0.1260647359454855,0.6358587332393094,1.0,4/16,4.55%,PTPRD;PTPRT;PTPRO;PTPRU
prerank,protein kinase binding (GO:0019901),-0.24977248533872662,-1.341638889543924,0.0,0.6567643504057511,1.0,163/479,25.62%,IQGAP1;NEDD9;SASH1;MAP3K1;NR3C1;DUSP16;STAP1;BCL2L1;AP2A2;CASS4;CSK;STK38;CRK;PTPN23;NBR1;TPCN2;PTPRC;PDLIM5;CDK5RAP2;TRIM14;PJA2;ATG13;PRKAB1;LYST;RARA;EEF1A1;KIF11;PRKACA;PTPN1;TOP2A;IFNAR2;MAPKAPK2;BORA;ESR1;TUBA4A;PRC1;ADAM9;LIMS1;PPP1R12A;CEP250;UTRN;MSN;RPS7;NOD2;ERCC6L2;TFRC;SMAD3;CCND1;PDCD10;CAV1;KIF13B;CD24;TEX14;CIT;RNF13;PRKAG2;BLNK;YWHAG;HIF1A;HSF1;CD226;RACGAP1;CDKN2C;BANK1;SIKE1;SMCR8;MAD2L2;ADCY6;GPRC5B;MAPRE1;MAP3K11;SPRY2;GHR;AGAP2;LCK;MAPKAPK3;PGAM1;CALM3;CCNA2;CSPG4;GRB2;SKAP1;CEACAM1;FAM83H;PRKCSH;CAVIN3;MAPK8IP3;CEP68;CCND2;EMP2;CALM2;RACK1;TRIM5;PTN;IRAK4;MTCP1;SIK1;DUSP1;QARS1;NPM1;PRKRIP1;SHC1;PRKAB2;HSPB1;CDC25A;RELB;MAPK7;PARD6A;KIF20A;PEBP1;BCAR1;SLC12A7;MAP2K7;SQSTM1;PPP1R15A;DCTN2;CD247;TPX2;KCNQ1;PLK1;CDKN2A;INKA1;INKA2;RGCC;GDF3;PRAM1;SOCS1;WARS1;ACVR1;TRIM21;GSKIP;CDC25C;LAX1;TNIP1;MAP3K2;DUSP19;CASP9;NBEAL1;TOP2B;CD3E;CCNB1;DCX;KAT2B;PAX6;GSTP1;RND1;MAP2K3;NOX4;DSP;DACT3;BMPR2;APPL1;RPS6;JTB;RAC1;DUSP7;RYR2;ILK;AP2A1;PHYHIP;DUSP3;CAMK2N2;ATF2
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.47402324191898415,-1.3412615502304994,0.10880829015544041,0.6435847573238919,1.0,8/15,28.10%,SESTD1;PLA2G4E;SH3PXD2B;LANCL2;PLEKHF1;VEPH1;SAP30L;SNX3
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.5038180254068457,-1.3404538255013079,0.13466334164588528,0.6321360454433272,1.0,6/12,13.99%,POU2F1;TAF1;H3-3A;STAT1;HDAC1;FOS
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.4812181484055917,1.3376522156020862,0.12086092715231789,0.651677224991724,1.0,6/19,8.06%,GABRG1;GABRG2;GRIK5;GRIK2;GRID2;GABRA2
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.5326366712480206,1.3359332944716613,0.12343470483005367,0.6476266463335547,1.0,3/12,8.54%,ATP2A3;BCL2L13;NOD1
prerank,kinase binding (GO:0019900),-0.2532553788919794,-1.3322564722846715,0.0,0.6458781333877474,1.0,126/434,20.97%,IQGAP1;SASH1;SP100;MAP3K1;NR3C1;PTPN22;STAP1;BCL2L1;AP2A2;CRK;PTPN23;TPCN2;PTPRC;CDK5RAP2;PPP2R5A;TRIM14;CNOT9;ATG13;PRKAB1;LYST;EEF1A1;KIF11;PRKACA;PTPN1;IFNAR2;BORA;ESR1;TUBA4A;PRC1;LIMS1;PPP1R12A;CEP250;UTRN;MSN;RPS7;FAS;NOD2;ERCC6L2;TFRC;SMAD3;BCAR3;CCND1;PDCD10;CAV1;KIF13B;CD24;UBQLN1;TEX14;CIT;PRKAG2;BLNK;HIF1A;HSF1;CD226;RACGAP1;EIF4ENIF1;CDKN2C;SIKE1;SMCR8;WDCP;ADCY6;GPRC5B;MAPRE1;SPRY2;GHR;AGAP2;LCK;ATF5;CTNNB1;BARD1;PGAM1;CALM3;CCNA2;CSPG4;GRB2;SKAP1;CEACAM1;FAM83H;CEP68;CCND2;EMP2;CALM2;TRIM5;PTN;IRAK4;RB1;MTCP1;SIK1;QARS1;NPM1;PRKRIP1;EGFR;SHC1;PRKAB2;TNS2;HSPB1;CDC25A;CHP1;RELB;KIF20A;PEBP1;BCAR1;SLC12A7;PFKL;MAP2K7;GSN;SQSTM1;PPP1R15A;DCTN2;LAPTM4B;TPX2;FLNA;PLK1;CDKN2A;INKA1;INKA2;RGCC;GDF3;PRAM1;SOCS1;WARS1;CASP1;TRIM21;GSKIP;CDC25C;LAX1
prerank,chemokine receptor binding (GO:0042379),-0.37526469459765166,-1.3309089284565416,0.08629441624365482,0.6370715892189647,1.0,6/35,15.52%,ITCH;CXCL16;CCL25;PF4;CCRL2;CCL28
prerank,ionotropic glutamate receptor activity (GO:0004970),0.48153496334116064,1.3281750909480927,0.12006578947368421,0.665987843735384,1.0,7/17,9.74%,GRIA2;GRIA1;GRIK5;GRIK2;GRIA4;GRIN1;GRIN2B
prerank,actin monomer binding (GO:0003785),-0.41642717854265154,-1.3274273081217085,0.12162162162162163,0.6351041454111664,1.0,9/22,21.32%,MTSS1;ABL2;PRKCE;ABITRAM;COBL;PFN2;LIMA1;MYL4;TMSB4X
prerank,glutamate receptor activity (GO:0008066),0.4702600058898049,1.3245239485536346,0.12136752136752137,0.6695415556463237,1.0,7/19,9.15%,GRIA2;GRM3;GRIA1;GRIK5;GRIK2;GRID2;GRIA4
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.47657849082944087,1.3234299431438257,0.1152542372881356,0.6533248756082026,1.0,6/17,14.23%,EFNA4;EFNB3;EPHA1;EFNA3;EPHA4;EPHB2
prerank,ephrin receptor activity (GO:0005003),0.47657849082944087,1.3234299431438257,0.1152542372881356,0.6533248756082026,1.0,6/17,14.23%,EFNA4;EFNB3;EPHA1;EFNA3;EPHA4;EPHB2
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.535012279503465,1.320519647731896,0.14545454545454545,0.6538765841990357,1.0,5/12,19.54%,TGFBR1;TGFBR3;ENG;LTBP4;BMPR1B
prerank,protein phosphatase binding (GO:0019903),-0.2941579436377038,-1.3198994019303123,0.025210084033613446,0.6456250679021863,1.0,36/117,19.10%,IQGAP1;PXN;KIF3A;VCP;ENSA;MET;TBK1;PPP6R1;AP3B1;PTPA;PPP6R3;SHOC2;BOD1;MTMR4;AKAP11;CDC27;LCK;FOXO1;CTNNB1;SKAP1;PPP1R3C;CEACAM1;PPP1R3F;PPP1R3E;RACK1;ARPP19;EGFR;LILRB1;ITGA1;MTMR3;RPA2;MAP2K7;AKAP5;PPP1R15A;KCNQ1;CD33
prerank,P-type ion transporter activity (GO:0015662),0.5356056323697751,1.3164097030506443,0.14782608695652175,0.6592838234361785,1.0,4/12,12.83%,ATP2A3;ATP2A2;ATP2C1;ATP2B3
prerank,semaphorin receptor binding (GO:0030215),0.44730008059233517,1.3140165882311858,0.14497528830313014,0.6590050662463792,1.0,10/23,19.11%,SH3BP1;SEMA7A;SEMA6C;SEMA6B;RIT2;SEMA3D;SEMA4F;SEMA4B;SEMA3C;PLXNB1
prerank,water transmembrane transporter activity (GO:0005372),-0.5137452233454955,-1.3136260340041404,0.14410480349344978,0.6537341662873377,1.0,5/11,36.37%,AQP11;PDPN;AQP1;SLC5A1;SLC4A11
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.3879304708932566,1.3074482766554332,0.10944527736131934,0.6728324247075431,1.0,18/46,23.43%,HEXB;B3GNT9;B3GNT6;B4GAT1;B3GALT2;PIGQ;PIGP;OGT;B3GALNT1;MGAT5B;MGAT4B;POMGNT1;GCNT7;GCNT4;GCNT1;LARGE1;EXT2;RFNG
prerank,ionotropic glutamate receptor binding (GO:0035255),0.5555400644965505,1.3065069354058432,0.14774774774774774,0.6671501430654524,1.0,4/10,18.02%,IGSF11;SHANK3;GNAS;SHANK1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.2809459269820733,-1.3047137137692324,0.03278688524590164,0.6688215610069014,1.0,28/147,9.38%,VAV3;FGD4;DENND1A;ITSN1;FGD6;RIC1;DENND4C;RCC1L;DENND1B;DOCK2;RIC8A;LAMTOR5;CCDC88C;ARHGEF18;ARHGEF6;RASGRP4;GAPVD1;HPS1;DENND6B;CYTH3;FGD1;SMCR8;EIF2B2;RASGRP2;EEF1D;DENND2A;RABGEF1;ABR
prerank,mRNA 5'-UTR binding (GO:0048027),-0.39850591274846503,-1.3025282235249436,0.15064935064935064,0.6642920094434009,1.0,8/24,14.85%,RPL5;RPS14;RPS13;RPS7;LARP6;LARP1;SYNCRIP;RPL41
prerank,poly-pyrimidine tract binding (GO:0008187),0.4397471922656342,1.3002688172760397,0.12419354838709677,0.6809322885082939,1.0,5/23,6.10%,PABPC1L;PATL1;PABPC4L;HNRNPH1;PTBP1
prerank,chemokine binding (GO:0019956),0.41682318563602044,1.298560034730762,0.13333333333333333,0.6785691447080283,1.0,11/30,16.11%,ACKR4;ACKR3;CCR1;CXCR6;CX3CR1;FGF2;CXCR4;CCR6;HMGB1;CCR9;ACKR2
prerank,adenylyltransferase activity (GO:0070566),-0.41838722400931283,-1.2964593488451053,0.1282051282051282,0.6721703370010517,1.0,9/21,19.47%,OAS2;OASL;FLAD1;TENT2;OAS3;FICD;NMNAT3;TENT4B;TENT4A
prerank,ribosomal small subunit binding (GO:0043024),-0.4309048920501669,-1.2939174317771793,0.1462140992167102,0.6683439825725453,1.0,7/17,17.90%,DHX29;EIF4B;PIM1;LARP1;NPM1;CPEB2;EIF1B
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.3731356125323179,-1.2928613696249918,0.1099476439790576,0.6597492491214851,1.0,12/31,16.28%,UBE2D3;UBE2K;BIRC6;TAF1;UBE2Q1;CDC34;UBE2L3;UBE2Q2;AKTIP;UBE2E3;UBE2L6;UBE2C
prerank,cyclic nucleotide binding (GO:0030551),0.446941093306712,1.2927349771048706,0.14173228346456693,0.6904696398602361,1.0,10/21,32.24%,HCN1;PDE4A;CNGB1;SLC19A1;POPDC3;PDE11A;RAPGEF2;KCNH1;RAPGEF4;PDE10A
prerank,DNA secondary structure binding (GO:0000217),-0.3748621782223352,-1.2905494357164446,0.11855670103092783,0.6554369517434065,1.0,11/31,20.20%,RAD51B;RBBP8;LIN54;HMGB2;CLSPN;YY1;HMGA2;FANCM;XPC;NEIL3;HMGA1
prerank,voltage-gated sodium channel activity (GO:0005248),0.44076981714435404,1.2886952028337184,0.13689482470784642,0.6960824791157743,1.0,10/22,28.56%,HCN1;PKD2;CACNA1G;SCN2A;SCN3B;SCN1B;SCN8A;SCN7A;CACNA1H;SCN1A
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.3675004769899302,-1.2875850542746918,0.11081081081081082,0.6533251960516447,1.0,13/34,16.28%,UBE2D3;UBE2K;BIRC6;TAF1;UBE2Q1;CDC34;UBE2L3;UBE2Q2;UFC1;AKTIP;UBE2E3;UBE2L6;UBE2C
prerank,neuropeptide binding (GO:0042923),0.4662423842295753,1.2812156499448255,0.16220735785953178,0.7147059958502443,1.0,5/18,22.87%,NMUR1;MC4R;OPRM1;OPRD1;SSTR2
prerank,ion channel activity (GO:0005216),0.33542583388971414,1.2749195810341463,0.1043115438108484,0.7288877930884149,1.0,19/80,12.66%,TMC3;TMC8;GRIA2;TRPM3;TRPM2;KCNK3;TMEM63A;GRIA1;GRIK5;GRIK2;GRID2;CNGB1;PKD2;GRIA4;GRIN1;GRIN2B;TMEM63B;TRPC6;UNC80
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.32146740042371297,-1.272524946506319,0.08547008547008547,0.6885625788088549,1.0,16/49,17.60%,VCP;ZRANB3;TNIP3;UBL7;UBQLN1;EPS15;BAG6;ABRAXAS1;ATRIP;RAD23B;WDR81;FAAP20;OPTN;BRCC3;UIMC1;SQSTM1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.47787745010907,-1.2721249559050753,0.15815085158150852,0.6785993383336992,1.0,5/13,8.79%,TARBP1;TRMT10C;THUMPD3;WDR4;TRMT1L
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.5339047984447476,1.267757418599041,0.1927927927927928,0.746671586428006,1.0,3/10,8.06%,GABRG1;GABRG2;GABRA2
prerank,poly(U) RNA binding (GO:0008266),0.44638867349040834,1.2676495464645818,0.15141430948419302,0.7378256802487139,1.0,4/20,3.70%,PABPC1L;PATL1;PABPC4L;HNRNPH1
prerank,ribosome binding (GO:0043022),-0.33574346703748625,-1.264341059113716,0.09635416666666667,0.693611678908991,1.0,18/46,20.83%,EIF2A;ETF1;SHFL;IGHMBP2;NAA10;NAA16;BAG6;CPEB4;ZC3H12A;EIF2S1;SRP72;SEC61A1;RACK1;GTPBP6;NOMO1;CPEB2;EFL1;CPEB3
prerank,SH2 domain binding (GO:0042169),-0.36559443161190897,-1.2630353580750617,0.1358695652173913,0.6866101497707707,1.0,14/31,20.97%,CRK;SH3PXD2B;BLNK;DAG1;LCK;SKAP1;NLK;RACK1;SLAMF1;LILRB1;NUP62;SQSTM1;AFAP1L2;LAX1
prerank,cAMP binding (GO:0030552),0.5169235035564291,1.2624632877399409,0.2036727879799666,0.7480901679184894,1.0,2/11,4.44%,HCN1;PDE4A
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.36698167324150305,-1.2610379107523677,0.14583333333333334,0.6822824286992418,1.0,18/29,39.91%,DUSP16;NBR1;MAPKAPK2;MAPKAPK3;DUSP1;MAPK7;TNIP1;DUSP7;GCH1;PPM1D;PRMT1;DUSP4;DUSP8;DUSP9;DUSP6;NFATC1;PTPRJ;MAPK14
prerank,leak channel activity (GO:0022840),0.45368733698037844,1.2609888725880491,0.1847457627118644,0.7447875390796167,1.0,6/18,18.64%,KCNK12;KCNK3;KCNK6;PANX1;KCNK9;KCNK2
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.48541954664805287,-1.2561965231865597,0.2078239608801956,0.6872906496727308,1.0,4/12,7.23%,XDH;CIAPIN1;SDHB;CISD2
prerank,chemokine activity (GO:0008009),-0.3666143541197331,-1.2552710411904588,0.1564102564102564,0.6795638502147786,1.0,11/31,37.15%,CXCL16;CCL25;PF4;CCL28;CCL7;CXCL12;CCL24;CKLF;CCL8;CXCL9;CXCL1
prerank,hydro-lyase activity (GO:0016836),0.3706598740953358,1.25126558181301,0.1467304625199362,0.7724527570761213,1.0,6/41,4.79%,IREB2;CYP2S1;ECHDC1;CA1;CA3;CA4
prerank,purinergic nucleotide receptor activity (GO:0001614),0.4785344827952629,1.2502622229236422,0.19834710743801653,0.7671700651262238,1.0,4/15,13.02%,P2RY12;GPR34;P2RY1;GPR171
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.4028885225776265,-1.249462505446006,0.15406162464985995,0.6862889636015249,1.0,5/22,4.03%,ATP6V0D1;ATP6V0D2;ATP6V1B2;ATP6V0A1;ATP6V0B
prerank,GTPase activator activity (GO:0005096),-0.2412430202601482,-1.2458218713198204,0.021739130434782608,0.687964023921267,1.0,54/313,10.67%,IQGAP1;VAV3;ARHGAP15;IQGAP2;FGD4;DENND1A;ITSN1;ARHGAP10;FGD6;RIC1;NRP1;TBC1D1;STARD8;ARHGEF10L;DENND4C;RCC1L;DENND1B;ARHGAP17;DOCK2;ARHGAP19;RANBP2;RIC8A;RASA4;LAMTOR5;CCDC88C;ARHGEF18;RASA1;ARHGEF6;RASGRP4;RABGAP1;ARHGAP18;TBC1D2;ASAP1;ARAP1;GAPVD1;ARHGAP30;HPS1;DENND6B;CYTH3;RACGAP1;FGD1;ARHGAP24;SMCR8;EIF2B2;RASGRP2;EEF1D;DENND2A;RABGEF1;SEC23A;ABR;RALGAPA2;CYTH1;AGAP2;RANBP3
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.4200200039276139,1.2450568366706354,0.16666666666666666,0.7774692951437048,1.0,4/23,7.58%,PLCH1;PLCD1;PLCG1;CCR1
prerank,DNA replication origin binding (GO:0003688),-0.38496663826902616,-1.243967368598719,0.1787709497206704,0.6841742606384419,1.0,9/23,15.40%,ORC5;HSPD1;ORC2;GRWD1;MCM2;ORC4;MCM9;MCM8;KAT7
prerank,potassium ion leak channel activity (GO:0022841),0.46591535073739276,1.2409422739207563,0.18181818181818182,0.7838472002103752,1.0,5/15,18.64%,KCNK12;KCNK3;KCNK6;KCNK9;KCNK2
prerank,gated channel activity (GO:0022836),0.481439130635381,1.2400404735538042,0.18537414965986396,0.7782207989465525,1.0,4/14,10.34%,TMC3;TMC8;TMEM63A;TMEM63B
prerank,phosphatase binding (GO:0019902),-0.27680919249837227,-1.2371085086643927,0.07662835249042145,0.6955955987380119,1.0,28/105,17.01%,IQGAP1;PXN;KIF3A;VCP;MET;TBK1;PPP6R1;AP3B1;PPP6R3;SHOC2;PPP3R1;MTMR4;SMAD3;CRY2;CDC27;LCK;CTNNB1;SKAP1;PPP1R3C;CRY1;CEACAM1;PPP1R3F;RACK1;EGFR;ITGA1;MTMR3;RPA2;MAP2K7
prerank,platelet-derived growth factor binding (GO:0048407),0.5153029028643866,1.2353120122060188,0.203125,0.7871358959223844,1.0,5/11,21.58%,COL5A1;COL2A1;PDGFB;PDGFRB;COL6A1
prerank,cAMP response element binding (GO:0035497),-0.49767288347266125,-1.227927878318778,0.2111650485436893,0.7136502481905512,1.0,5/10,28.84%,CREB5;CREB3L1;HMGA2;ATF2;CREB1
prerank,DNA polymerase binding (GO:0070182),-0.41243210153016463,-1.2252742852234064,0.18592964824120603,0.7125141267324867,1.0,7/18,19.46%,SMARCA4;PCNA;RTEL1;CDT1;FANCI;NAT10;SMG6
prerank,"DNA binding, bending (GO:0008301)",0.4769762454146706,1.2237054929843596,0.21489001692047377,0.8239366771533932,1.0,6/14,15.30%,HHEX;TFAM;FOXD1;FOXC1;HMGB1;HMGB3
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.459270804403779,1.2219948174451418,0.20907617504051865,0.8214570666079732,1.0,3/16,4.37%,IDO2;ALOX12;BCO2
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.4063529480031189,1.2181140856600774,0.2137030995106036,0.8275725704949574,1.0,7/26,18.78%,B3GNT9;B3GNT6;B3GALT2;B3GALNT1;CSGALNACT1;B4GALNT3;CHSY1
prerank,N-acyltransferase activity (GO:0016410),0.3880898372934039,1.2142056760993722,0.18253968253968253,0.8341909834075176,1.0,11/32,16.79%,PLAAT5;SAT2;TLCD3B;SMARCE1;NAT8L;CERS4;CERS6;CERS5;CERS1;ESCO1;NMT1
prerank,endopeptidase inhibitor activity (GO:0004866),0.3180019873391647,1.2127689109040805,0.14627285513361463,0.8306926426904826,1.0,10/82,8.10%,GAPDH;SPOCK3;BIN1;CST3;SPOCK2;PRNP;PSMF1;SERPINH1;SPINT2;UBE2Z
prerank,chloride channel inhibitor activity (GO:0019869),0.5160765960564857,1.2116146038337363,0.23118279569892472,0.8262117684798242,1.0,7/10,34.79%,CFTR;WNK1;VTI1B;WNK4;STX8;WNK3;STX7
prerank,Tat protein binding (GO:0030957),-0.49740851138307296,-1.2102645795241072,0.2334096109839817,0.7513042500392947,1.0,2/10,3.63%,MDFIC;SMARCA4
prerank,heme binding (GO:0020037),0.32867363412735173,1.2097211117944546,0.16885007278020378,0.8250018462393914,1.0,14/65,17.57%,CYP2S1;CYP2U1;SLC48A1;HEBP2;ABCB6;PGRMC2;FLVCR1;SDHC;PXDN;HEBP1;CYP27A1;PGRMC1;BACH1;CYB5B
prerank,NAD binding (GO:0051287),-0.3697928470243243,-1.2079327890757388,0.17079889807162535,0.7493411767101512,1.0,11/26,22.29%,HSD17B8;CRYZ;SORD;ALDH1A1;PARP9;NUDT6;ZC3HAV1;GRHPR;SIRT2;ALDH2;ALDH1B1
prerank,UDP-glycosyltransferase activity (GO:0008194),0.3233617588408963,1.2057988190456839,0.16363636363636364,0.8321934238038902,1.0,21/70,23.43%,HEXB;B3GNT9;B3GNT6;B4GAT1;B3GALT2;OGT;GXYLT1;B3GALNT1;CSGALNACT1;MGAT4B;POMGNT1;GCNT7;B3GAT3;B4GALNT3;GCNT4;CHSY1;GCNT1;LARGE1;EXT2;UGT1A6;RFNG
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.4565873321165598,-1.2057524552174341,0.23433874709976799,0.7462782338445118,1.0,8/12,35.00%,GPR88;OPN3;RRH;GPR52;OPN1MW3;OPN1MW;OPN5;OPN4
prerank,insulin-like growth factor I binding (GO:0031994),0.4782321871667462,1.2057281386686844,0.20695652173913043,0.8239108631889811,1.0,5/13,15.97%,IGFBP6;LRP2;IGFBP2;INSR;ITGA6
prerank,calcium-activated potassium channel activity (GO:0015269),0.4999963849939418,1.20562827406062,0.225130890052356,0.8158068094214328,1.0,5/11,22.92%,KCNMA1;KCNN4;KCNMB3;KCNN3;KCNN2
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.4631915892561556,-1.2040221304766299,0.22682926829268293,0.7419668666163832,1.0,2/11,2.62%,PRPF19;UBE2K
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.4271152711800216,1.203010217513376,0.23717948717948717,0.8170112826618179,1.0,6/20,14.16%,DGAT2;PNPLA3;LPCAT1;LPCAT2;AGPAT1;ABHD5
prerank,RNA polymerase core enzyme binding (GO:0043175),0.37657410605695885,1.2017476887883556,0.21018062397372742,0.8137439128401244,1.0,13/33,25.19%,MAF1;CTR9;SMYD2;ELP2;RRN3;SPTY2D1;CCAR2;PAF1;ELOF1;SCAF8;GTF2B;ELP4;URI1
prerank,metallocarboxypeptidase activity (GO:0004181),-0.3625545491274106,-1.2011116537553728,0.2202970297029703,0.7419505654056503,1.0,7/26,9.89%,CPD;CPA6;PEPD;AGTPBP1;AGBL5;CPE;CPM
prerank,exoribonuclease activity (GO:0004532),-0.4556548610137788,-1.1978739188848473,0.23728813559322035,0.7422512256248464,1.0,6/12,25.10%,EXOSC8;ZC3H12A;EXOSC10;EXOSC9;EXOSC1;EXOSC7
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.24768260199393402,-1.1970688698898686,0.0663265306122449,0.7352138709810093,1.0,49/188,17.97%,ARID4B;SOX6;LIN54;ATF3;GABPB2;CDK5RAP2;HMGB2;CIITA;TCF12;PPARG;SOX11;AHR;PROX1;NFKB1;ETV5;YY1;CEBPB;PRDM9;SMAD3;EGR2;SP1;BCOR;YAP1;TBL1X;HSF1;CRY2;HINFP;BRCA1;MZF1;CTCF;ATF5;FOXJ1;TCF7;SMAD6;NR1H3;AHRR;KMT2D;CREB3L1;FOS;ZBTB20;TNF;FOXK2;KLF11;ARID5B;GATA3;HMGA2;SMAD4;GLIS2;PER2
prerank,acetylcholine receptor activity (GO:0015464),-0.37860441927323635,-1.1955013196747255,0.21666666666666667,0.7312002621293694,1.0,9/22,35.47%,CHRM2;CHRNB2;CHRNA4;CHRNA5;HRH3;CHRNA3;CHRNB4;CHRM1;CHRNB3
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.465074163949626,1.1939400071041055,0.2391304347826087,0.8364670896341017,1.0,5/13,15.66%,ARHGDIG;ARHGDIA;ITGB1BP1;GDI1;SH3BP4
prerank,carboxypeptidase activity (GO:0004180),-0.3374221515361504,-1.1936620597363432,0.21236559139784947,0.7275074417262596,1.0,8/35,9.89%,CPD;CPA6;PEPD;AGTPBP1;AGBL5;CPE;CTSA;CPM
prerank,sterol binding (GO:0032934),-0.2991661507520863,-1.1882898388954435,0.1536144578313253,0.7360172147060433,1.0,12/56,9.63%,OSBPL8;NPC2;OSBP;STARD3NL;OSBPL9;GPR183;OSBPL1A;CAV1;ERLIN2;OSBPL2;OSBP2;ABCG1
prerank,metalloaminopeptidase activity (GO:0070006),0.43724691296065415,1.1882503469572163,0.23639455782312926,0.8511706605772141,1.0,7/16,18.23%,MMP16;RNPEPL1;XPNPEP1;XPNPEP3;TRHDE;ENPEP;MMP17
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.494516848908978,1.1860720996026504,0.2664359861591695,0.8516063878350558,1.0,4/10,6.12%,LACC1;ADARB2;APOBEC2;ADA
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.3840777194305366,1.1854674414697606,0.21963394342762063,0.8460874455832773,1.0,13/27,27.44%,POLR2L;POLR2F;POLR3F;POLR2G;POLR3A;POLR1F;PRIM1;POLR3B;POLR2C;POLR3K;POLR2D;POLR1A;POLRMT
prerank,RNA cap binding (GO:0000339),0.43504885963946904,1.1829723690408311,0.24915824915824916,0.8472795947002897,1.0,7/16,18.89%,LSM1;NCBP3;SNUPN;CYFIP1;GEMIN5;EIF4A1;EIF3D
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.35877557471750665,-1.1817738466021965,0.2282051282051282,0.7483919258632106,1.0,6/25,7.42%,HIP1;KIF16B;SESTD1;PLA2G4E;HIP1R;GAB2
prerank,insulin-like growth factor binding (GO:0005520),0.4465279907760142,1.180009908486575,0.25844594594594594,0.8509195433325841,1.0,6/15,16.75%,IGFBP6;LRP2;IGFBP2;INSR;ITGA6;IGFALS
prerank,aminopeptidase activity (GO:0004177),0.3808228200431543,1.1789708457348638,0.2247557003257329,0.847054379013913,1.0,9/26,18.23%,MMP16;RNPEPL1;XPNPEP1;METAP1D;XPNPEP3;TRHDE;LAP3;ENPEP;MMP17
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.5070122616521405,1.1788544974758084,0.24100719424460432,0.8396239717170605,1.0,1/10,0.79%,SLCO2B1
prerank,cholesterol transfer activity (GO:0120020),-0.4071524829404757,-1.177888560137335,0.24465558194774348,0.7523754773378061,1.0,6/16,16.30%,NPC2;PLTP;OSBPL2;ABCG1;GRAMD1C;GRAMD1B
prerank,carboxylic acid binding (GO:0031406),0.355698543731417,1.1778217990282551,0.2507836990595611,0.8355585294951339,1.0,8/38,11.54%,GLRA3;AKR1C1;EPDR1;GLRB;GRIN1;GRIN2B;GLRA2;MAG
prerank,diacylglycerol kinase activity (GO:0004143),0.48208878924845183,1.1773941493344908,0.26124567474048443,0.8297099047814375,1.0,5/11,20.67%,DGKI;DGKQ;DGKZ;DGKE;DGKH
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.4482633218533232,-1.1743635256107763,0.23076923076923078,0.7549581599423113,1.0,6/11,35.13%,CHRNB2;CHRNA4;CHRNA5;CHRNA3;CHRNA9;CHRNB4
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.37415996404490076,-1.1732506943795633,0.23056994818652848,0.7497943958120626,1.0,10/22,25.49%,DUSP16;MTMR2;DUSP18;CDKN3;DUSP1;MTMR3;PPM1F;DUSP19;DUSP7;DUSP3
prerank,cysteine-type peptidase activity (GO:0008234),0.3155995215797812,1.1724568985408534,0.18234442836468887,0.8400949853476884,1.0,23/73,21.82%,USP10;CAPN3;USP35;OTULINL;USP11;LGMN;USP50;USP30;ATG4A;GGH;USP12;CASP3;SFRP1;USP33;CASP4;CASP7;OTUD7B;USP48;CTSK;CASP8;USP49;CASP2;CTSS
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.44513022383849166,1.1716552562349432,0.25795644891122277,0.8357031210082185,1.0,5/15,11.69%,SLC1A1;SLC25A18;SLC38A7;SLC1A3;SLC1A4
prerank,RNA methyltransferase activity (GO:0008173),-0.3961851202180551,-1.1701129701182529,0.23834196891191708,0.7514185819394686,1.0,8/19,16.53%,FTSJ3;MRM2;LCMT2;METTL8;TRDMT1;TRMT13;TRMT9B;FBL
prerank,syntaxin binding (GO:0019905),0.32277121637849765,1.169811033153921,0.20998531571218795,0.8351935778317695,1.0,18/61,20.36%,SNAP25;SCFD2;SYT1;NAPB;SYT6;STX16;SYNPR;UNC13B;CPLX2;VAMP3;STXBP2;BAIAP3;PTPN2;CACNA1A;STXBP4;STXBP5;UNC13C;VAMP1
prerank,phosphatidylinositol binding (GO:0035091),-0.26824766348668055,-1.169096153345811,0.1417004048582996,0.7461700858591408,1.0,14/91,6.85%,DENND1A;HIP1;SNX24;SESTD1;DENND1B;SNX8;PLEKHF2;SNX1;FCHO2;ZFYVE16;HIP1R;PICALM;ITPR1;SNX9
prerank,tropomyosin binding (GO:0005523),0.42447186455592967,1.165864122009104,0.2638655462184874,0.8437911331276164,1.0,4/16,12.97%,NEBL;LMOD1;TMOD2;LMOD3
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.4556267729615388,1.1626178170057466,0.30017452006980805,0.8485330408226982,1.0,4/13,15.04%,DNASE1;DNASE1L2;FAN1;FEN1
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.30350462970161357,-1.1620725210912288,0.18042813455657492,0.7608246308134546,1.0,6/47,4.77%,SLC38A6;SLC1A5;SLC7A1;SLC43A2;SLC6A6;SLC7A11
prerank,alpha-tubulin binding (GO:0043014),0.3777806406275766,1.1617351817261239,0.2396825396825397,0.844708167348631,1.0,9/31,18.40%,DIP2B;DLEC1;BEX4;ARL4C;TBCE;DNAL1;TAOK1;EML4;TTLL7
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.44339718351656077,1.1597642278284552,0.2568027210884354,0.8448850926221825,1.0,6/14,21.34%,IREB2;NDUFS1;CIAO3;ISCU;EXO5;NUBPL
prerank,aspartic-type peptidase activity (GO:0070001),0.48267168708012076,1.1519254943772426,0.2939068100358423,0.8677534060815874,1.0,2/10,6.11%,ASPRV1;BACE1
prerank,nucleosomal DNA binding (GO:0031492),-0.3711621593600318,-1.1517941585188052,0.23333333333333334,0.7863390136750258,1.0,10/21,21.72%,GATAD2B;SMARCA4;MBD2;H3-3A;H1-0;HDAC2;HDAC1;HMGA2;HNRNPC;RCC1
prerank,carboxy-lyase activity (GO:0016831),0.3870679273746371,1.1513253194050224,0.26143790849673204,0.862903680744865,1.0,8/23,20.02%,ECHDC1;PPCDC;CSAD;AZIN2;UROD;UXS1;FAHD1;BCKDHA
prerank,nuclear import signal receptor activity (GO:0061608),-0.40840143483879815,-1.1501475217754455,0.29,0.782988723279734,1.0,5/15,22.04%,KPNB1;KPNA2;HIKESHI;KPNA3;RANBP6
prerank,nucleotidyltransferase activity (GO:0016779),-0.37179554385245733,-1.149409674033792,0.25735294117647056,0.7768445452045204,1.0,9/19,25.02%,PAPSS2;TENT2;NUDT5;YRDC;TENT4B;TENT4A;THG1L;DNTT;TERT
prerank,four-way junction DNA binding (GO:0000400),-0.3888959639233497,-1.1483716775189012,0.26405867970660146,0.7715324230451734,1.0,3/17,5.42%,RAD51B;HMGB2;YY1
prerank,histone deacetylase binding (GO:0042826),0.29468929757103535,1.1474003173142118,0.20926966292134833,0.8703220004402014,1.0,24/88,20.76%,YWHAE;NACC2;PKN1;RELA;HIC1;SP2;BEX4;ZMYND15;MEF2C;AKAP8L;PHF6;NCOR2;HDAC5;PRKN;AKAP8;USF1;NUDT21;PRDM1;BHLHE41;HDAC3;DHX36;YWHAB;HSP90AB1;GLI3
prerank,organic anion transmembrane transporter activity (GO:0008514),0.28349890075200285,1.1472547080943278,0.19337748344370861,0.863658760246449,1.0,41/134,24.96%,SLC4A8;SLC35A1;SLCO2B1;SLC25A2;SLC5A12;SLC38A2;SLC1A1;SLC2A2;SLC38A9;SLC25A18;SLC26A4;SLC38A7;SFXN1;CFTR;SLC26A7;MFSD10;SLC66A1;SLC1A3;SLC39A8;CTNS;SLC1A4;SFXN2;SLC3A1;SLC6A1;SLC19A1;MPC1;SLC25A23;SLC16A12;SLC35B2;SLC13A3;ABCG2;SLC25A38;SLC6A9;SLC38A3;SLC19A2;SLC6A7;SLC35B1;SLCO4A1;SLC16A7;SLC25A1;ABCC5
prerank,snoRNA binding (GO:0030515),-0.3471675448153271,-1.1467149799676417,0.24489795918367346,0.76855402707056,1.0,11/30,19.33%,UTP6;BYSL;NOP58;TSR1;NUDT5;WDR3;TBL3;DDX21;NOP10;NUDT7;DKC1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.49024173382365116,1.1458799810217764,0.30570902394106814,0.8617475025561899,1.0,7/10,37.20%,APEX1;FEN1;EXD2;TATDN1;POLD1;MGME1;DCLRE1A
prerank,mRNA binding (GO:0003729),-0.2291065640436212,-1.1458071342300535,0.08588957055214724,0.763216549591027,1.0,64/249,19.53%,RBM47;HNRNPLL;NOVA2;SRSF4;EIF2A;CELF1;NOCT;RPS26;RPL5;ZC3H12D;HNRNPM;NCBP1;ETF1;PURB;RBM8A;RPS14;DHX33;SAMD4A;PUM2;EIF2S2;RPS13;SLC4A1AP;SHFL;RPS7;RPS5;HNRNPAB;LUC7L;HNRNPK;DDX6;EIF4ENIF1;LARP6;CPEB4;AQR;ZC3H12A;SSB;CRYZ;RC3H1;DCP1B;ZC3H12B;RBPMS;LUC7L2;HNRNPA2B1;AGO2;TYMS;CSTF2;LARP1;NSRP1;SYNCRIP;PCF11;RPL41;RBMX;UPF3B;RC3H2;LARP4B;FXR2;CPEB2;CELF3;EIF3A;RNF20;SNRNP35;SRBD1;RPL26;HNRNPU;CELF2
prerank,histone acetyltransferase activity (GO:0004402),-0.34583508908968735,-1.143190339968734,0.23636363636363636,0.7640927236863446,1.0,9/30,15.40%,BAZ1A;EPC1;KAT6B;EPC2;TAF1;HAT1;EP300;KAT5;KAT7
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.422308698125471,-1.1424830248834463,0.26044226044226043,0.7586683200175799,1.0,4/12,7.64%,STAP1;FRS2;GAB2;BLNK
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.45585247898742964,-1.1421938949226003,0.30303030303030304,0.7515681153561427,1.0,2/10,11.73%,CYBB;CYBA
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.37118588055981444,1.1391453866987418,0.2841269841269841,0.88077101676456,1.0,6/28,8.06%,GABRG1;GABRG2;GRIK5;GRIK2;GRID2;GABRA2
prerank,FMN binding (GO:0010181),0.47178995104869975,1.138224342609131,0.3086003372681282,0.877546966648532,1.0,2/11,4.45%,PPCDC;NDOR1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.47949183136856105,1.1377684163006003,0.30303030303030304,0.8721385533881753,1.0,6/10,23.33%,CASP3;CASP4;CASP7;CASP8;CASP2;CFLAR
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.40507135083438967,-1.1345847166109297,0.31295843520782396,0.767363236661138,1.0,7/14,20.88%,MTMR2;MTMR14;MTMR4;MTM1;MTMR12;MTMR3;MTMR10
prerank,anion:anion antiporter activity (GO:0015301),0.4200067497895331,1.1320996376379353,0.31958762886597936,0.8875757087438932,1.0,5/17,14.60%,SLC25A4;SLC26A4;SLC26A7;SLC25A5;SLC19A1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.2972303409504522,-1.1308119027127137,0.23545706371191136,0.7723490401670093,1.0,19/44,24.62%,NSD2;SETDB2;SETD7;DOT1L;SETD3;PRDM9;WDR82;KMT2C;KMT2D;EHMT1;SMYD3;RBBP5;EED;KMT2B;SETD2;MECOM;SETD1A;KMT2A;EZH2
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.3129030052679553,1.1288046462458772,0.25920471281296026,0.893221050205272,1.0,18/60,20.04%,MERTK;NTRK1;FLT4;NTRK3;RYK;EPHA1;ERBB4;ACVR1B;TEK;EPHA4;EPHB2;INSR;NTRK2;FLT3;PDGFRB;BMPR1B;ROR1;EPHA5
prerank,microtubule motor activity (GO:0003777),-0.29233292031006164,-1.1266964364528238,0.2204968944099379,0.7779583809987523,1.0,25/51,30.36%,KIF3A;KIF16B;KIF23;KIF11;KIFC2;KIF20B;KIF13B;KIFC1;KIF24;KIF21A;KIF4A;KIF20A;DNAH8;KIF18B;KIF19;KIF27;KIF7;DNAH17;KIF3B;DNAH1;KIF15;KIF18A;KIF22;KIF5C;KIF5A
prerank,epidermal growth factor receptor binding (GO:0005154),-0.34896196584175415,-1.1251011046380084,0.3010471204188482,0.7760198100493081,1.0,12/25,31.77%,HIP1;CNOT9;SNX1;GRB2;SHC1;TGFA;PLSCR1;EGF;SNX2;CCDC88A;FAM83B;EFEMP1
prerank,Toll-like receptor binding (GO:0035325),-0.44456522007630456,-1.124894839291448,0.31002331002331,0.7691285025191148,1.0,4/11,19.66%,TLR2;CD36;TLR1;MYD88
prerank,omega peptidase activity (GO:0008242),0.29496634327854665,1.124698039886836,0.2496551724137931,0.9015638326409333,1.0,25/89,21.61%,MPND;OTUD7A;USP32;USP10;GGT7;USP35;USP11;GGT5;USP50;USP51;USP30;GGH;USP12;USP33;PSMD14;OTUB1;BAP1;OTUD7B;OTUD5;USP48;STAMBP;CYLD;COPS5;USP49;APEH
prerank,delayed rectifier potassium channel activity (GO:0005251),0.3506049665229442,1.1246789097606953,0.28794992175273865,0.8946469463267817,1.0,4/32,5.65%,KCNH2;KCNA5;KCNE2;KCNC1
prerank,tRNA binding (GO:0000049),-0.30087265687878767,-1.1237480636797048,0.2620481927710843,0.7651538636613351,1.0,15/43,16.03%,XPOT;EIF2A;EEF1A1;AIMP1;TRNAU1AP;TRMT10C;FARS2;IGHMBP2;PSTK;ALKBH8;SSB;YARS2;NSUN2;TRMT9B;YRDC
prerank,3'-5' exonuclease activity (GO:0008408),0.3338253257518118,1.1222030557135794,0.2775193798449612,0.897350537871076,1.0,15/45,21.89%,ERI3;REXO2;POLG;ANGEL1;EXD1;EXOSC5;ERI2;CNOT8;APEX1;ANGEL2;WRN;REXO4;APLF;DIS3L;EXD2
prerank,calcium channel inhibitor activity (GO:0019855),-0.43297834194246343,-1.1174725853035137,0.3121951219512195,0.7770952597711769,1.0,5/11,17.97%,MCUB;ITPR1;PHPT1;CALM2;SLC30A1
prerank,ephrin receptor binding (GO:0046875),0.38863350856487955,1.117263836191636,0.3054607508532423,0.9096173188164882,1.0,7/21,12.50%,CHN1;EFNA4;EFNB3;PIK3CG;ANKS1B;EFNA1;EFNA3
prerank,receptor ligand activity (GO:0048018),0.25439590306962223,1.116819836859086,0.23058542413381122,0.9043371717560783,1.0,44/245,17.64%,WNT4;FGF10;SEMA7A;FGF16;GDF11;FGF9;SLURP1;IL17F;SEMA6C;WNT3;FGF7;IL6;AREG;DAND5;SEMA6B;NDP;IL2;PPY;SEMA3D;BMP4;TNFRSF11B;SST;TAFA2;TGFB1;WNT8B;CLCF1;NRG3;FGF2;PDGFB;SEMA4F;GREM2;INHA;HMGB1;THPO;TAFA1;WNT7A;SEMA4B;GDF1;SEMA3C;IL7;AGT;ANGPTL3;IL1A;IL18
prerank,histone demethylase activity (GO:0032452),-0.3320098078465129,-1.1164001052179213,0.27956989247311825,0.7729192907491819,1.0,8/27,15.17%,RIOX2;KDM7A;JMJD6;KDM8;KDM6A;HR;RIOX1;KDM5C
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.45515015598896846,1.115716193262774,0.3371710526315789,0.901803388019944,1.0,3/12,6.53%,PDE8B;PDE4A;PDE3B
prerank,regulatory RNA binding (GO:0061980),-0.30532428699365305,-1.115314033123506,0.27808988764044945,0.7689996850457462,1.0,10/38,15.10%,TLR7;PUM2;ZNF346;ZC3H12A;RC3H1;PIWIL2;HNRNPA2B1;AGO2;DDX21;TRIM71
prerank,3'-5' DNA helicase activity (GO:0043138),0.4211374292826974,1.113189123471486,0.32894736842105265,0.9044490932960038,1.0,2/16,1.07%,NAV2;MCM5
prerank,lysine N-methyltransferase activity (GO:0016278),0.3886475932774461,1.1116650843030644,0.31825795644891125,0.9032932566649243,1.0,6/20,10.66%,SMYD2;METTL21C;EEF1AKMT2;METTL21A;SETD6;SETD4
prerank,chloride channel regulator activity (GO:0017081),0.43223698248207737,1.1105276747417006,0.3339160839160839,0.9008776616404948,1.0,8/14,34.79%,CFTR;CHRNA7;WNK1;VTI1B;WNK4;STX8;WNK3;STX7
prerank,tubulin binding (GO:0015631),0.25254453229444396,1.1103114979342619,0.21502890173410405,0.8951287960592336,1.0,87/295,22.97%,TPPP;STMN4;GAPDH;STMN3;MAP6;DIP2B;DST;IFT81;BLOC1S2;DLEC1;PAK1;PSRC1;MID2;STMN2;REEP2;BEX4;PRNP;PDCD5;NAV3;MAP1S;ARL4C;CLASP2;CCDC181;TBCE;PHF6;MAPRE2;KIF26A;MAP4K4;FSD1;CKAP5;EMD;PRKN;LRPPRC;RAE1;PEX14;FGF13;RMDN3;VASH2;TTLL6;DNAL1;CAMSAP1;DCTN1;DNM1L;MTCL1;KIF1C;SYBU;TTLL12;KIF2A;HOOK2;NDRG1;NEFM;RCC2;TUBGCP2;APC2;UXT;AGBL4;CLIP1;MAP9;KIF14;TAOK1;ALMS1;STARD9;TOGARAM2;HDGFL3;MAST2;EML4;TTLL7;HOOK1;ALDOA;EML6;ABRAXAS2;TPGS1;GABARAP;TUBGCP6;CEP57;TTLL5;KIF1B;TTLL1;KIF9;KIF17;MAP2;MAPRE3;SPAST;DRG1;MAP7D3;KIF21B;TPPP3
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.43003249692590384,1.109254964088579,0.32081911262798635,0.8927535434417767,1.0,4/14,11.07%,SLC1A1;SLC25A18;SLC38A7;SLC1A3
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.3326779580185942,1.1089053387232677,0.2985553772070626,0.8876334979008291,1.0,12/40,18.03%,LRTOMT;METTL2B;METTL2A;TPMT;MEPCE;METTL4;METTL9;COMT;FBLL1;N6AMT1;ASMT;PCMT1
prerank,Hsp90 protein binding (GO:0051879),-0.31737987387066435,-1.10735802714573,0.2640449438202247,0.7867567551069882,1.0,9/33,13.22%,NR3C1;AHR;ERN1;NOD2;HIF1A;HSF1;PACRG;KDR;CYP1A1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.4430884615167332,1.107319183570373,0.3380530973451327,0.8872492424212649,1.0,5/13,23.86%,PIK3C2G;PIK3CG;PIK3C2A;PIP4K2B;PIP4K2A
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.45551505470752285,1.105094191741552,0.3470483005366726,0.8890963227378653,1.0,6/11,23.33%,CASP3;CASP4;CASP7;CASP8;CASP2;CFLAR
prerank,organic cation transmembrane transporter activity (GO:0015101),0.40939390487984445,1.1049349079315514,0.3191126279863481,0.8834105203482705,1.0,5/16,22.96%,SLC44A2;SLC22A4;SLC18A3;SLC22A5;SLC25A26
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.4321628727005945,-1.104467159826507,0.34278959810874704,0.7883420904194401,1.0,4/10,14.55%,RIOX2;KDM7A;KDM8;RIOX1
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.4301231729245516,-1.102922563844601,0.3317972350230415,0.7857869374813605,1.0,4/11,16.92%,RPA1;HNRNPA2B1;TERF2;RPA2
prerank,aspartic-type endopeptidase activity (GO:0004190),0.44673910573610764,1.102263596913485,0.3462897526501767,0.8872260982476405,1.0,4/12,15.63%,ASPRV1;BACE1;SPPL2B;HM13
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.3279348728284797,-1.1015858694380334,0.2814207650273224,0.783136273192623,1.0,11/29,19.69%,PKIB;CIT;PRKAG2;CIB1;YWHAG;CDKN2C;SPRY2;HSPB1;CDKN2A;INKA1;INKA2
prerank,CCR chemokine receptor binding (GO:0048020),-0.3214383681918775,-1.0997158189758143,0.30617283950617286,0.782256459616605,1.0,7/28,27.27%,CCR2;CCL25;CCRL2;NARS1;NES;CCL7;CCL24
prerank,cell adhesion mediator activity (GO:0098631),0.3615173571464628,1.0991144162553876,0.31900826446280994,0.8926458854926128,1.0,9/24,19.72%,ROBO4;MYPN;CNTN2;DSCAM;BSG;DSCAML1;JAM3;NTNG1;LRRC4C
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.34296752528853863,1.0960187249118098,0.3166397415185784,0.8978564374235696,1.0,5/33,6.00%,CTR9;SMYD2;DRAP1;ELP2;AR
prerank,small GTPase binding (GO:0031267),0.2591725977002114,1.0948932728597927,0.26794871794871794,0.8956308127406646,1.0,43/169,16.06%,IFT20;TSC2;RIN3;SRGAP2;GGA3;RAB11FIP3;SGSM2;MYCBP2;PAK1;PKN1;AP3M1;SGSM3;NCKAP1;CHM;PEX5;FGD2;CDC42EP5;RAB8A;CDKL5;MYO1C;OCRL;EHD1;UNC13B;RAP1GAP;RIMS1;KCTD13;USP33;ANKRD27;AKAP13;DNM1L;BICD2;RAB34;HACE1;RALBP1;MICALL1;CYFIP1;FMNL1;EXOC5;NDRG1;RCC2;SH3BP4;DOCK4;RNF152
prerank,transition metal ion binding (GO:0046914),0.24295616199526116,1.0946250566805864,0.25279642058165547,0.8905361192541504,1.0,108/397,22.13%,POLR2L;QPCTL;LACC1;NUDT12;TYW5;TET1;ANG;IKZF4;MMP16;MYCBP2;COA6;AFP;NSD1;GPC1;XPNPEP1;KDM1B;PRNP;ZFPM2;ADA;MTPAP;GALT;XPNPEP3;COMMD1;S100A13;ZNF205;WDFY1;SHANK3;CHORDC1;ENPP2;PHEX;MPPE1;MPPED2;GRIN2B;TRHDE;AOC2;PRKN;NEK4;ITGB1BP2;KLF7;MOXD1;KDM2B;SUV39H2;USP33;THAP1;RNF8;CHMP1A;MGAT5B;PHF8;SEC24D;PITRM1;TIMM13;DCT;SEC24B;FBXL19;TRIM8;KDM4A;MSRB3;ACR;PGGT1B;RNF2;ZBTB32;TRAF7;AOC1;ENPEP;FEN1;RPS27;NAPEPLD;POMGNT1;CLIP1;SIAH1;SEC24C;EPRS1;ESCO1;ATOX1;TK1;MT2A;IL1A;WRN;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;ISCU;ZEB1;PHF2;SNCB;ADAMTS3;ALAD;ARG2;COX17;RABGGTB;GALNT4;CDADC1;CYLD;GALNT2;CALB1;PLA2G15;FDX1;PTGR2;MDM4;EXD2;CXXC5;LARGE1;LANCL1
prerank,RNA binding (GO:0003723),-0.1916875002296694,-1.0938903547762424,0.07692307692307693,0.7939261162167527,1.0,335/1321,20.04%,APOBEC1;RFTN1;ASCC3;AHNAK;MYO5A;DDX42;RBM47;UTP6;PSMA6;HNRNPLL;NOL11;DDX60;XPOT;ANKRD17;ZCCHC7;MECP2;OAS2;NOVA2;SRSF4;EIF2A;FAM120A;KPNB1;CELF1;NOCT;VCP;RCC1L;RPS26;FTSJ3;SCAF4;ZNFX1;RPL39;TRIM25;MARK2;MBNL1;IFIH1;RPL5;ZC3H12D;CCT6A;RPS23;HMGB2;RPS24;HNRNPM;GOLGB1;FAM98B;IFIT2;ACTN1;PPHLN1;SNRPA;RPS16;TRUB2;WDR43;FAU;RBM34;GNL3L;AGFG1;NCBP1;LGALS1;EEF1A1;ZBP1;DHX29;RPL28;ETF1;EIF4B;PTPN1;FAM98A;ENO1;MKI67;AIMP1;TOP2A;PURB;RPGR;GPATCH1;SNTB2;KPNA2;RBM8A;FNDC3A;RPS14;SNRNP40;DHX33;TCOF1;IFIT1;RPS20;TLR7;CLNS1A;CTNNA1;SLTM;SAMD4A;ZCCHC17;TRNAU1AP;RPS12;FIP1L1;RPL35A;DDX49;RPL18A;TRMT10C;PUM2;EIF2S2;OASL;RPS13;SLC4A1AP;SREK1;NOL7;RPL27;MSN;YY1;BAG4;GANAB;RPL21;SHFL;RPS7;ZNF346;UBAP2L;CRKL;BST2;EIF3I;DDX52;RPF1;HSPD1;RPS5;SNRPD1;JMJD6;TFRC;HNRNPAB;FARS2;RPL30;DDX41;PLEC;LUC7L;TBCA;RPF2;RPL6;IFIT3;PRPF6;ILF2;MBNL3;RPL37A;RO60;SRRT;RRP12;RPP38;DHX38;FNDC3B;CISD2;ACAA2;UBC;TLR8;BYSL;IGHMBP2;HNRNPK;YWHAG;KMT2C;PSTK;DQX1;RAVER2;EIF3G;TXN;UTP4;RPL10;RPL15;FAM133B;DDX6;SNRPB;ALG13;EIF4ENIF1;TPT1;S100A4;CAPRIN1;DEK;TRMT1L;LARP6;CPEB4;UBE2L3;AQR;BRCA1;NOSIP;SNW1;ZC3H12A;DNAJC21;H1-0;GNL2;UTP11;UTP15;EXOSC10;VIM;RPP21;NUSAP1;MAPRE1;ALKBH8;DDX27;RPS10;SSB;YARS2;FASTKD1;HNRNPUL2;RPL14;MRPL1;IBA57;GDI2;EIF2S1;GRWD1;RPL9;SEC63;TENT5A;RC3H1;XRN2;BARD1;RPL32;RPL36;MRPS30;DCP1B;ZC3H12B;TES;MTO1;NOP58;SRP72;RBPMS;SPEN;GRB2;CCT3;HDAC2;LTA4H;RPL23A;CPSF4;RPN1;TSR1;LUC7L2;NUDT5;NSUN2;RPL31;SLC25A11;HNRNPA2B1;CHCHD1;LSM2;POLR2B;OAS3;YLPM1;LRRFIP1;AGO2;IMMT;CSTF2;LARP1;RACK1;CS;LRP1;CPSF2;LSM5;NSRP1;RPL3;EXOSC9;SYNCRIP;PCF11;NPM1;PRKRIP1;WDR3;PRPF40A;UTP18;PURG;UBTF;RPL41;TBL3;DDX21;FRG1;NMD3;TRMT9B;HSPB1;PHF5A;HMGN2;MKRN1;ZC3H18;RBM27;RBMX;RPL8;MYH9;DDX20;RBM7;YRDC;UPF3B;RC3H2;PEBP1;SEC23IP;USO1;CCDC9B;LARP4B;DUS2;FBL;NOP10;NOP53;SAP18;HADHB;FXR2;SLC3A2;CCDC59;CPEB2;KRI1;HELZ2;ANKHD1;CELF3;ZC3HAV1;EIF1B;POP1;NUDT7;TENT4B;RPL37;EIF3A;SNRPC;HNRNPD;MRPL4;MAGOHB;MAGOH;RNASEH1;MEX3D;FASTKD5;SNRNP35;SRBD1;FLNA;SCAF11;NAT10;ABT1;CDKN2A;RPL36A;RPL26;DKC1;SRP9;PRPF3;SMG6;HNRNPU;CELF2;TEP1;MRPS26;HSPA1B;PA2G4;EMG1;STAU1;HNRNPC;RPL11
prerank,channel activity (GO:0015267),-0.2950900576527691,-1.0906928231079718,0.3029411764705882,0.7970230871564319,1.0,18/41,35.50%,BCL2;MCUB;BAX;TMEM120B;TRPV2;TRPV3;AQP11;TMEM120A;TMEM266;ASIC4;PDPN;AQP1;MPV17;SLC14A1;TRPV4;PANX3;CHRNB3;TRPM5
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3155164614290905,1.0873089610837086,0.340393343419062,0.910894817149116,1.0,9/49,8.89%,SYT4;ANXA8;SYT13;SYT1;SYT6;PLA2G4C;ESYT2;DOC2B;CPNE6
prerank,androgen receptor binding (GO:0050681),-0.3262005694654615,-1.0853531539202883,0.31891891891891894,0.806760904028985,1.0,8/25,13.51%,SMARCA4;PRPF6;RNF14;RNF6;SNW1;PRMT2;EP300;FOXP1
prerank,PDZ domain binding (GO:0030165),0.30200619826562064,1.084429532236689,0.3433734939759036,0.9154005491069211,1.0,23/61,24.98%,F11R;CADM1;TGFBR3;GRIA1;GRID2;CFTR;PRKN;ATP2B3;ACOX1;SLC22A4;DOCK4;KIF14;CXADR;LLGL2;SDC2;PLEKHA2;PLEKHA1;SLC22A5;SSTR2;PDZK1;CXXC4;SRR;RAPGEF2
prerank,phosphate ion binding (GO:0042301),0.4503747289424586,1.0819114924481696,0.3520408163265306,0.9183914766005448,1.0,2/10,7.35%,RELA;PNP
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.37795136812834745,-1.0817959144681903,0.324455205811138,0.8112805206431615,1.0,10/16,33.33%,CD38;ADPRH;BST1;NTHL1;NEIL3;TDG;DNPH1;RPS3;MACROD1;SMUG1
prerank,calcium:sodium antiporter activity (GO:0005432),0.45487911783635493,1.0817266915927384,0.3738656987295826,0.9130473342216315,1.0,5/10,18.70%,SLC24A5;SLC8A1;SLC8A3;SLC24A3;SLC24A4
prerank,hexosyltransferase activity (GO:0016758),0.2767022931032915,1.0811179312151946,0.31763122476446837,0.9094717782398605,1.0,28/101,22.44%,HEXB;B3GNT9;B3GNT6;B4GAT1;B3GALT2;TMTC4;ALG1;DPY19L4;PIGB;POFUT1;OGT;B3GALNT1;DPY19L3;CSGALNACT1;MGAT4B;POMGNT1;ALG5;GCNT7;B3GAT3;B4GALNT3;GCNT4;CHSY1;B4GALT2;GBA2;GCNT1;LARGE1;EXT2;UGT1A6
prerank,potassium ion antiporter activity (GO:0022821),0.4079575970854707,1.0807648132455168,0.35581787521079256,0.9048626879150152,1.0,6/15,22.22%,SLC24A5;SLC9A4;SLC9A5;SLC24A3;SLC24A4;SLC9A1
prerank,GTPase binding (GO:0051020),0.2515598671784678,1.078890850257953,0.2866161616161616,0.9054747457676171,1.0,49/194,16.48%,IFT20;TSC2;RIN3;SRGAP2;GGA3;RAB11FIP3;SGSM2;MYCBP2;PAK1;PKN1;GNB3;AP3M1;SGSM3;NCKAP1;CHM;PEX5;FGD2;CDC42EP5;RAB8A;ATG16L1;GNB2;CDKL5;MYO1C;OCRL;EHD1;UNC13B;RAP1GAP;RIMS1;KCTD13;BECN1;USP33;ANKRD27;AKAP13;DNM1L;BICD2;RAB34;HACE1;RALBP1;MICALL1;SPTBN1;CYFIP1;FMNL1;EXOC5;NDRG1;RCC2;SH3BP4;DOCK4;RNF152;EPRS1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.31122744969122607,1.078272439532291,0.3490136570561457,0.9018974366256434,1.0,9/51,14.93%,SLC35A1;SLCO2B1;SLC5A12;SLC22A8;SLC46A2;SLC20A1;SLC35C1;TMEM241;SLC22A4
prerank,microtubule plus-end binding (GO:0051010),0.3821281752983974,1.077923370108402,0.35374149659863946,0.8972350643688718,1.0,5/20,16.20%,DST;CLASP2;MAPRE2;DCTN1;CLIP1
prerank,general transcription initiation factor binding (GO:0140296),0.36164619614586185,1.0776381872034018,0.3563025210084034,0.892649828379286,1.0,4/25,6.00%,HHEX;DRAP1;RELA;AR
prerank,protein tyrosine kinase activity (GO:0004713),-0.2422853384261882,-1.077166600957836,0.2950191570881226,0.8190321967417824,1.0,28/108,18.86%,PEAK1;AXL;ABL2;CSK;TEC;BAZ1B;MET;LMTK2;DYRK1A;FLT1;SYK;LYN;FYN;HCK;RET;WEE1;HIPK1;LCK;FRK;KDR;EGFR;PTK2B;EPHA2;EPHB4;ZAP70;HIPK2;PDGFRA;PKDCC
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.41426060079842225,-1.0767107487623098,0.3812785388127854,0.8135559300218604,1.0,3/11,10.20%,SASH1;STK38;MAP3K11
prerank,actinin binding (GO:0042805),-0.3447051206518159,-1.0750955307331374,0.32211538461538464,0.8116988998427856,1.0,6/21,8.44%,PDLIM5;PPARG;RARA;NFKB1;SYNPO2;DAG1
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.34140684549141515,1.0742067504289727,0.35222052067381315,0.899171200729397,1.0,8/31,18.64%,HCN1;SLC12A2;KCNK3;PKD2;SLC12A6;ABCC8;KCNK9;KCNQ4
prerank,metallopeptidase activity (GO:0008237),0.2694878774411642,1.0730129352508861,0.3135935397039031,0.897644870641526,1.0,27/113,20.50%,ADAM2;MPND;MMP16;MEP1B;ADAMTS20;METAP1D;PSMD7;PHEX;ADAMTSL1;ADAMTS15;ADAM15;ADAM12;LAP3;ADAMTS19;THSD4;CHMP1A;PSMD14;ADAMTS14;PITRM1;MMP1;COPS6;THOP1;ADAMTS4;MMP17;ADAMTS3;COPS5;OMA1
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.21588327277309022,-1.071781447487766,0.2361111111111111,0.8156806730603211,1.0,68/232,24.00%,ITCH;CBLB;WWP1;RNF149;UBE2D3;MSL2;TRIM25;CUL3;TRIM7;ARIH1;PRPF19;NSMCE2;TRIM14;DTX3L;SIAH2;SMURF2;TRIM17;UHRF2;RNF216;HECW1;EGR2;ARIH2;TRIM62;RNF13;ZNRF3;NHLRC3;RNF14;RNF150;RNF6;RNF157;SH3RF1;RNF220;RC3H1;PIAS2;TRIP12;TRIM44;BIRC2;CBL;RNF38;TRIM5;FBXO2;PELI1;TRIM71;MKRN1;RC3H2;MUL1;TRAF3IP2;DTX4;RNF144A;TRIM3;RNFT1;RNF130;TRIM37;RNF121;RNF24;TRIM21;RNF125;NEURL4;ASB12;KCMF1;XIAP;MEFV;NEURL2;TRIM72;BFAR;PIAS4;TRIM69;PIAS3
prerank,protein serine/threonine phosphatase activity (GO:0004722),-0.263027041311294,-1.07084598875392,0.3136645962732919,0.8116849481805768,1.0,20/60,19.07%,LRRC39;CDC14B;PPM1H;PPP3R1;CTDNEP1;TAB1;LCK;CDKN3;PPP3CA;PPP1R3C;CTDSP1;LRRK2;DUSP1;PPP2CB;TIMM50;RPAP2;MTMR3;PGAM5;PPM1F;PPEF1
prerank,RNA polymerase binding (GO:0070063),0.38895547889545046,1.070073177520288,0.35927152317880795,0.9024459549618951,1.0,3/18,2.11%,YTHDC2;BIN1;PPIB
prerank,glucuronosyltransferase activity (GO:0015020),0.3801311939903651,1.0697014533558131,0.3775167785234899,0.8981441307534843,1.0,8/19,22.44%,B4GAT1;CSGALNACT1;B3GAT3;CHSY1;B3GAT2;LARGE1;EXT2;UGT1A6
prerank,amyloid-beta binding (GO:0001540),-0.2519875048236877,-1.068725170923768,0.2975778546712803,0.8120231102021512,1.0,12/79,6.81%,FCGR2B;CD74;APOE;MSR1;TM2D1;ITM2B;TLR2;CD36;PICALM;LDLRAP1;LDLR;PFDN5
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.3955537900341372,1.067778987655558,0.37828371278458844,0.8991056116506635,1.0,6/17,21.40%,TM7SF2;AKR1C1;MECR;TECR;DECR2;PTGR2
prerank,cholesterol binding (GO:0015485),-0.27955211902361754,-1.0676553337276373,0.29705882352941176,0.8087334216668857,1.0,15/47,21.06%,OSBPL8;NPC2;STARD3NL;OSBPL1A;CAV1;ERLIN2;OSBPL2;OSBP2;ABCG1;NR1H3;GRAMD1C;GRAMD1B;SULT2B1;VDAC2;PTCH1
prerank,NADPH binding (GO:0070402),-0.39644618071063753,-1.0669684670426836,0.34491315136476425,0.8044740602305138,1.0,8/13,20.76%,DECR1;CRYZ;CBR3;MTRR;DUS2;KCNAB1;GRHPR;DHFR
prerank,GTPase activity (GO:0003924),0.2508839967043556,1.0650280981873415,0.3182374541003672,0.902966270412272,1.0,38/192,17.50%,TPPP;RAB6B;RAB1B;RAB43;RAB3A;RHOV;GNB3;SEPTIN9;GTPBP1;ATL1;RHOBTB1;RAB8A;GNB2;GNA15;RIT2;TBCC;GNG11;RHOT1;NKIRAS2;RAB24;DIRAS2;RAB38;RAB5A;GFM2;RAP1GAP;RAB28;DNM1L;EEF1A2;GNGT2;GNAI3;GNA11;HRAS;GSPT1;RRAS2;GNAS;RHOQ;SRPRA;RHOBTB2
prerank,protein kinase C activity (GO:0004697),0.40601166891963225,1.0643187088240251,0.4066666666666667,0.8998836670520666,1.0,7/14,17.58%,PKN1;PRKCZ;PRKCI;PRKCA;PRKD1;PRKCG;SMG1
prerank,calcium-release channel activity (GO:0015278),-0.3701183634774111,-1.0641942407035938,0.3564102564102564,0.8066125665133654,1.0,4/17,6.34%,MCOLN2;TPCN2;TPCN1;ITPR1
prerank,SH3 domain binding (GO:0017124),-0.26229897684010733,-1.063562735298312,0.2857142857142857,0.8021080847015958,1.0,15/62,12.78%,CBLB;SH3BP2;PTPN22;SYNJ2;CRK;SOCS7;ADAM9;WIPF1;CABYR;DNM2;GRB2;SKAP1;CYBA;CBL;VASP
prerank,endopeptidase regulator activity (GO:0061135),0.31860912060808055,1.0623637392457095,0.34890965732087226,0.9010703646918466,1.0,8/40,14.11%,CST3;VSIR;PSMF1;SPINT2;PSME3;PSENEN;PSMD14;ABCA2
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",-0.22022504191156475,-1.061715805928914,0.2561576354679803,0.8012976818934222,1.0,61/173,27.03%,ZEB2;TRPS1;NR3C1;MITF;TGIF1;ATF3;ETV6;PEG3;PPARG;TFEC;MNT;ERF;ENO1;PATZ1;PROX1;NFKB1;YY1;PPARD;CEBPB;HSF1;MZF1;CTCF;FOXP4;ZBTB18;ZNF148;ZBTB5;LRRFIP1;FOXP1;E2F8;FOXP2;CREB3L1;ZBTB20;DACH1;ZBTB2;FOXK2;DEAF1;SATB1;HEY2;ZBTB39;GATA3;HES1;MXI1;MYT1L;BHLHE40;NFATC3;HEYL;HOXD9;SKIL;ZNF3;TFAP2C;ZFP90;MAFK;PLAGL1;IRX2;BCL6;ZBTB33;NFX1;TBX21;OTP;IRX1;THAP11
prerank,histone methyltransferase binding (GO:1990226),-0.4148719202861395,-1.0604010585246162,0.38497652582159625,0.7985183976165062,1.0,4/11,13.99%,LCOR;LCORL;CTNNB1;PRDM4
prerank,translation initiation factor activity (GO:0003743),-0.29813875422191205,-1.0561543166492875,0.35911602209944754,0.8054826201645297,1.0,14/36,24.43%,EIF2A;EIF2S2;EIF3I;EIF3G;EIF2B2;EIF2S1;EIF3K;AGO2;EIF2B4;EIF1B;EIF3A;EIF3E;EIF4A2;EIF3L
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.39714778070250956,-1.0557323442918918,0.4004474272930649,0.8005383854714405,1.0,3/11,14.63%,MAP3K1;MAP3K15;EGFR
prerank,sodium channel regulator activity (GO:0017080),0.3229322304898259,1.0554805306573236,0.37315875613747956,0.9201089581314776,1.0,7/37,10.89%,FGF14;FGF12;FGF11;COMMD1;PTPN3;NEDD4;FGF13
prerank,phosphatidylinositol kinase activity (GO:0052742),0.38990343779324854,1.0547717203754454,0.37478991596638656,0.9168901171986783,1.0,3/15,7.23%,PIK3C2G;PIK3CG;PI4K2A
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.20341859551057478,-1.0519729868392815,0.22608695652173913,0.8059073226439061,1.0,82/346,18.40%,ITCH;CBLB;WWP1;RNF149;UBE2D3;MSL2;KLHL20;TRIM25;CUL3;TRIM7;ARIH1;PRPF19;TRIM14;PJA2;UBE2K;CUL4A;DTX3L;FBXL14;BIRC6;RNF213;SIAH2;OBI1;SMURF2;TRIM17;UHRF2;TAF1;UBE2Q1;RNF214;RNF216;RNF146;RMND5B;HECW1;ARIH2;CDC34;TRIM62;BCOR;RNF13;ZNRF3;NHLRC3;RNF14;TTC3;RNF150;LMO7;RNF6;UBE2L3;BRCA1;RNF157;SH3RF1;RNF220;KLHL21;RC3H1;BARD1;UBE2Q2;TRIP12;TRIM44;BIRC2;RNF103;AKTIP;CBL;RNF38;UBE2E3;TRIM5;FBXO2;PELI1;FBXO3;UBE2L6;TRIM71;TRIM45;MKRN1;TRAF1;RC3H2;MUL1;UBE2C;ASB4;TRAF3IP2;DTX4;DTL;RNF144A;TRIM3;RNFT1;RNF130;RNF20
prerank,deoxyribonuclease activity (GO:0004536),0.40735131705066935,1.051927337128227,0.37993421052631576,0.9211711567863726,1.0,7/14,25.76%,DNASE1L2;MAP1S;NME1;APEX1;APLF;ERCC4;DFFB
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.3022046938653037,1.050240300793189,0.38271604938271603,0.9218082102443524,1.0,12/53,13.69%,SLC25A2;SLC38A2;SLC1A1;SLC38A9;SLC25A18;SLC38A7;SFXN1;SLC66A1;SLC1A3;CTNS;SLC1A4;SLC3A1
prerank,alpha-actinin binding (GO:0051393),-0.3227064027277995,-1.0491926309164938,0.38144329896907214,0.8081171158444385,1.0,6/24,8.44%,PDLIM1;PDLIM5;PPARG;RARA;SYNPO2;DAG1
prerank,death receptor activity (GO:0005035),-0.41339363932256723,-1.0491876755185285,0.3752913752913753,0.802057923851837,1.0,4/11,17.56%,FAS;TNFRSF19;TNFRSF1B;TNFRSF25
prerank,calcium channel regulator activity (GO:0005246),-0.28728480306504073,-1.0485481297343753,0.3665768194070081,0.7979736104203277,1.0,15/37,22.16%,MCUB;ITPR1;CACNG4;NRXN2;INAFM2;PHPT1;REM1;CALM2;STIM2;SLC30A1;NPY;NPY2R;STIMATE;SGK3;CACNB3
prerank,symporter activity (GO:0015293),0.4392465829964921,1.0482295895483063,0.4181494661921708,0.9234264014021709,1.0,2/10,7.26%,SLC5A12;SLC46A2
prerank,acetyltransferase activity (GO:0016407),-0.302282351203456,-1.047220328780581,0.372972972972973,0.7960447474425091,1.0,11/31,20.24%,PAFAH1B2;KAT6B;NAA10;NAA16;GNPNAT1;EP300;DBT;NAT14;NAT10;PAFAH1B3;ESCO2
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.39778428795053167,1.0467610940007528,0.40683760683760684,0.9231848570721105,1.0,2/14,4.77%,SPOCK3;SPOCK2
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.2497755803179983,-1.0447965897778055,0.3707482993197279,0.7975853905579875,1.0,22/74,16.54%,PIK3C3;PAPSS2;FCSK;FAM20A;DGKK;NADK;GALK2;PANK1;FAM20B;IPPK;PIK3CA;HK1;PANK3;SHPK;FAM20C;GK5;SPHK2;GK;PGM2L1;DGKA;POMK;PI4KA
prerank,ubiquitin protein ligase activity (GO:0061630),-0.20931741815740731,-1.044734444101754,0.34838709677419355,0.792033932113546,1.0,62/228,22.96%,ITCH;CBLB;WWP1;RNF149;UBE2D3;MSL2;TRIM25;CUL3;TRIM7;ARIH1;PRPF19;TRIM14;UBE2K;DTX3L;SIAH2;SMURF2;TRIM17;UHRF2;RNF216;HECW1;ARIH2;TRIM62;RNF13;ZNRF3;NHLRC3;RNF14;RNF150;RNF6;RNF157;SH3RF1;RNF220;RC3H1;TRIP12;TRIM44;BIRC2;CBL;RNF38;TRIM5;FBXO2;PELI1;TRIM71;MKRN1;RC3H2;MUL1;TRAF3IP2;DTX4;RNF144A;TRIM3;RNFT1;RNF130;TRIM37;RNF121;RNF24;TRIM21;RNF125;NEURL4;ASB12;KCMF1;XIAP;MEFV;NEURL2;TRIM72
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.42135034344961975,-1.0416717278598873,0.3968253968253968,0.7956307108339754,1.0,7/10,37.74%,DSEL;DSE;RENBP;FUOM;GALM;GLCE;GNE
prerank,transcription cis-regulatory region binding (GO:0000976),-0.1944670813275225,-1.041641698866135,0.31683168316831684,0.7900036372666139,1.0,133/406,27.33%,TRPS1;NR3C1;NFXL1;ARID4B;SOX6;SP3;ATF3;GABPB2;CDK5RAP2;HMGB2;RUNX3;ETV6;CIITA;TCF12;PEG3;PPARG;MNT;RARA;MEF2D;ENO1;PURB;SOX11;AHR;PROX1;NFKB1;ETV5;YY1;CEBPB;PRDM9;SMAD3;EGR2;SP1;BCOR;YAP1;MLXIP;TBL1X;HIF1A;HSF1;CRY2;SATB2;HINFP;BRCA1;MZF1;CREBRF;CTCF;RFX5;ATF5;XRN2;CUX2;NFE2;FOXJ1;RXRB;HDAC1;TCF7;ZBTB5;SMAD6;AGO2;NR1H3;AHRR;FOXP1;SCX;RB1;E2F8;KMT2D;CREB3L1;FOS;ZBTB20;IRF2;NPM1;DACH1;PURG;LHX1;TNF;FOXK2;DEAF1;E2F7;TIPARP;KLF11;SATB1;RFXANK;ARID5B;GATA3;HMGA2;SMAD4;GLIS2;PER2;ZFP3;FOXN2;RBBP5;TFAP2B;MXI1;TAF7;HOXD8;ESRRB;HMGA1;KLF4;NCOR1;BASP1;HDAC4;RBAK;NPAS4;TCF24;NR1H4;RREB1;TWIST1;HOXD9;PSPC1;ZNF3;TFAP2C;FLI1;ZFP90;TBL1XR1;PAX6;MAFK;PLAGL1;ASCL4;TEAD1;ATF2;CEBPA;SREBF1;NFX1;LEF1;PURA;ARID5A;E2F3;TBX21;MSC;FOXN1;OTP;ISL1;LMX1A;SOX12;MSX1
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.3087512393397199,-1.0414416993913984,0.3775,0.7848337193892767,1.0,11/29,16.85%,ACER3;CTBS;GANAB;HEXD;IDUA;HPSE2;HPSE;GLA;GAA;GALC;HYAL3
prerank,phosphoric diester hydrolase activity (GO:0008081),0.3254160056810246,1.039638447831638,0.39375,0.9429261379813823,1.0,14/35,26.49%,PLCL1;PLCXD1;PLD4;ENPP2;MPPE1;MPPED2;APEX1;NAPEPLD;PLCXD3;PLCB2;GPLD1;PDE11A;SMPD2;PLCXD2
prerank,hexose transmembrane transporter activity (GO:0015149),0.4239993112477,1.038793483857647,0.41924398625429554,0.9405994897289788,1.0,2/12,6.74%,SLC2A3;SLC2A2
prerank,voltage-gated anion channel activity (GO:0008308),-0.37335909898590774,-1.0360615917558131,0.41496598639455784,0.7947646819219792,1.0,7/15,22.10%,CLCN1;CLCN5;VDAC3;ANO1;VDAC2;GPR89B;GPR89A
prerank,protein serine/threonine kinase activity (GO:0004674),-0.20113870489788807,-1.0355675218906528,0.2867647058823529,0.790582465740463,1.0,100/334,25.39%,MAP3K1;STK3;CSNK1G1;SLK;PRKCH;STK38;PRKCE;STK17B;RAF1;ALPK1;CDK6;MARK2;MAP3K8;PIK3R4;CDK8;FAM20A;BRAF;NUAK2;GAK;STK35;TBK1;PRKACA;MKNK1;MAPKAPK2;PIM1;LMTK2;STK24;ERN1;TAF1;PRKD3;MAP3K15;TESK2;DYRK1A;RPS6KA6;RIPK1;SYK;CIT;PRKCQ;CDKL3;TAOK3;CAMK2D;UHMK1;MAP3K11;HIPK1;MAPKAPK3;CDK1;DAPK1;FAM20C;RPS6KA2;NLK;SIK2;IRAK4;LRRK2;SIK1;CDK12;EGFR;PTK2B;PRKAB2;CDK14;MAPK7;MAPK8;MAP4K1;HIPK2;CAMK1G;CLK4;SQSTM1;PKN3;CDK19;MAPK12;PLK1;MYLK;NEK8;ACVR2A;CDC42BPG;MELK;STK38L;ACVR1;CDK9;MAP3K2;SGK3;SGK2;HUNK;SBK3;MAP3K20;BCR;MARK4;MAPK11;BRSK1;RPS6KA3;STKLD1;MASTL;PIM2;HTATIP2;BMPR2;STK32C;EIF2AK2;CDK13;ULK3;ILK;ERN2
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.4068739251756488,1.034882698935782,0.4066666666666667,0.9483855566507884,1.0,5/13,14.16%,PNPLA3;LPCAT1;LPCAT2;AGPAT1;ABHD5
prerank,1-phosphatidylinositol binding (GO:0005545),-0.36744390287828793,-1.0339897307264898,0.39195979899497485,0.7895901677941892,1.0,5/15,8.59%,SESTD1;ZFYVE16;PICALM;SNX9;WDFY3
prerank,chemorepellent activity (GO:0045499),0.34488871820269734,1.033544367771483,0.41903171953255425,0.9476673256586317,1.0,8/25,16.66%,SEMA7A;SEMA6C;SEMA6B;SEMA3D;NRG3;SEMA4F;SEMA4B;SEMA3C
prerank,glutathione transferase activity (GO:0004364),-0.32614969997795396,-1.0315988594345822,0.3811881188118812,0.7914953146337251,1.0,6/23,18.33%,MGST3;GSTA3;GSTZ1;GSTM1;GSTM5;LTC4S
prerank,NF-kappaB binding (GO:0051059),-0.3154145553252335,-1.0313829465941218,0.37567567567567567,0.786601741431,1.0,7/24,14.32%,PSMA6;ANXA4;EP300;BRMS1;HDAC2;HDAC1;NPM1
prerank,myosin binding (GO:0017022),0.2895248115791145,1.0310130903103518,0.38699690402476783,0.9508244553133058,1.0,13/55,18.49%,RAB6B;RAB3A;GIPC1;DMD;MYBPC3;RAB8A;RAB3D;CXCR4;CORO1A;ARFGEF1;HAP1;STXBP5;LLGL2
prerank,nucleoside-triphosphatase activity (GO:0017111),0.23651032003352182,1.0291117447605949,0.4011764705882353,0.9520520892545626,1.0,50/248,17.84%,TPPP;RAB6B;KLC1;RAB1B;RAB43;RAB3A;RHOV;GNB3;ABCB6;SEPTIN9;GTPBP1;ATL1;RHOBTB1;CLU;ATAD1;RAB8A;GNB2;GNA15;RIT2;TBCC;MYO6;GNG11;KIF26A;RHOT1;NKIRAS2;RAB24;MYL6;CFTR;DIRAS2;RAB38;RAB5A;GFM2;RAP1GAP;RAB28;DNM1L;EEF1A2;GNGT2;KIF1C;KIF2A;GNAI3;GNA11;KIF14;HRAS;GSPT1;RRAS2;GNAS;RHOQ;SRPRA;RHOBTB2;ABCD2
prerank,ATP hydrolysis activity (GO:0140603),-0.2747876225072716,-1.028812147028978,0.4037940379403794,0.789008595804941,1.0,9/41,11.05%,VCP;VWA8;RNF213;SMCHD1;CHD1L;KIF20B;TOR1B;ABCG4;TOR3A
prerank,microtubule minus-end binding (GO:0051011),0.40775792461866495,1.0275259680852789,0.4204355108877722,0.9522017488731432,1.0,6/13,25.29%,HAUS4;CAMSAP3;CAMSAP1;TUBGCP2;TUBGCP6;TUBGCP5
prerank,mannosyltransferase activity (GO:0000030),0.35488338182032664,1.027434161966123,0.40353697749196143,0.9471259951986692,1.0,5/21,10.03%,TMTC4;ALG1;DPY19L4;PIGB;DPY19L3
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.41553831093499016,1.0266386002655081,0.4397810218978102,0.9444744408066691,1.0,4/12,14.92%,GABRG1;GABRG2;GABRA2;GABRB1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.34965299743880085,1.0263401815201407,0.42857142857142855,0.940256721317406,1.0,12/22,29.93%,SYT1;CLU;APBB1;HSP90B1;APBB3;LANCL1;ANKRA2;SNX17;CLTC;DNAJA1;HSPG2;AP2M1
prerank,N-acetyltransferase activity (GO:0008080),0.3601966663938956,1.0262458452701708,0.4213197969543147,0.9354169986065327,1.0,4/19,7.21%,SAT2;SMARCE1;NAT8L;ATAT1
prerank,gamma-tubulin binding (GO:0043015),-0.33323669580891113,-1.0258261954370005,0.4088397790055249,0.7921919744996996,1.0,11/21,23.46%,CDK5RAP2;GIT1;DIXDC1;RACGAP1;TUBGCP4;RAB11FIP5;TUBGCP3;B9D2;OFD1;MARK4;BRSK1
prerank,adrenergic receptor binding (GO:0031690),0.38241983055006984,1.0244283948311554,0.42105263157894735,0.9362877266349354,1.0,7/16,26.67%,ADRA2A;APLP1;NEDD4;GNAS;MAGI2;RAPGEF2;DLG4
prerank,pre-mRNA binding (GO:0036002),0.3362355484632901,1.0242928777878784,0.4310897435897436,0.9314969478971412,1.0,4/28,6.10%,DDX5;TRA2B;SRSF6;PTBP1
prerank,ion gated channel activity (GO:0022839),0.345081820542169,1.023966286623229,0.40222575516693165,0.9275760890337059,1.0,7/24,16.91%,TMEM63C;TMEM63A;ANO2;TMEM63B;KCNT1;KCNT2;ANO3
prerank,Hsp70 protein binding (GO:0030544),-0.2983729050192243,-1.0225256463680759,0.4064327485380117,0.7963863775876208,1.0,15/31,28.47%,DNAJC8;ERN1;NOD2;PACRG;DNAJC10;HIKESHI;CYP1A1;FICD;SPN;DNAJB1;GPR37;DNAJB14;RNF207;DNAJB12;TSC1
prerank,MHC class II protein complex binding (GO:0023026),0.41703585064992954,1.0224446202663802,0.4359861591695502,0.927596300710801,1.0,3/11,8.42%,YWHAE;ATP1B1;CD81
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.31154674379846065,-1.022107984752064,0.43351063829787234,0.7922315823383609,1.0,7/25,22.37%,PARP4;PARP14;PARP9;TIPARP;ZC3HAV1;SIRT2;PARP16
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.3342014503655092,1.0211823702595493,0.42289348171701113,0.9269360217593666,1.0,7/28,15.04%,RPP40;ELAC2;DROSHA;PRORP;RPP30;APEX1;FEN1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.32960338563573854,1.0206989360235064,0.4356589147286822,0.9236897423124272,1.0,7/29,14.60%,SLC1A1;SLC25A18;SLC26A4;SLC38A7;SLC26A7;SLC1A4;SLC19A1
prerank,cytokine receptor binding (GO:0005126),-0.23453334199880366,-1.0187168189222353,0.4103448275862069,0.7969533870149168,1.0,30/83,27.79%,SDCBP;LIFR;PIBF1;CD300LF;IL6ST;KITLG;IL27;CCL25;SMAD3;SYK;IL1B;ERAP1;CCRL2;TIMM50;IL27RA;ADAM17;OSMR;USP15;EPO;TLR5;VEGFB;FADD;TLR9;CXCL12;PGF;IL12RB1;CSF1;TSLP;CRLF1;SPRED1
prerank,I-SMAD binding (GO:0070411),-0.37457238133892734,-1.0185039324135101,0.4322429906542056,0.7922924381233004,1.0,5/13,17.91%,SMAD9;SMAD3;CTNNB1;SMAD6;SMAD4
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.3491495886397732,-1.0183563685691785,0.4152334152334152,0.7875008467778245,1.0,4/18,11.57%,GAS6;TNFAIP8;BIRC5;BIRC2
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.4305215403958652,1.0178022546211096,0.4418604651162791,0.9283090764024541,1.0,3/10,17.97%,SLC10A2;SLC6A1;SLC10A1
prerank,manganese ion binding (GO:0030145),0.2960887218670588,1.0164883872816235,0.4375,0.92750397122473,1.0,20/48,27.84%,XPNPEP1;MTPAP;XPNPEP3;MPPE1;MPPED2;NEK4;MGAT5B;FEN1;POMGNT1;WRN;ARG2;GALNT4;GALNT2;EXD2;LARGE1;SOD2;GALNT3;PAPOLA;NUDT16;PPM1M
prerank,glucose transmembrane transporter activity (GO:0005355),0.3767765529563186,1.0146482725576782,0.4391080617495712,0.9285449500214411,1.0,2/17,6.74%,SLC2A3;SLC2A2
prerank,cytokine receptor activity (GO:0004896),0.26890689007785634,1.0137532099615791,0.43273231622746183,0.9266540223402207,1.0,20/83,19.22%,ACKR4;IL5RA;F3;IL2RA;CSF3R;CNTFR;PRLR;IL1RAP;CCR1;GPR17;CX3CR1;IL13RA1;GFRA1;CCR6;CCR9;ACKR2;IFNGR1;FLT3;IL1RAPL2;IL17RD
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.37686965811356965,-1.0136566950265418,0.3954659949622166,0.7956012104465596,1.0,2/13,2.55%,CSK;PJA2
prerank,nuclease activity (GO:0004518),0.2883024869423477,1.0129954605974292,0.4059561128526646,0.9243111981503559,1.0,15/52,19.53%,ANG;RNASE1;DNASE1L2;DDX1;MAP1S;OGG1;NME1;RNASEL;RNASE7;SND1;APEX1;FEN1;WRN;RNASE12;REXO4
prerank,metal ion transmembrane transporter activity (GO:0046873),0.34615456741211276,1.0115925920244915,0.44810543657331137,0.9240267209619535,1.0,5/27,5.80%,SLC4A8;ATP2A3;ITPR2;CLDN16;SLC12A2
prerank,cytokine activity (GO:0005125),0.24954028920496588,1.0100928418883843,0.44297082228116713,0.9240165837409077,1.0,24/131,20.20%,WNT4;GDF11;SLURP1;IL17F;WNT3;IL6;NDP;IL2;BMP4;TNFRSF11B;TGFB1;WNT8B;CLCF1;FGF2;INHA;HMGB1;WNT7A;GDF1;IL7;IL1A;IL18;CCL15;CCL5;IL34
prerank,WW domain binding (GO:0050699),0.33334746299591,1.0086496293856846,0.4415156507413509,0.9239781249666621,1.0,3/26,2.65%,TCEAL5;WBP1;SCNN1A
prerank,CARD domain binding (GO:0050700),0.39316034675826494,1.0047017093865527,0.4852459016393443,0.9318115195062148,1.0,6/14,24.95%,CARD14;NOD1;CASP4;CARD16;RIPK2;IRGM
prerank,ubiquitin-dependent protein binding (GO:0140036),0.42953827892538277,1.004584442151818,0.46471600688468157,0.9274571241342915,1.0,3/10,11.11%,ANKRD13D;DNAJC2;FAN1
prerank,antiporter activity (GO:0015297),0.35523723750476116,1.0023464454068602,0.46710526315789475,0.9303229217316671,1.0,9/20,28.92%,SLC35A1;SLC35C1;TMEM241;ATP1A3;SLC25A10;SLC35E2A;SLC35E2B;SLC25A16;CLCN3
prerank,muscle alpha-actinin binding (GO:0051371),-0.3520205660149944,-0.9998893459019332,0.42891566265060244,0.8305823577292287,1.0,3/15,4.64%,PDLIM1;PDLIM5;SYNPO2
prerank,magnesium ion binding (GO:0000287),-0.21651347756591124,-0.9995049946817788,0.43824701195219123,0.8262808870372799,1.0,47/135,25.39%,STK3;DIS3L2;ABL2;STK38;MARK2;IDH3A;RRAGC;NUAK2;TOP2A;NLRC4;IDH1;ERN1;TKT;HMGCL;UBA2;GCLC;CERK;EYA2;CLYBL;NUDT5;NLK;SIK2;LRRK2;SIK1;TESC;PRKACB;ADPRH;FOXK2;PDE2A;MAP2K7;MTHFD2;XYLT2;RAP2A;MAPK12;PLK1;CDC42BPG;STK38L;MVK;MAP3K20;PPA2;THG1L;PLSCR1;BRSK1;PIF1;TDG;TDP2;ERN2
prerank,phosphatidate phosphatase activity (GO:0008195),0.3871504585678962,0.999268905162487,0.46236559139784944,0.9353839381517044,1.0,5/13,25.56%,PLPP5;PLPPR4;PLPP1;PLPP2;PLPPR1
prerank,solute:proton symporter activity (GO:0015295),0.3678135543330872,0.9992615521787159,0.4749568221070812,0.9307533849721322,1.0,4/16,20.13%,SLC33A1;SLC39A8;CTNS;SLC2A9
prerank,mRNA 3'-UTR binding (GO:0003730),-0.2342158315935994,-0.9961949080292699,0.4725274725274725,0.830761090793033,1.0,24/79,21.13%,CELF1;CPSF1;RPL5;PUM2;RPS7;EXOSC8;CPEB4;ZC3H12A;CRYZ;RC3H1;HNRNPA2B1;LARP1;EXOSC9;RPL41;LARP4B;FXR2;CPEB2;RNF20;MEX3D;HNRNPU;CELF2;HNRNPC;CPEB3;PUM1
prerank,anion transmembrane transporter activity (GO:0008509),0.39800223340593893,0.9955327360026427,0.47038327526132406,0.9379640195290335,1.0,6/12,24.96%,SLCO2B1;MFSD10;SLC39A8;SLC19A1;ABCG2;ABCC5
prerank,metal ion:proton antiporter activity (GO:0051139),-0.3615444474693341,-0.9953901730207808,0.4405594405594406,0.8277427930919578,1.0,7/13,26.88%,SLC9B2;SLC9A9;SLC9A2;SLC11A1;SLC9A6;LETM1;SLC9A3
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.30770371216166986,0.9951890632380408,0.4552238805970149,0.9344412999981976,1.0,16/35,31.70%,NT5C3A;ELAC2;DTWD2;FTSJ1;TARS2;DUS4L;TRIT1;DUS1L;MRPL58;BCDIN3D;FTO;AARS1;GATB;QTRT2;TRPT1;ALKBH1
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.20027571444801,-0.9945195835062322,0.46258503401360546,0.8250539289502845,1.0,72/269,20.04%,BCL2;ITCH;PTPN22;MAP1LC3B;VCP;CUL3;RPL5;ARIH1;UBE2K;CUL4A;DTX3L;PRKACA;FBXW7;STAT2;PATZ1;BAG4;HSPD1;RIPK1;SMAD3;EGR2;SNX9;UBC;TXNIP;PSMA3;ERLIN2;HIF1A;MID1;BAG6;SPOPL;PACRG;UBE2L3;BRCA1;UBA52;STAT1;FOXO1;TNFRSF1B;RRAGA;SMAD6;NLK;GPI;RALB;STAM;RB1;PARP9;DBT;EGFR;UBE2L6;MAGEC2;PRKACB;TRAF1;MUL1;UBE2C;VCL;ASB4;AMBRA1;RPA2;MAP1LC3A;SQSTM1;LAPTM4B;RNF20;TRAF4;CBS;TRIM37;PSMD1;GPR37;NKD2;NPLOC4;WFS1;CUL5;HSPA1B;PA2G4;RPL11
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.33215093120382244,0.993816206578038,0.4688026981450253,0.9342895238542223,1.0,5/25,15.72%,AKR1C1;NDOR1;MICAL3;FMO1;CYP27A1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.36512174302321654,0.9916906409315305,0.4631578947368421,0.9363451004444289,1.0,7/17,23.59%,NME1;AK5;AK4;AK3;DTYMK;AK1;AK9
prerank,5'-3' RNA polymerase activity (GO:0034062),0.32100416580424557,0.9908608152031355,0.4563758389261745,0.9344095919028588,1.0,12/27,27.44%,POLR2L;POLR2F;POLR3F;POLR2G;POLR3A;POLR1F;POLR3B;POLR2C;POLR3K;POLR2D;POLR1A;POLRMT
prerank,metal ion binding (GO:0046872),0.21543698885273183,0.9868086888941646,0.5180327868852459,0.9424825444597426,1.0,91/477,17.78%,TPPP;AGRN;NUDT12;SYT4;ANXA8;ANXA8L1;ATP2A2;HMGCLL1;CAPN3;ITPR2;EFHD1;CDH23;NIM1K;DCHS1;STK26;TRIM26;SYT13;SYT1;TNNC1;NT5C3A;SPOCK2;STK11;SYT6;LRP2;DNASE1L2;SMOC2;PLA2G4C;ASPH;PRNP;GSS;NRXN1;TRPM2;ESYT2;MTPAP;KCNIP4;S100A2;FKBP9;S100A13;CDH18;PI4K2A;CDC42BPA;MICU2;NUDT3;NME1;ADGRL3;S100G;OTOF;PKD2;CPNE6;ENPP2;GRIN1;HPRT1;SLC8A1;BGLAP;HSP90B1;PPA1;PDCD6;ADPRS;CISD3;CCDC47;FAN1;CDH4;ITPR3;CSGALNACT1;HSPE1;NUCB1;CLGN;RCN2;BAIAP3;AOC1;APEX1;FEN1;TCHH;SLC25A23;NDUFAB1;HPCA;CDC42BPB;POSTN;SDF4;MT2A;WRN;CANT1;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;MAST2
prerank,triglyceride lipase activity (GO:0004806),0.3487205912959973,0.9864763152328782,0.48105436573311366,0.9388397505560716,1.0,6/20,22.74%,PNPLA3;ABHD5;LIPC;PLA2G15;LIPE;DAGLB
prerank,ion channel inhibitor activity (GO:0008200),-0.27515071113849365,-0.9856892928702194,0.47802197802197804,0.8458258170922802,1.0,10/35,17.97%,MCUB;ENSA;RASA1;ITPR1;CAMK2D;PHPT1;CALM2;RACK1;RSC1A1;SLC30A1
prerank,motor activity (GO:0003774),-0.24305243722339276,-0.985549273239818,0.4625,0.8408901214898993,1.0,20/60,20.96%,KIF3A;KIF16B;KIF23;KIF11;KIFC2;KIF20B;KIF13B;KIFC1;KIF24;KIF21A;KIF4A;MYH9;GPR88;KIF20A;DNAH8;KIF18B;KIF19;KIF27;KIF7;MYO1E
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.3736353910225338,0.9840496444291145,0.4704918032786885,0.9416961220284596,1.0,6/15,18.23%,PNPLA3;LPCAT1;LPCAT2;AGPAT1;ABHD5;ABHD8
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.3044909286241249,-0.9823985957143844,0.46134020618556704,0.8451822723838759,1.0,7/24,17.49%,MKNK1;MAPKAPK2;CAMK2D;MAPKAPK3;DAPK1;PTK2B;CAMK1G
prerank,RNA polymerase II complex binding (GO:0000993),0.3067937112900243,0.9808955908118377,0.47145187601957583,0.9469174111441699,1.0,11/32,25.19%,CTR9;SMYD2;ELP2;BRD4;CCAR2;PAF1;ELOF1;SCAF8;GTF2B;ELP4;URI1
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),-0.20106125465172783,-0.9798994124730641,0.5380710659898477,0.8476340823602069,1.0,34/181,14.32%,RBPJ;MDFIC;PSMA6;RBBP8;PPARG;DTX3L;SMARCA4;NCOA7;PROX1;TAF1;BBS7;PPARD;NCOA1;SMAD3;EGR2;SP1;HIF1A;SNW1;MAD2L2;STAT1;ANXA4;PIAS2;CTNNB1;EP300;BRMS1;SPEN;HDAC2;CRY1;PRRX1;HDAC1;RB1;FOS;PARP9;NPM1
prerank,cardiolipin binding (GO:1901612),0.4168149138555693,0.9790689263658414,0.4929078014184397,0.9478909320208307,1.0,2/10,9.21%,GSDME;UQCC3
prerank,protein kinase C binding (GO:0005080),0.2876133464802081,0.978669085231617,0.4847094801223242,0.9446198552111176,1.0,8/43,10.96%,PKN1;PARD6B;AVPR1A;PARD6G;TWF2;HDAC5;PRKD2;IRS1
prerank,cysteine-type endopeptidase activity (GO:0004197),0.2581847233829775,0.9758496899760721,0.5118219749652295,0.948899438394474,1.0,15/78,12.64%,USP10;CAPN3;CAPN12;USP35;USP11;LGMN;USP30;CAPNS1;CAPN11;USP12;CASP3;SFRP1;USP33;CASP4;CASP7
prerank,GTPase regulator activity (GO:0030695),-0.20004776082165873,-0.9748113244392841,0.5543478260869565,0.8578567599400149,1.0,45/212,17.89%,IQGAP1;VAV3;ARHGAP15;IQGAP2;ARHGAP10;NRP1;TBC1D1;STARD8;ARHGEF10L;ARHGAP17;ARHGAP19;RANBP2;RIC8A;RASA4;RASA1;ARHGEF6;RABGAP1;ARHGAP18;TBC1D2;ASAP1;ARAP1;ARHGAP30;RACGAP1;ARHGAP24;SEC23A;ABR;RALGAPA2;AGAP2;RANBP3;ARHGAP39;ARHGAP28;TBC1D10C;TBC1D10A;USP6NL;ALDH1A1;LRRK2;RGPD1;ADPRH;CDC42SE1;RAB3GAP2;RGS8;CPEB2;PGAM5;ECT2;TBCK
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.3675226963074639,0.9730826827722775,0.4898989898989899,0.9531607205623676,1.0,2/14,11.74%,RDH10;RDH5
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.33737007840934685,0.9724582873204117,0.4901639344262295,0.9506622535624001,1.0,6/20,24.48%,OTULINL;USP50;OTUB1;OTUD5;COPS5;USP7
prerank,DNA-binding transcription factor binding (GO:0140297),0.227203835296134,0.9694658302190428,0.5310945273631841,0.9556969970011281,1.0,34/189,15.02%,HHEX;TLE3;ZFPM1;TLE2;LDB2;LDB1;USF2;RELA;PPARA;CRTC1;ZFPM2;AR;CTBP1;MEF2C;MAP3K10;GTF2I;LMO2;LHX3;TCF7L2;DGKQ;HDAC5;BBS5;TAF9;NFE2L2;IFI27;USF1;GABPA;TBX6;PRDM16;HMGB1;RBL2;DMAP1;ZBTB49;RBL1
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.3653069252418602,0.968786928985937,0.4940577249575552,0.9533425194100034,1.0,2/15,5.38%,PLA2G3;PLA2G4C
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.3434867089279645,-0.9682535852645985,0.4839506172839506,0.8715611551609088,1.0,4/14,8.09%,BLVRB;MTHFR;PYCR2;MTHFD1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.3201988177724336,0.9681250318774772,0.5128617363344051,0.9508733416409565,1.0,9/26,29.51%,SLC16A6;SLC5A12;SLC6A1;MPC1;SLC16A12;ABCG2;SLC16A7;SLC16A9;MPC2
prerank,nuclear localization sequence binding (GO:0008139),-0.32574531604211604,-0.9668602246149087,0.4835443037974684,0.8702035819115039,1.0,3/18,7.95%,KPNB1;KPNA2;NUP153
prerank,protein heterodimerization activity (GO:0046982),-0.2003339162170002,-0.9667544927811612,0.5833333333333334,0.8652250622985119,1.0,46/178,22.26%,BCL2;CYBB;HIP1;BCL2L1;EXT1;SDCBP;ZHX2;ATF3;PAFAH1B2;MCL1;RRAGC;BAX;TOP2A;SNX1;TCOF1;AHR;TAF1;HIF1A;HSF1;UBA2;ABCG4;ABCG1;RALGAPA2;BARD1;CYBA;RRAGA;LSM5;GCA;TLR4;FXR2;ADRA1A;MICU1;TPM4;TFAP2B;PAFAH1B3;SDCBP2;PAFAH1B1;TAF7;TUBB2B;BHLHE40;RCC1;FZD4;TOP2B;NPAS4;CD3E;VAPB
prerank,metalloexopeptidase activity (GO:0008235),0.2768458914248679,0.9663447184264125,0.5218068535825545,0.9520349138497987,1.0,14/51,18.37%,MMP16;RNPEPL1;XPNPEP1;METAP1D;XPNPEP3;VASH1;AEBP1;TRHDE;VASH2;LAP3;ENPEP;AGBL4;MMP17;FOLH1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.3574256206320574,0.9642549465041592,0.502454991816694,0.9542115517849417,1.0,6/16,22.37%,SLC1A1;SLC25A18;SLC38A7;SLC1A4;SLC13A3;SLC25A10
prerank,filamin binding (GO:0031005),0.39536069170974886,0.963629251135454,0.5296229802513465,0.9516207030100886,1.0,2/11,4.65%,NEBL;CRMP1
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.2447407632285296,-0.9633567589747917,0.5353846153846153,0.8704471012142316,1.0,19/53,26.20%,CYBB;XDH;ACOX3;MTHFR;KMO;CRY2;SQOR;MTO1;CRY1;MTRR;ACADL;MICAL1;MICAL2;POR;GSR;ACOXL;NOX4;NQO2;AIFM1
prerank,kinase activity (GO:0016301),-0.2139812722703729,-0.9624371940800687,0.5634920634920635,0.8677843416008355,1.0,27/109,16.54%,PIK3C3;PAPSS2;FCSK;DGKK;NADK;TAF1;PRKD3;PANK1;CERKL;LYN;PSTK;IPPK;PIK3CA;TRRAP;CERK;PANK3;SHPK;LRRK2;GK5;SPHK2;GK;FN3KRP;PGM2L1;ITPKA;DGKA;POMK;PI4KA
prerank,double-stranded DNA binding (GO:0003690),0.20695439579477728,0.9617395275681824,0.5971769815418024,0.9529848926153986,1.0,87/531,18.05%,HOXA5;NUCKS1;SCRT2;HSF4;PQBP1;ONECUT2;POU2F2;TFCP2;USF2;HOXD4;ESRRG;LBX2;NEUROG2;NR1I2;FOSL1;NRL;SIX4;NR1I3;ATOH7;HIC1;SKOR1;NEUROD2;NFIB;SP2;SOX10;TFCP2L1;MEOX2;SOX4;BCL11B;ZBTB12;HOXB9;HOXB7;E2F1;HDGFL2;XRCC6;NR2F6;MEF2C;GTF2H4;RXRG;HOXC10;ZBTB22;HEY1;TBX2;ZNF23;SNAI2;DMRTA1;CGAS;HSF2;ZNF32;ZFP1;DMC1;HOXB2;ZFP41;POU3F4;POLR3F;USF1;TFEB;GABPA;HLF;HOXB5;TBX6;LHX5;TEF;HMGB1;ZBTB32;BARX2;LMX1B;APEX1;FEN1;PRDM1;HMGB3;ZNF740;ERG;IRF5;BATF;TCF7L1;EN2;KLF16;BHLHE41;CENPS;PSIP1;MAX;BACH2;ZIC5;HDGFL3;KLF12;XBP1
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.22414624399937588,-0.9608450841085261,0.5641891891891891,0.8669461022896172,1.0,12/91,6.30%,SVIL;HIP1;KIF16B;SESTD1;SDCBP;PLA2G4E;SH3PXD2B;GBF1;FCHO2;HIP1R;PICALM;LDLRAP1
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.3023735720400581,0.9607026098859041,0.5364667747163695,0.9516927705187456,1.0,8/34,15.74%,CNOT2;ERI3;REXO2;ANGEL1;EXOSC5;ERI2;CNOT8;ANGEL2
prerank,zinc ion binding (GO:0008270),0.218157272012968,0.9589115359091906,0.5810185185185185,0.9527542863136672,1.0,73/293,20.61%,POLR2L;QPCTL;NUDT12;TET1;IKZF4;MMP16;MYCBP2;AFP;NSD1;KDM1B;ZFPM2;ADA;GALT;S100A13;ZNF205;WDFY1;SHANK3;CHORDC1;ENPP2;PHEX;GRIN2B;TRHDE;PRKN;ITGB1BP2;KLF7;KDM2B;SUV39H2;USP33;THAP1;RNF8;CHMP1A;PHF8;SEC24D;PITRM1;TIMM13;SEC24B;FBXL19;TRIM8;KDM4A;MSRB3;ACR;PGGT1B;RNF2;ZBTB32;TRAF7;AOC1;ENPEP;RPS27;NAPEPLD;CLIP1;SIAH1;SEC24C;EPRS1;ESCO1;TK1;MT2A;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;ZEB1;PHF2;ADAMTS3;ALAD;RABGGTB;CDADC1;CYLD;CALB1;PLA2G15
prerank,sequence-specific DNA binding (GO:0043565),0.20586603908315318,0.9587748395135934,0.6262083780880774,0.9489201309599142,1.0,102/590,18.54%,HOXA5;HHEX;SCRT2;TET1;HSF4;ONECUT2;MYRFL;POU2F2;CSRNP3;TFCP2;USF2;HOXD4;BPTF;ESRRG;LBX2;NEUROG2;NR1I2;FOSL1;NRL;SIX4;NR1I3;ATOH7;HIC1;SKOR1;NEUROD2;NFIB;SP2;SOX10;TFCP2L1;TFAM;PPARGC1A;MEOX2;SOX4;BCL11B;ZBTB12;PPARA;HOXB9;HOXB7;E2F1;FOXD1;XRCC6;NR2F6;MEF2C;RXRG;ZNF35;HOXC10;LHX3;SP4;TCF7L2;ZBTB22;FOXC1;HEY1;TBX2;ZNF23;SNAI2;DMRTA1;GRHL3;HSF2;NFE2L2;ZNF32;ZFP1;KDM2B;HOXB2;ZFP41;POU3F4;THAP1;USF1;TFEB;GABPA;EPAS1;HLF;HOXB5;TBX6;FBXL19;LHX5;TEF;MYRF;PRDM16;ZBTB32;BARX2;LMX1B;ZBTB49;UPF1;PRDM1;ZNF740;ERG;IRF5;BATF;TCF7L1;CALCOCO1;EN2;KLF16;BHLHE41;MAX;BACH2;SMG1;ZIC5;KLF12;XBP1;POU3F3;ZBTB7B;CHTOP
prerank,microtubule binding (GO:0008017),0.22528933407740107,0.9587509359462513,0.5700245700245701,0.944807650495677,1.0,63/222,22.86%,TPPP;GAPDH;MAP6;DST;HAUS4;PSRC1;MID2;REEP2;PRNP;NAV3;MAP1S;CLASP2;CCDC181;MAPRE2;KIF26A;MAP4K4;FSD1;CKAP5;CAMSAP3;LRPPRC;RAE1;PEX14;FGF13;RMDN3;VASH2;CAMSAP1;DCTN1;DNM1L;MTCL1;KIF1C;SYBU;KIF2A;HOOK2;NDRG1;NEFM;RCC2;TUBGCP2;APC2;UXT;CLIP1;MAP9;KIF14;ALMS1;STARD9;TOGARAM2;HDGFL3;MAST2;EML4;HOOK1;EML6;ABRAXAS2;TPGS1;TUBGCP6;CEP57;KIF1B;KIF9;KIF17;MAP2;MAPRE3;SPAST;DRG1;MAP7D3;KIF21B
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.395585839188737,0.9587116400970239,0.5061295971978984,0.9408050328399693,1.0,5/11,26.88%,NUDT10;NUDT3;NUDT16L1;NUDT16;NUDT4
prerank,calcium ion binding (GO:0005509),0.2144639617078945,0.9585103363803198,0.5963511972633979,0.9372203490333669,1.0,44/323,11.94%,AGRN;SYT4;ANXA8;ANXA8L1;ATP2A2;CAPN3;ITPR2;EFHD1;CDH23;DCHS1;SYT13;SYT1;TNNC1;SPOCK2;SYT6;LRP2;DNASE1L2;SMOC2;PLA2G4C;ASPH;PRNP;NRXN1;TRPM2;ESYT2;KCNIP4;S100A2;FKBP9;S100A13;CDH18;MICU2;ADGRL3;S100G;OTOF;PKD2;CPNE6;ENPP2;GRIN1;SLC8A1;BGLAP;HSP90B1;PDCD6;CCDC47;CDH4;ITPR3
prerank,O-methyltransferase activity (GO:0008171),0.39639324889097,0.9581817181508362,0.5155393053016454,0.9341251652106821,1.0,6/10,27.27%,LRTOMT;MEPCE;COMT;ASMT;BCDIN3D;CMTR2
prerank,tau-protein kinase activity (GO:0050321),-0.3092163676352859,-0.957969185873417,0.4892086330935252,0.8701249615669778,1.0,3/20,7.14%,MARK2;DYRK1A;FYN
prerank,amino acid binding (GO:0016597),0.2997477673895902,0.9566941209229537,0.5366242038216561,0.934379489486005,1.0,7/31,16.88%,GLRA3;GLRB;GRIN1;GRIN2B;GLRA2;DDAH2;AGXT
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.35672114965509555,0.9547655187662692,0.5317324185248714,0.9355481025426275,1.0,5/15,13.95%,SLA2;SOCS3;SOCS2;SOCS6;SOCS4
prerank,phospholipase inhibitor activity (GO:0004859),-0.3759766312054073,-0.9542897255077218,0.5100222717149221,0.8757803092074627,1.0,3/10,12.77%,ANXA1;ANXA4;APOC1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.24884286190095006,-0.9540150818676981,0.5509554140127388,0.8714650315916814,1.0,17/48,23.11%,TMEM165;ATP6V1B2;TRPC1;SLC46A1;RHD;TRPM4;TRPV2;TRPM6;PIEZO2;CALHM6;SLC12A7;PKD1L3;CALHM5;MCOLN1;GRIN3B;TRPM1;MMGT1
prerank,transcription coactivator binding (GO:0001223),-0.30415290336651446,-0.953916398236043,0.5378787878787878,0.8666741761243342,1.0,5/20,7.13%,AHR;ESR1;PPARD;SMAD3;CIT
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.2317065998377345,-0.9528715946674985,0.5659163987138264,0.8648602130051456,1.0,18/72,19.16%,SVIL;HIP1;SESTD1;SDCBP;PLA2G4E;FCHO2;HIP1R;PICALM;LDLRAP1;OSBPL2;PLEKHA4;STXBP6;VILL;SNX21;PFN2;GSN;KCNQ1;SDCBP2
prerank,gap junction channel activity (GO:0005243),0.3329962704085124,0.951852510315607,0.5510534846029174,0.9400486201963261,1.0,3/22,11.89%,GJC3;GJA5;PANX1
prerank,thiol-dependent deubiquitinase (GO:0004843),0.25210213418949534,0.951361118497697,0.5521978021978022,0.9374686719603404,1.0,20/83,20.35%,MPND;OTUD7A;USP32;USP10;USP35;USP11;USP50;USP51;USP30;USP12;USP33;PSMD14;OTUB1;BAP1;OTUD7B;OTUD5;USP48;STAMBP;CYLD;COPS5
prerank,miRNA binding (GO:0035198),-0.2801809461676555,-0.9513002823574241,0.5371900826446281,0.864298293804643,1.0,10/30,21.50%,PUM2;ZNF346;ZC3H12A;RC3H1;HNRNPA2B1;AGO2;DDX21;TRIM71;PUM1;ZC3H7A
prerank,solute:sodium symporter activity (GO:0015370),0.31394338924588155,0.9503646352364686,0.5016393442622951,0.9361528091409512,1.0,4/27,13.49%,SLC4A8;SLC20A1;SLC4A10;SLC4A7
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.3795064261396368,-0.9500215503215966,0.4930232558139535,0.8628500290382835,1.0,2/10,9.53%,DPP4;PRCP
prerank,protein homodimerization activity (GO:0042803),0.20472862528427374,0.9498580248223538,0.6606189967982924,0.9335442241421195,1.0,153/589,23.45%,TPPP;MYOM1;HHEX;TSC2;HOGA1;STARD3;MKLN1;TYW5;ANG;ADCY8;SRGAP2;KCNH2;RAB11FIP3;LDB1;NACC2;DGAT2;ADD2;F11R;USF2;STK26;RELA;DUSP29;NTRK1;FLT4;IL17F;MID2;CADM1;TNNC1;TENM1;PTPRT;PTPRO;SYT6;XPNPEP1;DEFA6;GSS;MTHFD1L;MTPAP;XPNPEP3;SPPL2B;COMMD1;NDP;ADRA2A;MAP3K10;S100A13;PSMF1;DAB2IP;NOD1;ACSL6;BAK1;PKD2;NAGA;ACHE;PSMD7;ERBB4;NECTIN3;TENM3;GGCT;INPP5F;PAXX;GUCY2D;RBPMS2;PDCD6;RAP1GAP;TRIM9;ZDHHC2;EXD1;DROSHA;TRPC6;STK25;RDH5;KYAT1;THAP1;USF1;PDGFB;RNF8;DNM1L;MTMR1;TARS2;DCK;CHMP1A;MTCL1;CORO1A;CADM3;GADD45A;TRIM8;MIGA1;ACOX1;MAP3K13;NUDT21;TPST2;CRYL1;AOC1;SNX6;NTRK2;DSCAML1;OXA1L;HM13;NAA60;TCF3;PGRMC1;PPCS;EPRS1;HARS1;BHLHE41;AGXT;GALE;SCARB2;MFF;TRIM68;WRN;CANT1;ABCD2;ASMT;UXS1;ALS2;POU3F3;NADK2;ZBTB7B;CHRNA7;HOOK1;CCL5;CAV2;ERP29;SSBP1;CDADC1;ABCB7;SRF;CLN6;SNF8;CR2;ABCG2;HSP90AB1;CEP57;PSPH;MMAA;PIP4K2B;PEX11B;HPGDS;EXD2;AXIN1;IRF3;EXT2;UGT1A6;RAB11FIP2;FXR1;KCNN2;SPPL2A;PEX11A;CAMK2B;GBP2;IL6R;RIPK2;NUDT16L1
prerank,translation elongation factor activity (GO:0003746),0.3638231763870051,0.9474381409880044,0.5361552028218695,0.9362811690797692,1.0,6/14,20.85%,GTPBP1;GFM2;EEF1A2;EIF5AL1;EIF5A;EIF5A2
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.35809375377594876,0.9406456027910116,0.5470085470085471,0.9516303471496438,1.0,4/14,10.43%,CAPN3;CAPN12;CAPNS1;CAPN11
prerank,tRNA methyltransferase activity (GO:0008175),-0.3211102137651015,-0.9382005651299518,0.5352112676056338,0.8915360919392226,1.0,7/16,15.24%,TARBP1;THUMPD3;LCMT2;ALKBH8;TRDMT1;TRMT13;TRMT9B
prerank,deubiquitinase activity (GO:0101005),0.24661128908274352,0.9373325742646522,0.5891364902506964,0.9569876248846031,1.0,20/88,20.35%,MPND;OTUD7A;USP32;USP10;USP35;USP11;USP50;USP51;USP30;USP12;USP33;PSMD14;OTUB1;BAP1;OTUD7B;OTUD5;USP48;STAMBP;CYLD;COPS5
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.3761144391260713,-0.9358523956845731,0.5473441108545035,0.8927820245177291,1.0,3/10,6.17%,NSD2;SETD3;PRDM9
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.31781788595745264,-0.9352700295821452,0.5577395577395577,0.8893743997125196,1.0,7/18,12.88%,SOCS7;SOCS5;AGAP2;WDR91;WDR81;PIK3R6;PIK3R5
prerank,disordered domain specific binding (GO:0097718),0.3194336906847611,0.9346068062063303,0.5582137161084529,0.9606061483379692,1.0,3/23,4.72%,GAPDH;HSPA2;PPIL1
prerank,pyrophosphatase activity (GO:0016462),0.2711714023862819,0.9344567036082221,0.5622254758418741,0.9570021253473464,1.0,17/50,26.88%,PLPP5;NUDT10;NUDT9;TRPM2;NUDT3;ENTPD6;ALPL;PPA1;FITM2;DXO;PLPP1;NUDT16L1;ENTPD1;DDX3X;ENTPD2;NUDT16;NUDT4
prerank,R-SMAD binding (GO:0070412),0.3363002958274323,0.9337792531932293,0.5596638655462185,0.9549961431006138,1.0,4/18,11.47%,LDLRAD4;DDX5;PPM1A;DROSHA
prerank,ATPase binding (GO:0051117),-0.22710987144336306,-0.9324264002004183,0.5816326530612245,0.8921086502691927,1.0,22/71,19.77%,CHMP4A;ATP6V0A1;TOR1AIP1;ESR1;TRPC1;CAV1;NR1H2;PSEN1;CLPP;DNAJC10;VCPKMT;LCK;S100A1;NOP58;PPP3CA;RALB;EGFR;FBL;DNAJB1;NKD2;WFS1;ATP6V0A4
prerank,5'-3' exonuclease activity (GO:0008409),0.36500998888459113,0.9320484264470975,0.5557620817843866,0.9560456295118653,1.0,4/14,18.98%,CPSF3;FAN1;FEN1;DXO
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.30531157269087716,0.9290865541826157,0.563011456628478,0.9603497766895022,1.0,7/27,18.16%,RNF19A;PPARA;RNF180;DCUN1D2;PRKN;SIAH1;SIAH3
prerank,fibroblast growth factor binding (GO:0017134),0.32704094898975733,0.929021196091218,0.5776293823038398,0.956600388017682,1.0,3/21,7.14%,KLB;GPC1;S100A13
prerank,mannose binding (GO:0005537),0.37606479558209754,0.9286747770474117,0.5409252669039146,0.9535638064618646,1.0,3/12,18.66%,MBL2;ACR;LMAN2L
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.22254717713058447,-0.9285352010217296,0.6387096774193548,0.8979067373760647,1.0,24/71,21.65%,PTPN22;PTPN23;PTPRC;PTPN1;CDC14B;PTPN21;EYA1;PTPN7;DUSP18;EYA3;CDKN3;EYA2;DUSP1;TIMM50;TNS2;CDC25A;MTMR3;HACD2;PTPRZ1;PTP4A3;PTPRH;CDC25C;PTPN4;CDC14A
prerank,nuclear receptor binding (GO:0016922),0.23622811890281722,0.9269814150221739,0.6187919463087248,0.9542283658798291,1.0,15/111,8.49%,DCAF1;MED24;DDX5;PKN1;NR1I2;WBP2;PPARGC1A;NSD1;MED4;BRD8;SMARCE1;TRIP6;TADA3;NCOR2;TCF7L2
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.35599698776153255,0.9267096037869405,0.5588752196836555,0.9510868808512283,1.0,6/14,23.59%,NME1;AK5;AK4;DTYMK;AK1;AK9
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.2462217868079344,-0.9262424570119114,0.5601173020527859,0.8991642804447902,1.0,7/42,9.74%,EMB;PDLIM1;PDLIM5;CD47;NPTN;ANXA1;RAB10
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.2501325575970205,0.9260984122686704,0.5968660968660968,0.9489554424778367,1.0,15/69,16.79%,DGAT2;PLAAT5;AWAT2;PLA2G4C;SOAT2;ZDHHC8;CERS4;ZDHHC1;ZDHHC2;KAT8;CERS6;CERS5;CERS1;ESCO1;NMT1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.19767253126383497,0.9258521783163035,0.7518557794273595,0.9458193463871166,1.0,154/731,22.49%,ZFHX3;HOXA5;HHEX;SCRT2;HSF4;SALL3;IKZF4;NACC2;ONECUT2;POU2F2;TFCP2;USF2;HOXD4;BPTF;ZNF394;ESRRG;RELA;KDM6B;ZBTB3;NEUROG2;NR1I2;FOSL1;NRL;SIX4;NR1I3;SOX21;ATOH7;HIC1;SKOR1;NEUROD2;NFIB;ZKSCAN7;KCNIP3;DMRT2;SP2;SOX10;TFCP2L1;WBP2;NSD1;MEOX2;SOX4;BCL11B;ZBTB12;PPARA;HOXB9;HOXC6;PBX2;HOXB7;E2F1;AR;FOXD1;NR2F6;RFX6;MEF2C;RXRG;ZNF205;MAZ;HOXC10;SP4;TCF7L2;EBF1;HDAC5;FOXC1;HEY1;ZFP82;TBX2;ZNF23;SNAI2;ZKSCAN8;KLF7;DMRTA1;GRHL3;HSF2;NFE2L2;ZNF32;ZFP1;HOXB2;POU3F4;PBX3;ZNF383;THAP1;USF1;TFEB;GABPA;HLF;HOXB5;TBX6;TEF;PRDM16;PLAG1;ZSCAN12;ZBTB32;MYNN;ZBTB49;IKZF2;NKX2-2;PRDM1;ZNF740;ERG;IRF5;BATF;REST;TCF7L1;TCF3;PRDM15;CALCOCO1;EN2;KLF16;BHLHE41;BACH1;MAX;BACH2;ZIC5;ZBTB34;ZNF750;ZFP30;ZEB1;KLF12;XBP1;POU3F3;TEAD3;ZFP92;ZBTB7B;FOSL2;SNAPC3;POU5F2;RORA;REL;SRF;DHX36;IRX5;PRDM5;ZNF467;GLI3;SMAD1;SMAD2;GRHL2;KLF5;PRMT5;HOXC5;NFE2L3;ZFAT;TEAD2;TOP1;ZNF628;SOX13;IRF3;EBF3;ZSCAN18;NFYB;NPAS2;ZIC4;SKOR2;CC2D1A
prerank,single-stranded RNA binding (GO:0003727),-0.252327377540481,-0.9252640833195741,0.6069182389937107,0.8967775010470679,1.0,8/43,9.60%,DDX60;IFIH1;EIF4B;TLR7;JMJD6;TLR8;AQR;EXOSC10
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.32370669274442715,0.9193916071026479,0.5752961082910322,0.9595039480562358,1.0,7/20,23.59%,DLG2;LRGUK;AK4;AK3;DTYMK;AK1;AK9
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.32729324438224133,0.9187155923616737,0.5725806451612904,0.9576493048358468,1.0,3/21,6.53%,PDE8B;PDE4A;PDE3B
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.3707900275024343,-0.9180879050329038,0.576036866359447,0.9109033550648431,1.0,1/10,2.10%,CD47
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.33873398303608304,-0.9157040508432185,0.5639810426540285,0.9121309179024729,1.0,4/13,19.95%,BMP5;BMP2;BMP3;BMP7
prerank,proton transmembrane transporter activity (GO:0015078),0.2738070445752406,0.9148643530299634,0.589041095890411,0.9640005168435989,1.0,10/39,24.16%,UQCRC1;SLC33A1;NDUFA4;CTNS;UQCR11;COX4I1;COX6B1;SLC9A1;UQCR10;COX10
prerank,neuropeptide receptor binding (GO:0071855),0.348234732861188,0.9137452441026391,0.5697278911564626,0.9630419503879547,1.0,3/14,18.02%,PPY;GAL;SHANK1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.1947774207094409,0.9131089957676494,0.7870762711864406,0.9608479910070669,1.0,152/732,22.49%,ZFHX3;HOXA5;HHEX;SCRT2;HSF4;SALL3;IKZF4;NACC2;ONECUT2;POU2F2;TFCP2;USF2;HOXD4;BPTF;ZNF394;ESRRG;RELA;KDM6B;ZBTB3;NEUROG2;NR1I2;FOSL1;NRL;SIX4;NR1I3;SOX21;ATOH7;HIC1;SKOR1;NEUROD2;NFIB;ZKSCAN7;KCNIP3;DMRT2;SP2;SOX10;TFCP2L1;WBP2;NSD1;MEOX2;SOX4;BCL11B;ZBTB12;PPARA;HOXB9;HOXC6;PBX2;HOXB7;E2F1;AR;FOXD1;NR2F6;RFX6;MEF2C;RXRG;ZNF205;MAZ;HOXC10;SP4;TCF7L2;EBF1;HDAC5;FOXC1;HEY1;ZFP82;TBX2;ZNF23;SNAI2;ZKSCAN8;KLF7;DMRTA1;GRHL3;HSF2;NFE2L2;ZNF32;ZFP1;HOXB2;POU3F4;PBX3;ZNF383;THAP1;USF1;TFEB;GABPA;HLF;HOXB5;TBX6;TEF;PRDM16;PLAG1;ZSCAN12;ZBTB32;MYNN;ZBTB49;IKZF2;NKX2-2;PRDM1;ZNF740;ERG;IRF5;BATF;REST;TCF7L1;TCF3;PRDM15;CALCOCO1;EN2;KLF16;BHLHE41;BACH1;BACH2;ZIC5;ZBTB34;ZNF750;ZFP30;ZEB1;KLF12;XBP1;POU3F3;TEAD3;ZFP92;ZBTB7B;FOSL2;SNAPC3;POU5F2;RORA;REL;SRF;DHX36;IRX5;PRDM5;ZNF467;GLI3;SMAD1;SMAD2;GRHL2;KLF5;HOXC5;NFE2L3;ZFAT;TEAD2;TOP1;ZNF628;SOX13;IRF3;EBF3;ZSCAN18;NFYB;NPAS2;ZIC4;SKOR2;CC2D1A
prerank,solute:anion antiporter activity (GO:0140323),-0.32701927626582905,-0.9130767988946744,0.5872641509433962,0.9142503540543977,1.0,2/14,4.77%,SLC26A11;SLC7A11
prerank,wide pore channel activity (GO:0022829),0.3126656180976581,0.9110492973048884,0.6054313099041534,0.9626403344235871,1.0,3/23,11.89%,GJC3;GJA5;PANX1
prerank,endopeptidase activator activity (GO:0061133),0.3856697904007303,0.9107567134730494,0.5920138888888888,0.9596308401914188,1.0,4/10,12.89%,VSIR;PSME3;PSENEN;PSMD14
prerank,SUMO binding (GO:0032183),0.3566211057093607,0.9102607614770731,0.5792988313856428,0.9572228516336108,1.0,3/13,11.25%,HERC2;SIMC1;CBX4
prerank,vitamin D receptor binding (GO:0042809),-0.331608107420964,-0.9102106039623127,0.5575447570332481,0.9170252979309416,1.0,3/14,9.21%,MED13;MED16;SNW1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.28261213633483984,0.9095625698909668,0.5957446808510638,0.9552834084384303,1.0,11/34,18.79%,SMYD2;METTL21C;EEF1AKMT2;METTL21A;SETD6;SETD4;TTLL12;SMYD1;KMT2E;N6AMT1;SETDB1
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.3170276431785614,-0.9062566773602818,0.5683646112600537,0.917944488170045,1.0,6/16,26.73%,TTYH2;ANO5;ANO8;ANO1;ANO10;ANO4
prerank,intracellular chloride channel activity (GO:0061778),-0.3170276431785614,-0.9062566773602818,0.5683646112600537,0.917944488170045,1.0,6/16,26.73%,TTYH2;ANO5;ANO8;ANO1;ANO10;ANO4
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.1914410094839756,0.9027713045980266,0.8152400835073069,0.9690761708809965,1.0,174/831,22.49%,ZFHX3;HOXA5;HHEX;SCRT2;HSF4;ZFP57;SALL3;IKZF4;NACC2;ONECUT2;POU2F2;TFCP2;USF2;HOXD4;BPTF;ZNF394;ESRRG;RELA;KDM6B;ZBTB3;NEUROG2;NR1I2;FOSL1;NRL;SIX4;NR1I3;SOX21;ATOH7;HIC1;SKOR1;NEUROD2;NFIB;ZKSCAN7;KCNIP3;DMRT2;SP2;SOX10;TFCP2L1;WBP2;NSD1;MEOX2;SOX4;BCL11B;ZBTB12;PPARA;HOXB9;HOXC6;PBX2;HOXB7;E2F1;AR;FOXD1;NR2F6;RFX6;MEF2C;RXRG;ZNF35;ZNF205;MAZ;HOXC10;LHX3;SP4;TCF7L2;EBF1;ZBTB22;HDAC5;FOXC1;HEY1;ZFP82;TBX2;ZNF23;AEBP1;SNAI2;ZKSCAN8;KLF7;DMRTA1;GBX1;GRHL3;HSF2;ZFP69;NFE2L2;ZNF32;ZFP1;HOXB2;ZFP41;POU3F4;RFXAP;PBX3;ZNF383;THAP1;USF1;TFEB;GABPA;EPAS1;HLF;HOXB5;TBX6;LHX5;TEF;PRDM16;PLAG1;ZSCAN12;RBL2;ZBTB32;MYNN;BARX2;LMX1B;ZBTB49;IKZF2;NKX2-2;RBL1;PRDM1;ZNF740;ERG;IRF5;BATF;BHLHA9;REST;TCF7L1;TCF3;LHX2;PRDM15;CALCOCO1;EN2;KLF16;BHLHE41;BACH1;MAX;BACH2;ZIC5;ZBTB34;ZNF750;ZFP30;ZEB1;KLF12;XBP1;POU3F3;TEAD3;ZFP92;ZBTB7B;FOSL2;SNAPC3;POU5F2;RORA;REL;SRF;DHX36;IRX5;PRDM5;ZNF467;GLI3;SMAD1;SMAD2;GRHL2;KLF5;TFDP2;HOXC5;NFE2L3;ZFAT;NPAS3;LHX4;ZBTB46;TEAD2;TOP1;ZNF628;SOX13;IRF3;EBF3;ZSCAN18;NFYB;NPAS2;ZIC4;SKOR2;CC2D1A
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.19344664918948956,0.9016218411981132,0.7874601487778958,0.9683381709632157,1.0,90/597,16.72%,HOXA5;HHEX;SCRT2;MCM5;HSF4;KCNH2;ONECUT2;POU2F2;TFCP2;USF2;HOXD4;ESRRG;RELA;LBX2;NEUROG2;NR1I2;FOSL1;NRL;SIX4;NR1I3;ATOH7;HIC1;SKOR1;NEUROD2;NFIB;SP2;SOX10;TFCP2L1;TFAM;MEOX2;SOX4;BCL11B;ZBTB12;HOXB9;HOXB7;E2F1;GABPB1;AR;XRCC6;NR2F6;RFX6;MEF2C;RXRG;MCM3;HOXC10;TCF7L2;ZBTB22;HDAC5;FOXC1;ERBB4;HEY1;TAF9;ZW10;TBX2;ZNF23;SNAI2;DMRTA1;HSF2;NFE2L2;ZNF32;ZFP1;HOXB2;ZFP41;POU3F4;SUV39H2;USF1;TFEB;GABPA;HLF;HOXB5;TBX6;LHX5;TEF;PRDM16;HMGB1;ZBTB32;BARX2;LMX1B;MLH3;PRDM1;ZNF740;ERG;IRF5;BATF;REST;TCF7L1;CALCOCO1;EN2;KLF16;BHLHE41
prerank,ATP binding (GO:0005524),-0.17763833868508241,-0.9005252073798727,0.8630952380952381,0.9283645374403846,1.0,41/266,13.52%,PEAK1;STK3;OAS2;STK38;STK17B;CDK6;HSPA4;MARK2;OLA1;RUNX3;P2RX4;ATP7A;RRM1;NUAK2;MKNK1;PTPA;MYO1F;NLRC4;RTEL1;PIM1;LMTK2;ERN1;PRKAG2;IGHMBP2;KIFC1;EIF2B2;UBA2;HASPIN;ABCG1;UHMK1;YARS2;AGAP2;CAD;LIG4;PANK3;DAPK1;OAS3;NLK;N4BP2;SIK2;FICD
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.37693406734098395,0.8994128286636768,0.610051993067591,0.97019580423561,1.0,2/10,6.71%,PIK3C2G;PIK3CG
prerank,telomerase RNA binding (GO:0070034),-0.2836866260845256,-0.8987817631027811,0.6191709844559585,0.9279931517808518,1.0,14/22,30.02%,SNRPB;EXOSC10;NOP10;TENT4B;DKC1;SMG6;HNRNPU;TEP1;HNRNPC;NAF1;NHP2;TERT;PINX1;SMG5
prerank,peptidase inhibitor activity (GO:0030414),0.2790398307328783,0.8973952104926334,0.6206896551724138,0.971578526278826,1.0,4/33,10.58%,CST3;PSMF1;SPINT2;SIMC1
prerank,enoyl-CoA hydratase activity (GO:0004300),0.37433552648221163,0.8952728684129564,0.5971479500891266,0.9734873856880778,1.0,3/10,24.60%,ECHDC1;ECHS1;ECHDC2
prerank,damaged DNA binding (GO:0003684),-0.23802446008203382,-0.8946983534307918,0.6734104046242775,0.9336696362235581,1.0,11/44,19.58%,RBBP8;HMGB2;PCNA;NBN;CRY2;EP300;RPA1;NTHL1;RPA2;XPC;NEIL3
prerank,voltage-gated chloride channel activity (GO:0005247),-0.36821766508349246,-0.8938689292392671,0.5730088495575221,0.9313091495926631,1.0,3/10,19.02%,CLCN1;CLCN5;ANO1
prerank,retinoic acid receptor binding (GO:0042974),-0.3026092009988728,-0.8921398396464637,0.6075949367088608,0.9309341135993182,1.0,6/17,20.20%,PPARG;SNW1;PRMT2;TACC1;NRIP1;HMGA1
prerank,ubiquitin-specific protease binding (GO:1990381),0.3165502374285295,0.8895825879275309,0.6232638888888888,0.9843225932113941,1.0,8/19,28.64%,SELENOS;PRKN;DERL1;RHBDD2;AMFR;CLTC;PTEN;SUMO1
prerank,TBP-class protein binding (GO:0017025),0.31072135024833636,0.8894361240710871,0.6275510204081632,0.9810496674870263,1.0,2/21,1.60%,HHEX;DRAP1
prerank,nucleotidase activity (GO:0008252),-0.31264316052612995,-0.8873874750661395,0.6024691358024692,0.9382290309584728,1.0,4/15,18.56%,NT5DC1;NT5E;NT5DC2;BPNT2
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.3331328855709491,-0.887339796700227,0.5966981132075472,0.9335738454919867,1.0,5/13,18.94%,ERN1;PDGFD;PDGFC;PDGFRA;ITGB3
prerank,lysophospholipase activity (GO:0004622),0.3120239673145092,0.8872875057664853,0.6162420382165605,0.9826291110889999,1.0,4/20,9.01%,PLA2G4C;ABHD12;LYPLA1;ENPP2
prerank,phospholipase activity (GO:0004620),0.24408322360797144,0.8870867526753425,0.6510263929618768,0.9793348785721154,1.0,9/67,9.01%,PLCL1;PRDX6;PLAAT5;PLA2G4C;PNPLA3;ABHD12;LYPLA1;PLD4;ENPP2
prerank,lipoprotein particle receptor binding (GO:0070325),0.28921441259839603,0.8857386485338451,0.6188976377952756,0.9791488467914369,1.0,12/27,29.93%,SYT1;CLU;APBB1;HSP90B1;APBB3;LANCL1;ANKRA2;SNX17;CLTC;DNAJA1;HSPG2;AP2M1
prerank,BMP receptor binding (GO:0070700),-0.33874649540214297,-0.8854119425851921,0.6367816091954023,0.9334436886372547,1.0,4/12,19.95%,BMP5;BMP2;BMP3;BMP7
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.2575367881052299,-0.8826921020313668,0.6675191815856778,0.9352986931900429,1.0,4/30,5.89%,TMEM165;SLC39A10;ATP7A;SLC30A5
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.35840557590163313,-0.8824852959535331,0.6295454545454545,0.926417068232118,1.0,7/10,37.79%,DUSP16;DUSP1;DUSP7;DUSP4;DUSP8;DUSP9;DUSP6
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.35840557590163313,-0.8824852959535331,0.6295454545454545,0.926417068232118,1.0,7/10,37.79%,DUSP16;DUSP1;DUSP7;DUSP4;DUSP8;DUSP9;DUSP6
prerank,phosphatase activity (GO:0016791),0.24015850596204985,0.8816963355246528,0.6979472140762464,0.9852810983515665,1.0,25/73,27.89%,PLPP5;PTPRO;ENOPH1;SACM1L;PPP1CC;ALPL;OCRL;PPP5C;PTPMT1;PLPPR4;NT5C;FRA10AC1;PLPP1;PSPH;MDP1;PPP1CA;NUDT16L1;DUSP28;DUSP26;ACP4;PLPP2;PLPPR1;NUDT16;ACP2;DUSP10
prerank,thyroid hormone receptor binding (GO:0046966),0.2934714309289628,0.8803756825015576,0.676923076923077,0.9851294467218753,1.0,5/28,6.27%,MED24;NSD1;MED4;BRD8;TRIP6
prerank,exonuclease activity (GO:0004527),0.25687178156345175,0.8803701917748628,0.6610169491525424,0.9815114146271735,1.0,14/46,21.89%,REXO2;POLG;ENPP2;CPSF3;FAN1;EXD1;EXOSC5;APEX1;FEN1;WRN;DXO;REXO4;APLF;EXD2
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.3628619874694584,0.8797885160211754,0.6256499133448874,0.9793264655712342,1.0,4/11,21.31%,FBXO11;PRMT9;PRMT3;PRMT5
prerank,frizzled binding (GO:0005109),0.2727357977304138,0.8794722950405579,0.6308411214953271,0.9764466556636475,1.0,6/34,11.58%,WNT4;WNT3;RYK;NDP;WNT8B;SFRP1
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.3043485196139495,-0.8783856707974681,0.6295336787564767,0.9321431502644681,1.0,6/16,15.58%,MTMR2;MTMR14;MTMR4;MTM1;MTMR12;MTMR3
prerank,ATPase regulator activity (GO:0060590),-0.24484304295122844,-0.8781882034749855,0.6612903225806451,0.9279897193442523,1.0,9/38,19.21%,FNIP2;DNAJC1;TOR1AIP1;BAG4;DNAJC10;FXYD2;DNAJB6;DNAJC15;DNAJB1
prerank,transforming growth factor beta binding (GO:0050431),0.2984072288247211,0.8779719606987767,0.6360544217687075,0.9765022926821136,1.0,3/23,7.62%,LTBP3;TGFBR1;TGFBR3
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.2785473729706943,-0.8778548593017184,0.6498599439775911,0.9241536351361143,1.0,8/22,24.47%,CPSF1;EXOSC8;ZC3H12A;EXOSC9;CPEB2;MEX3D;CPEB3;ILF3
prerank,5'-nucleotidase activity (GO:0008253),-0.3219636542003015,-0.8760857347539586,0.624113475177305,0.9236230052145801,1.0,3/13,13.33%,NT5DC1;NT5E;NT5DC2
prerank,endoribonuclease activity (GO:0004521),-0.2583449865172689,-0.8755093121238164,0.6868131868131868,0.9204095297635706,1.0,11/32,25.39%,ZC3H12D;ERN1;ZC3H12A;ZC3H12B;PIWIL2;AGO2;ENDOG;SMG6;RNASEK;RIDA;ERN2
prerank,growth factor receptor binding (GO:0070851),0.22675057894458828,0.8740557042127515,0.7078189300411523,0.9824360895109512,1.0,14/95,12.26%,FGF10;FGF16;FGF9;KLB;IL1RAP;FGF7;IL6;AREG;TRIP6;IL2;ERBB4;ITGA5;FGF2;PDGFB
prerank,nuclear export signal receptor activity (GO:0005049),-0.3387330367120653,-0.873844172130403,0.6070528967254408,0.9195916901896319,1.0,2/11,9.73%,EIF4ENIF1;XPO1
prerank,bHLH transcription factor binding (GO:0043425),0.31020018585802556,0.8737089968779419,0.6580310880829016,0.9796738801479938,1.0,6/19,16.72%,USF2;MAP3K10;LMO2;USF1;TCF3;BHLHE41
prerank,transforming growth factor beta receptor binding (GO:0005160),0.3132915830323295,0.8725691836751558,0.6400651465798045,0.9788222358118732,1.0,5/18,20.91%,TGFBR1;TGFBR3;TGFB1;ENG;SMAD2
prerank,exopeptidase activity (GO:0008238),-0.22485079418444653,-0.8725378007646691,0.7142857142857143,0.9182341614722679,1.0,10/50,11.83%,ANPEP;DPP4;RNPEP;KDM8;CPE;CTSA;ERAP1;PRCP;CPM;LTA4H
prerank,single-stranded DNA binding (GO:0003697),0.22669162891395453,0.8723840587420923,0.7014725568942436,0.9757421866727048,1.0,23/93,23.78%,TOP3A;NUCKS1;MCM5;RTF1;RNF138;FUBP3;MCM3;DMC1;POLR2G;RAD52;MLH1;SUB1;HMGB1;HNRNPA1;REXO4;SSBP1;DHX36;NABP1;TOP1;POLA1;SSBP2;ERCC4;POLR2D
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.2731585199654002,0.872377567937747,0.6449612403100775,0.9722615435271315,1.0,11/32,23.01%,SLC38A2;SLC1A1;SLC38A9;SLC38A7;SFXN1;SLC1A4;SFXN2;SLC25A38;SLC6A9;SLC38A3;SLC6A7
prerank,GDP binding (GO:0019003),-0.21677106650523298,-0.8700374271118442,0.7508305647840532,0.9199112370308747,1.0,14/63,18.15%,RAB8B;RRAGC;RAB7A;RAB10;KRAS;RAB21;RALB;RASL12;RAP1B;RAP1A;RAB31;MIEF1;NRAS;RAP2A
prerank,metalloendopeptidase activity (GO:0004222),0.23105115681473912,0.869467059265774,0.7163323782234957,0.975454842018795,1.0,15/76,18.72%,MMP16;MEP1B;ADAMTS20;PHEX;ADAMTSL1;ADAMTS15;ADAMTS19;THSD4;ADAMTS14;PITRM1;MMP1;THOP1;ADAMTS4;MMP17;ADAMTS3
prerank,methylation-dependent protein binding (GO:0140034),0.24100527467678357,0.8684553123161469,0.7157584683357879,0.974306499226955,1.0,22/57,27.58%,BPTF;CBX2;NCAPD3;SPIN1;KAT8;PHF8;KDM4A;MORC4;KMT2E;PHF1;PHF2;CBX5;TDRD3;MPHOSPH8;ING2;ING3;WDR5;MBTD1;PHF13;CHD1;CHD8;LRWD1
prerank,U6 snRNA binding (GO:0017070),0.3313860911040418,0.868269008287818,0.6521739130434783,0.9713487138450947,1.0,6/14,22.90%,METTL16;LSM8;DDX39B;EIF5A;LSM4;LSM3
prerank,E-box binding (GO:0070888),0.26968324839493474,0.8676630526940899,0.6650563607085346,0.9693272569727152,1.0,8/34,17.98%,SCRT2;NEUROG2;NEUROD2;SNAI2;TCF3;BHLHE41;MAX;ZEB1
prerank,methyl-CpG binding (GO:0008327),-0.2732848778644861,-0.8665038512029434,0.688,0.9239242410598851,1.0,5/22,12.45%,MECP2;ZCWPW1;MBD2;MBD1;TET3
prerank,G protein-coupled receptor binding (GO:0001664),0.21475287236918866,0.8660537238598299,0.7438231469440832,0.9695662107843916,1.0,35/132,25.96%,WNT4;INSL3;REEP2;WNT3;RYK;ARRB2;NDP;GNA15;PPY;UTS2B;WNT8B;PRKN;HOMER2;SFRP1;USP33;GNAI3;GNA11;WNT7A;ADM;GNAS;BICD1;GHRL;RSPO1;DVL2;CCL5;ARRB1;RNF43;TULP3;TAFA5;ITGB4;GNAI1;PSMC5;WNT5B;STUB1;GNAQ
prerank,methylated histone binding (GO:0035064),0.23549495644415921,0.8643803682356644,0.7223021582733813,0.9700478429407771,1.0,24/62,27.58%,BPTF;CBX2;DPF2;NCAPD3;SPIN1;KAT8;PHF8;KDM4A;TTLL12;MORC4;KMT2E;PHF1;PHF2;CBX5;TDRD3;MPHOSPH8;ING2;ING3;WDR5;MBTD1;PHF13;CHD1;CHD8;LRWD1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.2850555994704262,0.8634149628312293,0.6816,0.9688605613991478,1.0,8/24,23.59%,IP6K1;NME1;AK5;AK4;AK3;DTYMK;AK1;AK9
prerank,protein phosphatase 1 binding (GO:0008157),-0.2724770279829219,-0.8621872919235536,0.674863387978142,0.9297695100266166,1.0,9/21,22.07%,SHOC2;AKAP11;PPP1R3C;PPP1R3F;PPP1R3E;LILRB1;PPP1R15A;KCNQ1;SMTNL2
prerank,cation transmembrane transporter activity (GO:0008324),0.250054277978644,0.8609540214855884,0.6855439642324889,0.9713536930950789,1.0,9/48,13.42%,SLC25A2;SLC38A2;SLC1A1;SLC38A9;SLC38A7;SFXN1;SLC66A1;SLC1A4;SFXN2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.34135915733513983,0.8600507128903937,0.643979057591623,0.9700798466861089,1.0,4/12,19.58%,SLC25A5;SLC19A1;SLC25A23;SLC35B2
prerank,BMP binding (GO:0036122),0.3543082609711148,0.8598858352345642,0.650088809946714,0.9670765962798222,1.0,3/11,22.76%,GREM2;ENG;UCMA
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.3297896767225482,-0.8598203429552725,0.6420047732696897,0.9306819313735386,1.0,4/11,19.58%,APEX2;NTHL1;HMGA2;NEIL3
prerank,peptidoglycan binding (GO:0042834),0.3596481829786258,0.8596121126072725,0.66890756302521,0.9642893735953164,1.0,3/10,10.32%,PGLYRP2;NOD1;RNASE7
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.23833073909907793,0.8578482020400682,0.7219730941704036,0.9649993802577049,1.0,16/60,20.04%,MERTK;NTRK1;FLT4;NTRK3;RYK;EPHA1;ERBB4;TEK;EPHA4;EPHB2;INSR;NTRK2;FLT3;PDGFRB;ROR1;EPHA5
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.31849898301455515,-0.8574842712021258,0.6382978723404256,0.9316916214260774,1.0,6/12,26.88%,SLC9B2;SLC9A9;SLC9A2;SLC9A6;LETM1;SLC9A3
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.1617926682155578,-0.8564610527480262,0.96875,0.929504104526914,1.0,67/431,14.21%,PEAK1;STK3;PSMA6;OAS2;STK38;STK17B;CDK6;HSPA4;MARK2;OLA1;RUNX3;P2RX4;ATP7A;TUBB6;RRAGC;RRM1;NUAK2;EEF1A1;RAB7A;MKNK1;PTPA;MYO1F;NLRC4;RTEL1;PIM1;LMTK2;TUBA4A;ERN1;TUBD1;ARF3;PRKAG2;GBP3;IGHMBP2;MTG2;KIFC1;RAB6A;EIF2B2;TUBE1;UBA2;HASPIN;GNL2;ABCG1;RAB10;RHOJ;KRAS;UHMK1;YARS2;DNM2;AGAP2;CAD;LIG4;TSR1;RAB21;PANK3;RRAGA;DAPK1;REM1;OAS3;NLK;N4BP2;SIK2;RALB;FICD;GBP4;LRRK2;SIK1;RASL12
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.34385237012233094,0.8549283013326857,0.6769759450171822,0.9680863177266613,1.0,3/12,11.95%,PIK3C2G;PIK3CG;IPMK
prerank,retinoid binding (GO:0005501),0.29691159404629974,0.8514622618876201,0.6672077922077922,0.9724134905200358,1.0,2/22,3.97%,PTGDS;CYP26C1
prerank,actin binding (GO:0003779),0.2030320815637646,0.8474856629038314,0.8093480934809348,0.9781482681387959,1.0,34/170,17.56%,KCNMA1;ANG;ADCY8;FSCN1;ADD2;EPS8L3;GIPC1;TNNI3;CORO2B;DMD;MYH10;RUSC1;MICAL3;MAP1S;MYO6;TWF2;VASH1;LDB3;EMD;PRKN;VASH2;KLHL2;CXCR4;LMOD3;CORO1A;EPS8L2;PHACTR3;PAWR;TWF1;SSH1;HPCA;SSH2;PTK2;SSH3
prerank,ankyrin binding (GO:0030506),0.30024246800065857,0.8471765585804797,0.6655737704918033,0.975430560328808,1.0,4/19,13.82%,SLC8A1;CACNA1D;NRCAM;SPTBN1
prerank,peptide N-acetyltransferase activity (GO:0034212),0.355628630588125,0.8460506890798304,0.6642984014209592,0.9746039999955386,1.0,2/10,15.76%,NAA30;NAA60
prerank,estrogen receptor binding (GO:0030331),0.26878950707578375,0.8433160513925788,0.7229299363057324,0.9771501712033256,1.0,3/32,4.33%,DCAF1;WBP2;NSD1
prerank,kinase activator activity (GO:0019209),0.2732705818547528,0.842968755943014,0.7115072933549432,0.9746065053788954,1.0,5/30,10.89%,RPTOR;NCKAP1L;STK11;IL2;FGF13
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.29256722645648514,0.8417942413648839,0.6873015873015873,0.9738437881317324,1.0,3/23,6.53%,PDE8B;PDE4A;PDE3B
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.2248128394782256,0.8398264909740053,0.769774011299435,0.9748101631496411,1.0,14/75,18.17%,RDH10;AKR1C1;PRXL2B;NSDHL;CBR4;HSD17B11;MDH1;RDH5;SDR42E1;CRYL1;LDHD;KDSR;HSD17B10;HPGD
prerank,alkali metal ion binding (GO:0031420),0.32842567288554014,0.8396654561230953,0.6815742397137746,0.9719078434363787,1.0,3/13,22.54%,CAPN3;ATP1A1;DRG1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.19208750707854955,0.8387584290336629,0.8550898203592814,0.9705221078212818,1.0,40/254,16.23%,HOXA5;HHEX;ONECUT2;TFCP2;HOXD4;RELA;NR1I2;NRL;NR1I3;NFIB;SOX10;TFCP2L1;MEOX2;SOX4;PPARA;PBX2;HOXB7;AR;RFX6;MEF2C;GTF2I;HOXC10;LHX3;FOXC1;KLF7;GRHL3;HSF2;SMARCD3;HOXB2;RFXAP;GABPA;HLF;PRDM16;PLAG1;BARX2;NKX2-2;ERG;IRF5;TCF3;PRDM15
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.3392501922261898,-0.8382282031710249,0.6830985915492958,0.9656155257924357,1.0,5/10,25.62%,HAT1;EP300;MSL3;NAA40;ATF2
prerank,store-operated calcium channel activity (GO:0015279),-0.34444759308346173,-0.8379765342584006,0.6772009029345373,0.9616149665977608,1.0,4/10,16.30%,TRPC5;TRPC1;ORAI2;STIM2
prerank,DNA binding (GO:0003677),0.1810865825789291,0.8379663354783439,0.9508881922675027,0.9689800348510929,1.0,145/694,22.34%,CCDC25;HOXA5;TOP3A;HHEX;NUCKS1;TET1;ANG;MCM5;DRAP1;SURF6;DENND4A;RTF1;PQBP1;MYRFL;POU2F2;CSRNP3;RNF138;TFCP2;USF2;BPTF;RELA;DNASE1;NRL;TRIM26;SOX21;HIC1;NFIB;SOX10;TFAM;PPARGC1A;MEOX2;POLG;PPARA;DNASE1L2;E2F1;HDGFL2;FOXD1;XRCC6;NR2F6;RBM5;MAP1S;BCLAF3;GTF2H4;FUBP3;SMC1A;ZNF35;MCM3;OGG1;REPIN1;TIMELESS;LHX3;SP4;TCF7L2;ZBTB22;FOXC1;TSHZ2;TAF9;TBX2;SNAI2;ZDHHC1;CGAS;GRHL3;TRNP1;NFE2L2;FAN1;KDM2B;DMC1;HOXB2;POLR3F;POLR2G;RAD52;THAP1;USF1;MBD6;EPAS1;HLF;MLH1;TSN;TBX6;SUB1;MYRF;DDB2;ACR;PRDM16;HMGB1;SPTY2D1;ZBTB32;BARX2;ZBTB49;APEX1;FEN1;RPS27;HMGB3;ERG;ERCC6;IRF5;BATF;SETX;HNRNPA1;APLP2;TCF7L1;TCF3;CALCOCO1;CENPS;BRIP1;PSIP1;MAX;HDGFL3;WRN;KLF12;XBP1;PHF1;POU3F3;TSNAX;TFPT;ZMYM6;SNAPC3;POGK;ARID4A;REXO4;ZMYM3;RORA;SSBP1;CENPC;DHX36;CR2;PRDM5;XRCC4;SMAD2;XRCC5;NABP1;GRHL2;UNG;MPG;LHX4;TAF4;TOP1;POLA1;ING2;CXXC5;SOX13;IRF3;NFYB;NPAS2;ZIC4
prerank,ribonuclease P activity (GO:0004526),0.34719641805187684,0.8365279581734036,0.6773109243697479,0.9688012240929172,1.0,3/11,13.32%,RPP40;PRORP;RPP30
prerank,rRNA binding (GO:0019843),-0.22273537542256017,-0.8357376248845747,0.7780898876404494,0.9619275839276155,1.0,18/42,29.26%,RCC1L;RPL5;RPS14;RPS13;RPS5;RPF2;DDX21;NOP53;GTF3A;FASTKD5;EMG1;RPL11;MRPS27;DDX28;MRPS18C;MRPL11;MDM2;RPL23
prerank,N-methyltransferase activity (GO:0008170),-0.270140553620572,-0.8336179128050837,0.7369727047146402,0.9620666490992708,1.0,10/20,31.96%,SETD3;TRMT1L;PEMT;ZCCHC4;METTL15;GNMT;RNMT;TRMT1;PRMT1;TFB1M
prerank,death receptor binding (GO:0005123),-0.2937740147609213,-0.8329679353119755,0.6986301369863014,0.9590228995629643,1.0,6/15,25.47%,RIPK1;PIDD1;EDA;MYD88;FADD;TMBIM1
prerank,ubiquitin protein ligase binding (GO:0031625),0.19058934592443105,0.8320698531323799,0.8661971830985915,0.9747946365790217,1.0,42/254,15.63%,WRAP53;YWHAE;PRDX6;FHIT;UQCRC1;UBE2B;KCNH2;RELA;CASC3;PPARGC1A;HERC2;CLU;UBE2G1;FBXO7;TRIB1;TRIB2;ARRB2;APBB1;FAF1;SUMO2;PRKN;LRPPRC;HSPA9;UBE2N;BECN1;ACVR1B;CXCR4;MC4R;CUL2;DERL1;RNF8;DNM1L;SLC25A5;OTUB1;ARRDC1;KDM4A;BLZF1;RFFL;UBXN1;HSPBP1;JKAMP;HM13
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.2366829432240672,-0.8319813435187686,0.7452574525745257,0.9525082798348741,1.0,7/34,11.32%,NDUFS4;NDUFV2;NDUFA5;NDUFS8;NDUFB3;NDUFB10;NDUFS7
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.2366829432240672,-0.8319813435187686,0.7452574525745257,0.9525082798348741,1.0,7/34,11.32%,NDUFS4;NDUFV2;NDUFA5;NDUFS8;NDUFB3;NDUFB10;NDUFS7
prerank,transaminase activity (GO:0008483),0.34300213618753056,0.8319575383736268,0.6861702127659575,0.9717911017820065,1.0,3/11,20.10%,BCAT1;AGXT;ABAT
prerank,NADP binding (GO:0050661),-0.23799243557773875,-0.8316211777925686,0.7594202898550725,0.9489955708538733,1.0,11/32,20.76%,DECR1;CRYZ;CBR3;HSD17B1;MTRR;GMDS;HSD11B1;DUS2;KCNAB1;GRHPR;DHFR
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.31581366235495206,-0.8281417728624572,0.7028985507246377,0.9519348179270639,1.0,5/12,23.01%,TENT2;TENT5A;TENT4B;TENT4A;TENT5C
prerank,MHC class I protein binding (GO:0042288),-0.3060465781642807,-0.8279695618075448,0.6642156862745098,0.94796801347382,1.0,6/13,31.92%,TAPBP;LILRB1;PILRA;TUBB4B;CD8B;CD8A
prerank,methyltransferase activity (GO:0008168),0.24203850543380423,0.825408332928035,0.7461538461538462,0.981797757571809,1.0,15/46,27.41%,LRTOMT;EEF1AKMT2;MEPCE;FTSJ1;METTL4;AMT;COMT;N6AMT1;ASMT;PRMT3;PRMT5;BCDIN3D;NSUN4;TRMT11;METTL3
prerank,endopeptidase activity (GO:0004175),0.19020687105762465,0.8241819309226277,0.8938679245283019,0.9809827281695661,1.0,51/257,21.82%,F3;PSMB1;USP10;PLAT;MMP16;RHBDL3;PRSS56;ASPRV1;MEP1B;GZMM;ADAMTS20;BACE1;USP35;USP11;LGMN;USP30;PSMA1;PHEX;ADAMTSL1;ADAMTS15;PSMA8;USP12;CASP3;SFRP1;ADAMTS19;USP33;CASP4;THSD4;CASP7;ADAMTS14;PITRM1;MMP1;ACR;PIK3IP1;KLK2;HPN;THOP1;ADAMTS4;TYSND1;PCSK2;MMP17;PSMB4;ADAMTS3;USP48;CTSK;CASP8;OMA1;USP49;APEH;CASP2;CTSS
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.26889375731444193,0.8236204102448038,0.7085346215780999,0.9789920029190052,1.0,8/27,22.22%,SLC4A8;SLC9A4;SLC8A1;SLC9A5;SLC8A3;ASIC3;CNNM4;SLC9A1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.26243168620958546,0.823313501963774,0.7302631578947368,0.9764180519845895,1.0,9/33,21.89%,ERI3;REXO2;ANGEL1;EXOSC5;ERI2;CNOT8;ANGEL2;DIS3L;EXD2
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.22242103676041036,-0.8222261722640991,0.7967479674796748,0.9552044185840529,1.0,14/42,27.14%,CCND1;CDKN2C;CCNH;CCNA2;CCNL1;CCND2;CDKN2A;CNPPD1;CCNY;CCNB1;KAT2B;CCNJ;CCNF;INCA1
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.27266370949821017,0.8220827064093258,0.7319422150882825,0.9757804529173383,1.0,5/27,12.71%,SLC22A8;SLC26A4;SLC26A7;SLC39A8;GET3
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.22405087778113963,-0.8167981149547343,0.8016304347826086,0.9615285473358902,1.0,18/37,33.41%,FARS2;IARS2;YARS2;PARS2;EARS2;QARS1;NARS1;WARS2;VARS2;WARS1;LARS1;FARSA;AARS2;HARS2;MARS2;LARS2;NARS2;DARS1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.22308048335664937,0.8162613413825738,0.8057553956834532,0.9840247105358394,1.0,8/73,11.82%,AVPR2;NMUR1;AVPR1A;LTB4R2;SORCS1;ADCYAP1R1;CX3CR1;MC4R
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.3169644245073867,0.8160788681732407,0.7161936560934892,0.9812843209634222,1.0,5/14,18.61%,RPP40;ELAC2;PRORP;RPP30;TSEN34
prerank,phospholipase binding (GO:0043274),-0.3024010922690041,-0.8151515651908217,0.7062937062937062,0.9603727095975798,1.0,4/13,10.56%,SYK;FYN;BLNK;LCK
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.2553979696335714,-0.8133554698695303,0.7704081632653061,0.9593753757707383,1.0,7/22,17.60%,ZRANB3;ATRIP;WDR81;FAAP20;OPTN;UIMC1;SQSTM1
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.25343726891066953,0.8120093042465889,0.7640449438202247,0.9858064403636637,1.0,5/33,10.07%,RNF19A;PPARA;RNF180;DCUN1D2;PRKN
prerank,acylglycerol lipase activity (GO:0047372),0.34326553376474966,0.8101891288361489,0.7191780821917808,0.9863350875882859,1.0,5/11,29.90%,ABHD12;ABHD2;LIPE;MGLL;FAAH
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.32550322872684656,-0.8093749269870093,0.7021276595744681,0.9628070395738518,1.0,2/10,7.23%,PKIB;PRKAG2
prerank,ubiquitin binding (GO:0043130),0.2163979484642347,0.8078310863520388,0.8104477611940298,0.9877536773706882,1.0,15/73,16.50%,GGA3;FBXO7;OTULINL;FAF1;NEDD4;PRKN;RAE1;UBE2N;CXCR4;USP33;RNF168;OTUB1;TOM1L1;UBXN1;UBAP1
prerank,carbohydrate kinase activity (GO:0019200),0.32675353554455777,0.8074757463622249,0.7344827586206897,0.985252862806185,1.0,4/11,16.07%,FGGY;KHK;HK2;GALK1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.33585630253872334,0.8053972645999309,0.7283950617283951,0.9859885012959467,1.0,2/10,14.40%,CRMP1;DPYSL2
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.3370862309967484,0.8053750574041035,0.7301038062283737,0.9829238255812379,1.0,4/11,29.56%,SLC22A4;SLC22A5;SLC25A45;SLC25A29
prerank,histone methyltransferase activity (GO:0042054),-0.22768674319091384,-0.8044469050160739,0.8077922077922078,0.9676397753129832,1.0,10/32,21.39%,SETD7;DOT1L;PRDM9;KMT2C;PRMT2;EHMT1;FBL;SMYD3;EED;SETD2
prerank,hexosaminidase activity (GO:0015929),0.3245153078566319,0.8035988661797218,0.745945945945946,0.9832036731023194,1.0,6/12,27.68%,HEXB;NAGA;HYAL4;OGA;SPAM1;CEMIP
prerank,ADP binding (GO:0043531),-0.2437262205522199,-0.8028146714118038,0.8098958333333334,0.9663262033143908,1.0,7/25,19.92%,ERN1;PRKAG2;GCLC;ABCG1;MYH9;MIEF1;MYO9B
prerank,monocarboxylic acid binding (GO:0033293),0.2876987576802992,0.8017293527616478,0.754653130287648,0.9836958352371443,1.0,2/18,3.97%,AKR1C1;CYP26C1
prerank,glutamate receptor binding (GO:0035254),0.2899654274359933,0.7974403836828714,0.740983606557377,0.9883259265803547,1.0,5/17,18.02%,IGSF11;SHANK3;HOMER2;GNAS;SHANK1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.2294524084268702,-0.7956195324387743,0.8367875647668394,0.9752363611629963,1.0,5/30,11.57%,GAS6;TNFAIP8;BIRC6;BIRC5;BIRC2
prerank,hormone receptor binding (GO:0051427),0.30466565457792744,0.7954423316979967,0.7461139896373057,0.9887043155835126,1.0,2/14,8.81%,SOCS2;ADCYAP1
prerank,cation:chloride symporter activity (GO:0015377),0.33341335430666097,0.7932661231175447,0.7448275862068966,0.9896220229088141,1.0,3/10,14.30%,SLC12A2;SLC12A6;SLC6A1
prerank,protein kinase regulator activity (GO:0019887),-0.18319764008664585,-0.7924119131932374,0.9217081850533808,0.9771037668039108,1.0,31/95,25.76%,GMFG;MARK2;NCK1;CCND1;PRKAG2;SMCR8;TAOK3;GPRC5B;CCNH;AGAP2;CCNA2;CCNL1;CCND2;QARS1;NPM1;PRKRIP1;SPRY4;DUS2;TPX2;RGCC;SOCS1;EPO;CNPPD1;GSKIP;CCNY;DUSP19;CCNB1;ITPRIP;KIDINS220;CCNJ;CCNF
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.28776369891836295,0.7916312264435852,0.7728026533996684,0.9894341084122908,1.0,4/18,18.00%,HSD17B2;AKR1C1;RDH5;HSD17B10
prerank,iron ion binding (GO:0005506),-0.20958206925186024,-0.7908967662578673,0.8379204892966361,0.9755641884838904,1.0,16/48,27.28%,ALOX5;TET2;KDM7A;JMJD6;ALKBH8;NFU1;LCN2;RIOX1;FTL;LTF;HEPH;DOHH;FBXL5;PHYH;ALOX15;EGLN1
prerank,ribosomal large subunit binding (GO:0043023),-0.308297194010425,-0.7902167948435053,0.7644341801385681,0.9725365856210791,1.0,5/11,17.31%,MALSU1;DHX33;NPM1;NMD3;CPEB2
prerank,ATPase activator activity (GO:0001671),-0.2596741833863279,-0.7897538722396038,0.7928571428571428,0.9691526932799167,1.0,7/20,19.21%,DNAJC1;TOR1AIP1;DNAJC10;FXYD2;DNAJB6;DNAJC15;DNAJB1
prerank,leucine zipper domain binding (GO:0043522),0.3334936168244256,0.789230351516869,0.747457627118644,0.9905490254889772,1.0,5/10,30.57%,NRL;PAWR;MRTFA;ATF4;DDIT3
prerank,adenyl ribonucleotide binding (GO:0032559),0.17886740891980604,0.7883310160164693,0.9589201877934272,0.9890418501785668,1.0,68/291,22.80%,HCN1;NIM1K;STK26;ABCG8;KCNJ8;HSPA2;ABCB6;DDX25;PDE4A;STK11;MYH10;GSS;MTHFD1L;TRIB1;MTPAP;PRKCI;PI4K2A;TGFBR1;CDC42BPA;PRAG1;MYO6;TWF2;NME1;STK36;CDKL5;MAP4K4;MPPED2;HSPA9;BTK;MINK1;ACVR1B;P2RY1;COQ8A;PFKM;PPP5C;ABCA2;SLC19A1;INSR;ERCC6;ACLY;GALK1;HSPA14;TWF1;DMPK;KIF14;HARS1;TAOK1;CDC42BPB;MAST2;ABCD2;PEX6;AKT3;MAP4K2;WNK1;BMPR1B;ABCC6;PFKP;ATP1A3;ATP1A1;DHX36;HSP90AB1;TOP1;PIP4K2B;LATS1;TRNT1;SIK3;PNPLA8;TLK2
prerank,nuclear receptor coactivator activity (GO:0030374),0.22684867397687794,0.7877693049512904,0.8313609467455622,0.9870852519448379,1.0,7/52,10.90%,MED24;PKN1;PPARGC1A;MED4;BRD8;SS18;FGF2
prerank,guanyl ribonucleotide binding (GO:0032561),0.18416852264327085,0.7793892117049473,0.9451728247914184,0.9979398591572969,1.0,66/196,30.09%,RAB1B;RHOV;RAB26;ARL5A;ATL1;RHOBTB1;RAB8A;ARL4C;ARL4A;RIT2;CNGB1;NME1;RHOT1;MPPED2;DIRAS2;ARL4D;RAB38;RAB5A;RAB28;RAB39A;RAB12;TUBB2A;SLC19A1;INSR;GNAI3;HRAS;RRAS2;RHOQ;RHOBTB2;RHOU;RHEBL1;CDC42;TUBA8;MMAA;RAP2C;PIP4K2B;ARF1;DRG1;ATL2;RANBP17;ARL5B;GBP2;RHOBTB3;PDE11A;RAPGEF2;RNF112;RHOA;GNAI1;GTPBP10;RRAGD;TUBA1B;TUBA1A;NUDT16;TGM2;RAB13;MRAS;ADSS1;RRAD;ARL11;GBP5;BMS1;RRAS;TUBA1C;RND3;SEPHS1;ARF5
prerank,endodeoxyribonuclease activity (GO:0004520),-0.2527331081440248,-0.7783538546355764,0.8267326732673267,0.9845958424307983,1.0,2/20,4.93%,RBBP8;ZRANB3
prerank,G protein-coupled receptor activity (GO:0004930),-0.15604206817367772,-0.7780291172010757,0.9941176470588236,0.9810002070993553,1.0,103/239,36.45%,ADGRE5;HRH1;GPR141;ADGRG6;TM2D1;C3AR1;S1PR2;C5AR1;GPR183;GPR157;VIPR1;DRD2;GPR85;GPR61;TRHR;GRM4;GPR22;GPR18;GPR65;MRGPRE;NPFFR2;GPR27;CALCRL;GPR88;FFAR1;ADRA1A;OPRK1;NPY;GPR37;ADGRG5;S1PR3;OPN3;DRD3;LTB4R;GPR156;ADGRL2;LPAR2;KISS1R;FFAR4;ADGRB1;VIPR2;APLNR;GPR101;RXFP2;PTH1R;FPR3;NTSR1;NMBR;GLP1R;GALR1;RRH;SCTR;S1PR4;ADORA2A;GPR52;LPAR3;ADGRG7;FPR2;TAPT1;GPR62;GPR4;GPR83;P2RY14;GPR15;AGTR2;ADGRG1;GPR75;OPRL1;CXCR2;PAX8;GPR26;ADGRG2;F2RL2;GIPR;LGR4;GPR35;P2RY6;OXTR;GPR55;GPR50;MC2R;CCR7;OPN1MW3;OPN1MW;OPN5;GPR151;RXFP3;CRHR2;OPN4;BDKRB1;ADGRD1;GPR143;CYSLTR2;DRD1;LGR6;GPR3;CALCR;FPR1;FSHR;TAS1R3;LHCGR;AGTR1;ADRA2C
prerank,tau protein binding (GO:0048156),0.23546251008853986,0.7768589949242726,0.8293051359516617,0.9988747977199569,1.0,12/40,21.69%,BIN1;CLU;LGMN;DCTN1;PPP5C;TAOK1;ROCK1;PIN1;ACTB;HSP90AB1;SMAD2;MAP2
prerank,FAD binding (GO:0071949),-0.23960969697096285,-0.7763066990619565,0.8328767123287671,0.9797501006084519,1.0,8/24,18.02%,MTHFR;KMO;CRY2;SQOR;CRY1;MTRR;MICAL1;MICAL2
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.2933355415935406,-0.7761011824569272,0.7662037037037037,0.9759230827984802,1.0,5/12,20.34%,IGF1;YWHAG;IGF2;SHC1;SOCS1
prerank,protease binding (GO:0002020),0.19838264017290114,0.7760423225287543,0.896011396011396,0.9972653028790883,1.0,8/99,5.56%,SELENOS;F3;BIN1;ATP9A;CST3;INSL3;POLG;PRNP
prerank,CoA-ligase activity (GO:0016405),0.2996287952953284,0.775957232709214,0.7633851468048359,0.994415317748834,1.0,4/14,19.55%,ACSS3;ACSBG1;ACSF3;ACSS1
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.24777216238365365,0.7751801834614475,0.803030303030303,0.9927201322983643,1.0,11/32,24.27%,TYW5;TET1;PHYHD1;KDM2B;PHF8;KDM4A;ALKBH4;ALKBH5;HIF1AN;ALKBH3;FTO
prerank,carboxylic ester hydrolase activity (GO:0052689),0.20577698939655426,0.7746060485908578,0.8942307692307693,0.9906486652523768,1.0,18/85,21.13%,PRDX6;CA1;PLAAT5;PLA2G4C;PNPLA3;ABHD12;LYPLA1;ACHE;ENPP2;TARS2;ABHD5;LYPLAL1;LIPC;ABHD8;ABHD2;PLA2G15;LIPE;MRPL58
prerank,peptidase activator activity (GO:0016504),-0.24920006419839902,-0.7712132632969319,0.832,0.9797642078303955,1.0,4/22,6.57%,VCP;PSME2;NLRC4;CAV1
prerank,sodium:proton antiporter activity (GO:0015385),-0.29363978383407013,-0.7706206381532933,0.7699530516431925,0.9766022166790662,1.0,3/11,11.76%,SLC9B2;SLC9A9;SLC9A2
prerank,sulfotransferase activity (GO:0008146),0.2451662172016348,0.7699729320313263,0.8149300155520995,0.9948565834540944,1.0,6/33,14.55%,CHST10;CHST1;HS6ST1;GAL3ST4;GAL3ST1;TPST2
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.21665502414113175,0.7697635840259994,0.8562783661119516,0.9921858725813488,1.0,14/55,24.51%,SLC16A6;SLC38A2;SLC38A9;SLC38A7;SLC3A1;SLC19A1;SLC22A4;SLC16A12;SLC13A3;SLC38A3;SLC25A10;SLC19A2;SLC38A10;SLC16A7
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.2950641817256455,-0.7679197780246617,0.7924107142857143,0.9766709141993639,1.0,3/11,15.02%,GNPTAB;PIGF;PIGO
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.25590499228919095,0.7672489333905378,0.8163265306122449,0.9931873487164888,1.0,10/24,27.09%,ZDHHC22;ZDHHC8;ZDHHC1;ZDHHC2;ZDHHC23;GOLGA7;ZDHHC15;ZDHHC19;GLUL;ZDHHC12
prerank,hormone activity (GO:0005179),-0.19602055404766627,-0.7670862267717233,0.9238095238095239,0.9738340229723795,1.0,23/54,36.76%,IGF1;METRNL;CCL25;AGRP;PTHLH;NPY;GNRH1;CRH;NMB;VIP;SPX;PNOC;INHBB;NPPC;EDN3;CORT;EDN2;NPPA;POMC;EDN1;GHRH;C1QTNF12;CALCB
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.3113834797117264,0.7654285179354561,0.773356401384083,0.9932158885027178,1.0,2/11,15.76%,NAA30;NAA60
prerank,pseudouridine synthase activity (GO:0009982),-0.2825962989660951,-0.7631966339753476,0.7745803357314148,0.9756935286442017,1.0,10/13,45.30%,TRUB2;DKC1;PUS3;RPUSD3;RPUSD2;RPUSD1;PUSL1;TRUB1;PUS10;PUS1
prerank,AMP binding (GO:0016208),-0.29493977676533345,-0.7627309432273371,0.7831858407079646,0.9723478341092359,1.0,3/11,16.88%,ACSS2;PRKAG2;PFKL
prerank,ligand-gated calcium channel activity (GO:0099604),0.2782693001497802,0.7620338601741018,0.7908611599297012,0.9954382669894486,1.0,4/19,11.94%,TRPM2;GRIN1;GRIN2B;ITPR3
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.2943024995655031,-0.76036819201103,0.7788944723618091,0.9716753909129763,1.0,7/12,24.83%,CDK6;CDK8;CDK1;CDK12;CDK19;CDK9;CDK13
prerank,serotonin receptor activity (GO:0099589),-0.23667889436508255,-0.7602618630345196,0.8522427440633246,0.9601352245378254,1.0,3/22,11.74%,HRH1;CHRM2;HTR1B
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.23667889436508255,-0.7602618630345196,0.8522427440633246,0.9601352245378254,1.0,3/22,11.74%,HRH1;CHRM2;HTR1B
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.23667889436508255,-0.7602618630345196,0.8522427440633246,0.9601352245378254,1.0,3/22,11.74%,HRH1;CHRM2;HTR1B
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.3224665156109529,0.759397258734965,0.7775862068965518,0.9965305818588475,1.0,2/10,11.11%,ANKRD13D;FAN1
prerank,C2H2 zinc finger domain binding (GO:0070742),0.3081100435164815,0.758135537718066,0.7756849315068494,0.9954353511892982,1.0,2/11,9.44%,SRRM2;TAF9
prerank,Notch binding (GO:0005112),0.2590703874477417,0.7544577666492269,0.8115015974440895,0.9977484929618459,1.0,4/22,11.09%,TCIM;NCOR2;AAK1;KCTD10
prerank,GTP binding (GO:0005525),0.18139893027311974,0.7544153351529196,0.9544895448954489,0.9948747980772632,1.0,59/172,30.09%,RAB1B;RHOV;RAB26;ARL5A;ATL1;RHOBTB1;RAB8A;ARL4C;ARL4A;RIT2;NME1;RHOT1;DIRAS2;ARL4D;RAB38;RAB5A;RAB28;RAB39A;TUBB2A;INSR;HRAS;RRAS2;RHOQ;RHOBTB2;RHOU;RHEBL1;CDC42;TUBA8;MMAA;RAP2C;PIP4K2B;ARF1;DRG1;ATL2;RANBP17;ARL5B;GBP2;RHOBTB3;RNF112;RHOA;GNAI1;GTPBP10;RRAGD;TUBA1B;TUBA1A;NUDT16;TGM2;RAB13;MRAS;ADSS1;RRAD;ARL11;GBP5;BMS1;RRAS;TUBA1C;RND3;SEPHS1;ARF5
prerank,MAP kinase kinase activity (GO:0004708),-0.2677053011480763,-0.7533079876980638,0.8131067961165048,0.9664581456309155,1.0,6/15,24.67%,MAPKAPK3;LRRK2;MAP2K4;MAP2K7;MAP2K3;SBK2
prerank,histone acetyltransferase binding (GO:0035035),-0.24805368633471106,-0.7500238242522946,0.8181818181818182,0.9669448530260131,1.0,10/21,30.86%,PCNA;HIF1A;STAT1;TAF7;BCAS3;SIRT2;PAX6;EGR1;KANSL1;EID1
prerank,transcription coregulator binding (GO:0001221),0.21445318913392805,0.7490627056425188,0.8726993865030674,0.9995433830308762,1.0,14/50,21.75%,CNOT2;RELA;AR;CTBP1;USP11;LMO2;ZBTB49;UBE2I;MED25;PHF1;HDAC3;RORA;TEAD2;CHD6
prerank,phosphatidylglycerol binding (GO:1901611),0.29270302274557164,0.7480459539691761,0.8347386172006745,0.9980833894550235,1.0,2/13,9.21%,GSDME;UQCC3
prerank,signal sequence binding (GO:0005048),0.2308457452313433,0.7476881608552776,0.839258114374034,0.9956925506569545,1.0,8/35,15.84%,KDELR3;PEX5;CABP1;SEC61A2;TIMM22;IPO5;TOMM70;KDELR2
prerank,phosphatidylcholine transporter activity (GO:0008525),0.27266598104455614,0.7470362523055177,0.8268551236749117,0.9936901229574777,1.0,10/17,33.87%,ABCB4;MTTP;ATP8B1;ABCA7;ATP8B2;ATP10B;ABCA3;PITPNA;PITPNM1;PITPNC1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.2901705848690276,-0.7457557996139039,0.7748815165876777,0.9689062707494169,1.0,3/11,15.13%,PPP1R1A;PPP1R2;PPP1R14C
prerank,potassium channel regulator activity (GO:0015459),0.2162878842010612,0.745115312016403,0.8948170731707317,0.9936523599633038,1.0,4/49,6.39%,YWHAE;KCNE2;KCNIP3;KCNIP4
prerank,dynactin binding (GO:0034452),0.29299506576284867,0.7397810522657925,0.8089285714285714,0.997964896303956,1.0,4/12,25.59%,BICD2;SNX6;BICD1;MAPT
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.29759752369916925,0.738741751800218,0.8188277087033747,0.9965567997358792,1.0,2/12,8.14%,AKR1C1;CBR4
prerank,GABA receptor binding (GO:0050811),0.30327054050220614,0.7385926377680067,0.8,0.9939027874483345,1.0,2/11,9.54%,LHFPL4;JAKMIP1
prerank,palmitoyltransferase activity (GO:0016409),0.2382454968754696,0.7385334141240055,0.8648648648648649,0.9911556998264206,1.0,11/28,27.09%,ZDHHC22;ZDHHC8;ZDHHC1;ZDHHC2;ZDHHC23;GOLGA7;ZDHHC15;ZDHHC19;GLUL;ZDHHC5;ZDHHC12
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.3057079646989686,0.7382794101493017,0.8044982698961938,0.9886635476382004,1.0,2/11,11.94%,TRPM2;ITPR3
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.2982032234236126,-0.7374627995276197,0.834841628959276,0.9757627582479304,1.0,5/10,30.47%,CDKN2C;CDKN2A;KAT2B;INCA1;CDKN2D
prerank,ribonuclease activity (GO:0004540),0.20804982364931918,0.735793830757832,0.9239940387481371,0.9892885105105077,1.0,9/56,12.60%,ANG;RPP40;RNASE1;ELAC2;RNASEL;CPSF3;RNASE7;EXOSC5;SND1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.2795251992169799,0.732568556962469,0.8375209380234506,0.9906658704808154,1.0,3/15,14.47%,ALDH9A1;ALDH1L1;ALDH4A1
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.2361084336265194,-0.7280173053190678,0.868421052631579,0.9837935912588772,1.0,7/21,21.23%,PJA2;PRKACA;WASF1;AKAP5;KCNQ1;GSKIP;AKAP9
prerank,snRNA binding (GO:0017069),0.2142284987425571,0.7273802625861862,0.9076175040518638,0.9941221212637366,1.0,14/42,25.49%,SNRNP70;MEPCE;HEXIM2;LSM8;SF3B3;DDX39B;GEMIN5;SNRPD3;EIF5A;LSM4;SNRPB2;SNU13;HEXIM1;COIL
prerank,cytochrome-c oxidase activity (GO:0004129),0.2746342273271087,0.7269339133456848,0.8507462686567164,0.9918914741729635,1.0,4/15,24.16%,NDUFA4;COX4I1;COX6B1;COX10
prerank,galactosyltransferase activity (GO:0008378),0.2982094798168076,0.7222110553466582,0.8589065255731922,0.994642845889704,1.0,3/11,18.91%,B3GNT6;A3GALT2;B4GALT2
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.3020162196580296,0.7214500662574506,0.8367346938775511,0.9927775244082246,1.0,3/10,20.09%,OTUD5;STAMBP;CYLD
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.29421376691560464,0.7189755753060187,0.8433098591549296,0.9929627961042178,1.0,3/12,15.69%,DAB2IP;ITGA5;CADM4
prerank,sulfuric ester hydrolase activity (GO:0008484),0.28796940253159464,0.7152559860990798,0.8245315161839863,0.9943713895921789,1.0,2/12,5.86%,ARSB;ARSG
prerank,cGMP binding (GO:0030553),0.29898259891808837,0.7143638396524904,0.8651079136690647,0.9926223135896828,1.0,3/11,24.98%,CNGB1;PDE11A;RAPGEF2
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.2551767520374977,0.7131126584386651,0.875605815831987,0.9913433122926466,1.0,3/18,12.76%,AKR1B1;ALDH9A1;ALDH6A1
prerank,acetylation-dependent protein binding (GO:0140033),-0.22994716840768276,-0.7124782149480656,0.8992042440318302,0.9941257257118303,1.0,3/20,5.88%,SMARCA4;TAF1;MLLT3
prerank,lysine-acetylated histone binding (GO:0070577),-0.22994716840768276,-0.7124782149480656,0.8992042440318302,0.9941257257118303,1.0,3/20,5.88%,SMARCA4;TAF1;MLLT3
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.26933611661910084,-0.7104993811185973,0.8574660633484162,0.9923580057255714,1.0,3/12,13.25%,NCBP1;AGO2;LARP1
prerank,lipid phosphatase activity (GO:0042577),-0.2583083941493346,-0.7101918212477295,0.8663484486873508,0.988811804302533,1.0,6/14,30.87%,PLPP7;SGPP1;INPP5K;PLPPR3;PLPP3;PLPPR5
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.24979149095660455,0.7091965944829419,0.8612903225806452,0.9901953431366083,1.0,2/21,1.65%,CDK7;CDK15
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.24979149095660455,0.7091965944829419,0.8612903225806452,0.9901953431366083,1.0,2/21,1.65%,CDK7;CDK15
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.2891718223102207,0.7070172102339238,0.8442028985507246,0.9898011178228794,1.0,2/12,13.45%,CNOT2;CNOT8
prerank,UDP-galactosyltransferase activity (GO:0035250),0.29231311165746965,0.7016513046300691,0.8450450450450451,0.9927487840673485,1.0,2/10,13.03%,B3GALT2;A3GALT2
prerank,NAD+ binding (GO:0070403),0.2765312363828482,0.698975335258472,0.8672268907563025,0.9927232010954794,1.0,3/12,18.17%,CRYL1;UXS1;HPGD
prerank,phosphatidic acid binding (GO:0070300),-0.23468300762497868,-0.6987675017263143,0.8940886699507389,0.9969405412435439,1.0,7/19,28.85%,SESTD1;PLTP;PACSIN2;GRAMD1B;ATP13A2;RAPGEF6;OPA1
prerank,sialyltransferase activity (GO:0008373),0.2465062534632802,0.6980654479067729,0.8717504332755632,0.9909337637822963,1.0,5/20,22.88%,ST3GAL5;ST6GALNAC2;ST3GAL6;ST3GAL3;ST6GALNAC4
prerank,serine-type peptidase activity (GO:0008236),0.18323118625214435,0.6976481947208754,0.9771197846567967,0.9886696474447871,1.0,23/96,26.68%,F3;PLAT;RHBDL3;PRSS56;GZMM;TMPRSS7;GZMK;ACR;PIK3IP1;KLK2;HPN;TYSND1;PCSK2;NAALAD2;APEH;RHBDD3;PCSK7;HTRA3;TPP1;CTSH;TMPRSS4;MASP2;RHBDL2
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.2770206147645091,0.6969237169686978,0.8606271777003485,0.9867330931259541,1.0,3/13,14.47%,ALDH9A1;ALDH1L1;ALDH4A1
prerank,protein phosphatase 2A binding (GO:0051721),-0.21832894529811406,-0.6877114506178033,0.9090909090909091,1.0,1.0,5/23,14.48%,ENSA;PTPA;BOD1;FOXO1;ARPP19
prerank,single-stranded DNA helicase activity (GO:0017116),0.24664489724024571,0.6857616975990177,0.8807631160572337,0.994711481712561,1.0,1/19,1.07%,MCM5
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.19039424867989085,0.6776197154095653,0.9532163742690059,0.9992689617966709,1.0,18/54,30.79%,PM20D1;HDAC5;ACY1;NTAQ1;AGA;ACR;HDAC3;ASPA;HDAC8;NIT1;GLS2;TGM2;NTAN1;NADSYN1;AMDHD2;HINT3;FAAH;ACER2
prerank,serine-type endopeptidase activity (GO:0004252),0.18159712283581542,0.6766621667858569,0.9754098360655737,0.9973742215004541,1.0,5/80,4.47%,F3;PLAT;RHBDL3;PRSS56;GZMM
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.18985725919152768,0.674086963401071,0.9672619047619048,0.9968762208710485,1.0,18/57,28.97%,NDUFA6;UQCRC1;NDUFA4;NDUFS1;UQCR11;NDUFA8;NDUFS6;CYB561A3;NDUFS2;NDUFB6;COX4I1;COX6B1;UQCR10;COX10;NDUFB5;NDUFV3;NDUFA9;NDUFA12
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.26201602690131354,-0.6706307162880195,0.8828633405639913,1.0,1.0,2/11,13.83%,SLC17A5;SLC5A3
prerank,phosphoric ester hydrolase activity (GO:0042578),0.19779140654235866,0.6705389807572414,0.9582712369597616,0.9972081675504841,1.0,19/49,31.66%,PLCXD1;PTPRO;SACM1L;PPP1CC;MPPED2;PPP5C;APEX1;PLCXD3;FRA10AC1;PPP1CA;DUSP28;ACP4;PLCXD2;ACP2;DUSP10;DUSP5;DUSP11;EPHX2;SMPD1
prerank,retinoid X receptor binding (GO:0046965),-0.26279943487401664,-0.6697607741099448,0.9121951219512195,1.0,1.0,9/11,40.85%,PPARG;TACC1;NRIP1;HMGA1;ARID5A;NCOA6;VDR;NR4A2;RARG
prerank,lipase activity (GO:0016298),0.19787495746194586,0.6630689745499955,0.9476831091180867,1.0,1.0,16/43,29.90%,PNPLA3;ABHD12;LYPLA1;ABHD5;LIPC;LDAH;ABHD2;PLA2G15;LIPE;PNPLA8;DAGLB;SMPD2;MGLL;CEL;LIPA;FAAH
prerank,endonuclease activity (GO:0004519),0.19344400910626644,0.6627479342245484,0.9678407350689127,0.9980510279881617,1.0,13/49,23.59%,ANG;OGG1;RNASEL;CPSF3;SND1;APEX1;FEN1;TSNAX;REXO4;APLF;INTS11;LACTB2;ERCC4
prerank,RNA stem-loop binding (GO:0035613),-0.2560670492751068,-0.6617732549047949,0.9140271493212669,1.0,1.0,6/12,25.58%,LARP6;ZC3H12A;RC3H1;RC3H2;CPEB3;CSDE1
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.236520571340191,-0.660950676931952,0.9206730769230769,1.0,1.0,1/14,1.02%,SLC26A11
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.2319644525903973,0.6603773189724045,0.9059561128526645,0.99717429761055,1.0,3/21,18.57%,GRIA1;CHRNA7;CHRFAM7A
prerank,telomeric DNA binding (GO:0042162),-0.19018908929607398,-0.659988794968903,0.9616438356164384,1.0,1.0,11/32,26.28%,UPF3A;RPA1;HNRNPA2B1;TERF2;UPF2;HNRNPD;SMG6;TINF2;PIF1;TERT;PURA
prerank,neuropeptide hormone activity (GO:0005184),0.22307782922346264,0.6533996670396609,0.9472,0.9997573643231252,1.0,5/22,23.39%,PPY;ADCYAP1;GAL;GRP;CCK
prerank,peptide hormone receptor binding (GO:0051428),0.26997746142526313,0.6511185833475333,0.8978102189781022,0.9986638522951021,1.0,3/11,25.25%,ADCYAP1;CCK;PSMC5
prerank,ribonuclease P RNA binding (GO:0033204),0.2742427674476242,0.6507989039545599,0.8914858096828047,0.9962683172970481,1.0,2/10,13.32%,RPP40;RPP30
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.22484566931210997,0.6472764036108897,0.9328125,0.9960745356927687,1.0,2/21,7.73%,GLRB;GRIK2
prerank,retinoic acid binding (GO:0001972),0.2602483997909236,0.6465309411048068,0.9,0.9940077370553279,1.0,1/12,3.97%,CYP26C1
prerank,transcription corepressor binding (GO:0001222),0.21065293158387832,0.6433011870635347,0.9494290375203915,0.9936327119657243,1.0,3/27,6.44%,CNOT2;CTBP1;USP11
prerank,mRNA methyltransferase activity (GO:0008174),-0.24362249380088274,-0.637449757252489,0.9261744966442953,1.0,1.0,3/12,12.34%,TRMT10C;METTL8;NSUN2
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.2523011537670894,-0.6265418781173473,0.9166666666666666,1.0,1.0,3/10,22.05%,SETDB2;EHMT1;MECOM
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.2559846095437974,0.6264393020441443,0.9177101967799642,1.0,1.0,3/11,19.58%,SLC19A1;SLC25A23;SLC35B2
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.21765633020604497,-0.6255961589489772,0.9537712895377128,1.0,1.0,2/17,7.24%,ACOT8;ACAA2
prerank,LRR domain binding (GO:0030275),0.23740450418197404,0.622000202983911,0.9320066334991708,1.0,1.0,6/14,30.57%,NRL;PAWR;MRTFA;ATF4;ROBO1;DDIT3
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.2490145332756389,0.621823958834463,0.9372822299651568,0.9987797671300599,1.0,3/13,13.69%,SLC38A7;SLC66A1;SLC3A1
prerank,MHC protein binding (GO:0042287),-0.19837958207349554,-0.6209290911265806,0.9605911330049262,1.0,1.0,9/20,31.92%,CD74;TAPBP;LILRB1;PILRA;TUBB4B;KIR3DL2;CD8B;CD4;CD8A
prerank,acid-thiol ligase activity (GO:0016878),-0.23336742109566955,-0.6174320340911897,0.9418604651162791,1.0,1.0,1/13,1.93%,ACSS2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.18611699475207222,-0.6166597888048269,0.9831932773109243,1.0,1.0,6/28,17.01%,PRKACA;MAPKAPK3;RPS6KA2;LRRK2;MAP2K4;MAP2K7
prerank,receptor antagonist activity (GO:0048019),0.2290675763611504,0.6111798349612952,0.9418803418803419,1.0,1.0,3/17,19.40%,PXDN;IL18BP;CCL5
prerank,CoA hydrolase activity (GO:0016289),-0.21486259157477341,-0.6100247002617551,0.9718969555035128,1.0,1.0,2/16,7.24%,ACOT8;ACAA2
prerank,protein tyrosine kinase activator activity (GO:0030296),0.2182051603618806,0.6064630662144331,0.9599332220367279,1.0,1.0,5/19,19.40%,DGKQ;NRG3;ERCC6;GHRL;CCL5
prerank,potassium:proton antiporter activity (GO:0015386),0.25747925131081423,0.6060746228380797,0.9469026548672567,0.9992905833702806,1.0,3/10,22.22%,SLC9A4;SLC9A5;SLC9A1
prerank,pentosyltransferase activity (GO:0016763),-0.17055530093658577,-0.6030255468432129,0.9775280898876404,1.0,1.0,2/36,1.39%,PARP4;PARP14
prerank,adenyl nucleotide binding (GO:0030554),-0.23880508346354323,-0.6025522174591836,0.9433497536945813,1.0,1.0,1/11,5.43%,BAG4
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.23880508346354323,-0.6025522174591836,0.9433497536945813,1.0,1.0,1/11,5.43%,BAG4
prerank,phospholipid transfer activity (GO:0120014),-0.1941409321537493,-0.6004507251586771,0.9778869778869779,1.0,1.0,3/21,9.27%,PLEKHA3;PLTP;OSBPL2
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.20647858679715742,0.5952388704448919,0.9693053311793215,1.0,1.0,3/21,13.00%,POLG;POLD3;POLM
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.20488498451605214,0.5915342594955906,0.9669421487603306,1.0,1.0,4/20,17.98%,SLC39A4;SLC39A8;SLC30A3;SLC39A3
prerank,kinesin binding (GO:0019894),-0.1775826311291672,-0.591117895326094,0.9844155844155844,1.0,1.0,4/27,17.81%,PRC1;TOR1B;MAPK8IP3;KIF18B
prerank,neuropeptide receptor activity (GO:0008188),0.19384788196799116,0.589590634935204,0.9779874213836478,0.9988627141460366,1.0,4/29,17.12%,NMUR1;SORCS1;GAL;OPRM1
prerank,transferrin receptor binding (GO:1990459),0.24720236497942527,0.5884996816506798,0.9392361111111112,0.9967288752958909,1.0,4/10,29.64%,CD81;RGMA;HFE;CHUK
prerank,phospholipase activator activity (GO:0016004),-0.2418426484795334,-0.5834129737904126,0.9585365853658536,1.0,1.0,2/10,10.56%,FYN;LCK
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.2291203436791358,-0.5823010264288067,0.952054794520548,0.9996107975494085,1.0,6/11,40.79%,PADI4;DDAH1;ARG1;AGMAT;PADI1;PADI2
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.15761594453739314,-0.5793505612863945,0.9972677595628415,0.9970307794592825,1.0,14/38,35.70%,SERPINC1;SERPIND1;SERPING1;APP;SERPINF2;SERPINB2;SPINK5;SLPI;SERPINB9;TFPI2;SERPINB5;HRG;SERPINA10;WFDC3
prerank,MAP kinase phosphatase activity (GO:0033549),-0.2194085207085167,-0.5767275922931884,0.9674418604651163,0.9944132096623275,1.0,8/12,37.79%,DUSP16;DUSP1;DUSP7;DUSP3;DUSP4;DUSP8;DUSP9;DUSP6
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.21331854355591906,-0.5694017664071671,0.9761904761904762,0.9932668141234818,1.0,4/13,37.20%,IDI1;HSD3B2;EBP;DDT
prerank,neurexin family protein binding (GO:0042043),0.2462901321567366,0.5693519896147193,0.948892674616695,1.0,1.0,1/10,3.44%,SYTL4
prerank,DNA polymerase activity (GO:0034061),0.1960093017454454,0.5691956410832899,0.9788961038961039,0.998399210963953,1.0,2/22,5.12%,POLG;POLD3
prerank,histone deacetylase activity (GO:0004407),-0.1874221055853496,-0.5681271449152892,0.980722891566265,0.9901813662796616,1.0,7/19,32.61%,HDAC2;HDAC1;SIRT2;HDAC4;MIER1;HDAC11;HDAC6
prerank,MAP kinase activity (GO:0004707),0.22028901308361293,0.5661163382200698,0.955810147299509,0.9969008764348886,1.0,3/14,15.93%,MAPK15;MAPK10;MAPK3
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.22687833150418238,0.565622843941899,0.9659863945578231,0.9945233920082347,1.0,5/12,29.04%,PHF8;KDM4A;PHF2;KDM4D;KDM3A
prerank,lipase activator activity (GO:0060229),-0.22910565944402028,-0.5654936543690118,0.955607476635514,0.9875246748032814,1.0,2/10,10.56%,FYN;LCK
prerank,ferrous iron binding (GO:0008198),-0.17963695747754535,-0.5455496790251539,0.9808219178082191,0.9892182739886651,1.0,21/21,82.07%,TET2;FTL;HEPH;PHYH;EGLN1;ALKBH2;FECH;SNCA;EGLN3;EGLN2;FXN;CDO1;ACP5;FTH1;DNAJC24;ALKBH1;HAAO;FTO;ALKBH3;HIF1AN;ISCU
prerank,nucleoside-diphosphatase activity (GO:0017110),0.2213939595735648,0.5449958821172954,0.9619377162629758,0.997833555726745,1.0,7/12,35.40%,ENTPD6;CANT1;ENTPD1;ENTPD2;ENTPD3;ENTPD7;NUDT18
prerank,pyridoxal phosphate binding (GO:0030170),0.18779047858309236,0.5377393811775215,0.9783333333333334,0.9970239922794604,1.0,20/20,81.24%,PYGM;AGXT;ABAT;SRR;PSAT1;PYGL;ACCS;PYGB;SHMT1;ALB;PNPO;PLPBP;OAT;PDXK;SHMT2;SDS;GLDC;CTH;THNSL2;CBS
prerank,alanine transmembrane transporter activity (GO:0022858),0.21432478006419545,0.5314846997604403,0.9809688581314879,0.9959320381611901,1.0,2/12,11.69%,SLC38A7;SLC1A4
prerank,myosin II binding (GO:0045159),0.2194785491896441,0.518546299820532,0.9813780260707635,0.9958915617666795,1.0,5/10,27.72%,STXBP5;LLGL2;SHROOM1;LLGL1;STXBP5L
prerank,Wnt-activated receptor activity (GO:0042813),0.19244929929776372,0.5178380680022553,0.9834437086092715,0.9935620886902292,1.0,5/15,29.76%,RYK;PKD1;ROR1;FZD5;LRP5
prerank,thioesterase binding (GO:0031996),0.20370410918001036,0.49519674261915003,0.9910873440285205,0.9943255289294852,1.0,1/11,6.94%,ADRA2A
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.15950940024996,-0.4432066798854834,0.9949238578680203,0.9986265676748968,1.0,6/14,37.54%,USP9X;MINDY3;USP15;YOD1;USP27X;ATXN3
